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CHAPTER 1 
INTRODUCTION 
1.1 Background of study 
Parasites are defined as any organism that derive key components for survival 
by inhabiting hosts like animals, plants or humans (Northrop-Clewes & Shaw, 2000; 
CDC, 2010). Parasites can be harmful to the host since they extract nutrients by 
infecting cells, organs as well multiplying within the host’s tissues to continue living 
and hence limiting the growth rate of the host (Northrop-Clewes & Shaw, 2000). 
Some examples of parasites include Ascaris lumbriocoides, Trichuris trichiura, 
Sparganum mansoni, Fasciola hepatica, Diphyllobothrium latum, and others that 
can potentially infect most of the living things (Northrop-Clewes & Shaw, 2000). 
In humans, parasitic infections can be considered dangerous as they are known 
to cause mild to serious illness which at times can lead to fatality (Northrop-Clewes 
& Shaw, 2000; WHO, 2005). Continuous threats to human health due to emerging 
or re-emerging parasitic infections are not only reported among rural populations 
but also in urban populations where millions of people are killed annually 
(Northrop-Clewes & Shaw, 2000; WHO, 2005). Three main classes of parasites that 
are capable of triggering diseases in humans are protozoa (i.e. Sarcodina, 
Mastigophora, Ciliphora and Sporozoa) helminthes (i.e. flatworms, thorny-headed 
worms and roundworms) and ectoparasites (i.e. arthropods) (CDC, 2010). Examples 
of parasitic diseases, the damage caused to humans and their causative agents that 
are considered harmful are summarized in Table 1.1 (WHO, 2005; Malla & Goyal, 
2012). 
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Table 1.1: Lists of parasitic diseases and their descriptions 
 
Parasitic diseases Descriptions 
Amoebiasis Disruption of the intestinal wall leading to ulcerating 
mucosal lesions by the protozoan parasite Entemoeba 
histolytica. 
Hookworm disease Causes anaemia and protein malnutrition due to infection by 
soil-transmitted helminth such as Necator americanus and 
Ancylostoma duodenale. 
Leishmaniasis Infection by several species of flagellated protozoan 
parasites known as Leishmania spp. causing serious 
disfigurement as well as death. 
Malaria Disease is caused by four species of the protozoan parasite 
Plasmodium leaving the infected patients with acute renal 
failure, cerebral malaria, pulmonary oedema and death to 
some extent.  
Schistosomiasis Also known as bilharziasis that is associated with bladder 
cancer or renal failure by Schistosoma haematobium and 
liver fibrosis and portal hypertension by S. mansoni. 
Trichomoniasis Sexually transmitted disease caused by the protozoa 
Trichomonas vaginalis 
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Sexually transmitted diseases (STDs) as defined by Malla and Goyal (2012) 
are diseases attacking human as a result of sexual contacts and are transmitted 
through infections by pathogens such as bacteria, fungi, viruses, parasites and 
ectoparasites. Among these Sexually Transmitted Infections (STIs), parasitic 
infections are progressively gaining attention due to the significant health 
implications it has on humans (Malla & Goyal, 2012). Based on the listed parasitic 
diseases in human (Table 1.1), trichomoniasis or also known as “trich” caused by T. 
vaginalis is reported as a highly-rated non-viral sexually transmitted disease (Malla, 
2012). It primarily infects the genitourinary tracts of humans (Harp & Chowdhury, 
2011; Malla, 2012). Being a widely prevalent and curable STI, human 
trichomoniasis has gained worldwide importance due to the significant illness and 
considerable economic and emotional burden that it leaves on the community (Malla 
et al., 2001). WHO has approximated the occurrence of trichomoniasis at a rate 
more than 170 million cases yearly accounting for almost half of all curable STIs 
globally (Schwebke, 2002; Malla, 2012) with United States  reporting about eight 
million cases per year  (Van Der Pol, 2007). Being the etiologic agent of this 
extremely common cosmopolitan infection in both genders, T. vaginalis is known as 
one of the widely studied parasitic protozoa worldwide (Petrin et al., 1998; Garber, 
2005).  
T. vaginalis is a flagellated parasite from the order Trichomonad and genus 
Trichomonas that potentially inhabits the genitourinary tract of the host (Schwebke 
& Burgess, 2004). Trichomonads form a large family of protozoan  species with 
wide range of host habitat varying from humans, other primates, cattle and avians 
(Wang, 2000). However, only three species from the genus Trichomonas infects 
humans; Trichomonas tenax isolated from oral cavity, Pentatrichomonas hominis 
found in intestinal tract and T. vaginalis from the urogenital tract (Wang, 2000; 
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Schwebke & Burgess, 2004). Among these three species, only T. vaginalis is 
pathogenic and causes disease, trichomoniasis due to their unique biological and 
morphological properties (Petrin et al., 1998;Wang, 2000; Schwebke & Burgess, 
2004). T. vaginalis was first identified and named by a French parasitologist known 
as Donné in 1936 (Thorburn, 1974) and was found to be transmitted through bodily 
contact (Lewis, 2005, 2010).  
T. vaginalis is investigated as important human parasites as it can cause a 
range of infections in both males and females with predominance in latter 
(Valadkhani et al., 2008). Examples of infections includes urethritis (Krieger et al., 
1993), vulvo-vaginitis, cervicitis (Sehgal et al., 2012), prostatitis, atypical pelvic 
inflammatory disease and infertility (Valadkhani et al., 2008; Noël et al., 2010). 
Many studies have been triggered due to: 
a. increase prevalence of T. vaginalis infection globally (Wang, 2000). 
b. the parasite being  highly contagious (Wang, 2000) 
c. the parasite having asymptomatic characteristics identified in some of the 
infected patients especially in males (Johnston & Mabey, 2008). 
d. the association  of trichomoniasis with other sexually transmitted diseases 
such as gonorrhea, cervical cancer and Human Immunodeficiency Virus 
(HIV) (Johnston & Mabey, 2008; Smith & Ramos, 2012). 
All these factors form the basis for many research studies to be mounted  on the 
possible mechanisms involved  in phenotypic, genotypic, biochemical and 
biological aspects of T. vaginalis (Noël et al., 2010; Afzan, 2011a; Sehgal et al., 
2012). 
This parasite appears in a few forms  i.e. trophozoites (Petrin et al., 1998) and 
pseudocyst (Pereira-Neves et al., 2003). These are the two notable forms that are 
predominantly well studied by many researchers. However, in recent years, another 
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morphological form of T. vaginalis known as the amoeboid form has been studied 
quite extensively. These forms exhibit properties related to adherence which 
contributes to the pathogenicity of the parasite (Arroyo et al., 1993; Gonzàles-
Robles et al., 1995; Pereira-Neves & Benchimol, 2007). 
Since the amoeboid forms are seen and that too when the parasites adhere to 
certain types of cells such as epithelial or  vaginal cells and  sometimes on the cover 
slips (Fiori et al., 1999), little attention was given to these forms of the parasite. 
Afzan & Suresh (2012a) reported that the amoeboid forms were observed on day 
three of the parasite culture isolated from cervical neoplasia patients. However, little 
is known on the factors that trigger amoeboid form to appear in cultures of T. 
vaginalis as well the transitional changes during this transformation.  
1.2 Research Questions 
The current study attempts to answer the following research questions: 
i. Can the present study repeat the findings of Afzan and Suresh (2012a) on 
the formation of amoeboid forms of T. vaginalis on day 3 culture of 
cervical neoplasia patients even after prolonged maintenance in in vitro 
cultures? 
ii. Do different types of stress conditions in the suspension culture trigger 
the formation of amoeboid forms of T. vaginalis? 
iii. If amoeboid forms are observed, then what are the morphological 
properties of such forms as well as what are the transformational changes 
that take place to differentiate the normal flagellated trophozoites and 
amoeboid of T. vaginalis? 
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1.3 Justification of the study 
Trichomoniasis is a urogenital disease affecting humans with higher 
prevalence among women than men. The urethra is the common site of infections in 
men while the vagina is the common site of infection in women (Lewis, 2010). 
Since trichomoniasis is often associated with the progression of other sexually 
transmitted infections, the present study was undertaken based on the findings by 
Yusof and Kumar (2012) who studied on parasite isolated from symptomatic 
women diagnosed with cervical intraepithelial neoplasia (CN) and non-cervical 
intraepithelial neoplasia (NCN). 
Morphological characteristics of the parasite are mostly used to differentiate 
the pathogenic causing forms resulting from acute to severe complication in patients 
(Rasmussen et al., 1986; Ryan et al., 2011; Malla, 2012; Sehgal et al., 2012). The 
flagellated trophozoite is the most common form of T. vaginalis which has been 
well-studied by many investigators (Petrin et al., 1998; Ryu & Min, 2006; Harp & 
Chowdhury, 2011; Yusof & Kumar, 2012). The other form of the parasite which is 
the pseudocyst has recently gained wide attention following the findings by Pereira-
Neves and team (2003) implicating the possible association of this form with 
pathogenicity of T. vaginalis. Abnormal shapes of T. vaginalis, precisely the 
amoeboid form has been long identified and was known to appear upon attachment 
with vaginal cells (Fiori et al., 1999; Tasca & De Carli, 2002). These forms have 
been continuously studied for their cytoadherence (Arroyo et al., 1993), 
cytopathogenicity (Fiori et al., 1999) and cytotoxic (Brugerolle et al., 1996) 
mechanisms contributing to increased risk of inflammation in women.  
In 2002, Tasca and De Carli suggested to study the significance of shape 
variations in T. vaginalis as well as the influence of culture medium components on 
the parasite development. This was supported by the recent findings of Afzan and 
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Suresh (2012a) on identifying amoeboid forms in suspension culture, triggering 
questions on the possible factors that sustain the formation of this shape under 
natural conditions. However, apart from these studies, there have been no detailed 
investigation on the phenotypic characteristics and the factors that trigger amoeboid 
form of T. vaginalis in suspension culture isolated from cervical neoplasia patients 
under normal and unfavourable conditions. 
Therefore, the present study was conducted to study the phenotypic 
characteristics of amoeboid forms of T. vaginalis from symptomatic cervical 
intraepithelial neoplasia and non-cervical intraepithelial neoplasia patients. It 
focused on the aspects that contribute to the appearance of amoeboid morphology by 
varying the culture conditions such as analyzing the effect of different 
concentrations of horse serum, effect of different parasite inoculum sizes and 
different concentrations of metronidazole. Further detection and characterization of 
the amoeboid forms were performed using staining method to elucidate the 
transformational changes from trophozhoites to amoeboid forms under light 
microscopy.  
1.4  Objectives of study 
a. To identify the phenotypic characteristics of amoeboid forms of T. vaginalis 
isolated from cervical intraepithelial neoplasia and non-cervical intraepithelial 
patients by means of; 
i. Generating the growth profile of amoeboid forms. 
ii. Generating the growth profile of trophozoites and correlating the 
numbers of trophozoite forms to the appearance of amoeboid forms. 
iii. Morphological analysis of the amoeboid forms using Giemsa and 
Modified Field’s Stain. 
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b. To elucidate the factors contributing to the formation of amoeboid forms by 
evaluating; 
i. Effect of different inoculum sizes on the formation of amoeboid 
morphology. 
ii. Effect of different concentration of horse serum on the formation of 
amoeboid morphology. 
iii. Effect of metronidazole drug on the formation of amoeboid forms. 
c. To observe and compare the transformational changes of trophozoites to 
amoeboid forms in stressed and normal cultures using light microscopy. 
1.5 Research approach 
Few approaches were undertaken in the attempt to meet the objectives of the 
present study encompassing four main stages as presented below: 
 
 
 
 
 
 
 
 
 
 
Stage 1 
 Screening of nine isolates of T. vaginalis obtained from Department of 
Parasitology, Faculty of Medicine, UM: 
 a. Three NCN isolates - NCN2, NCN3 NCN4 
       b. Six CN isolates    - CN1, CN2, CN3, CN4, CN5, CN6                                            
 
Stage 2 
 Preparation of culture medium for cultivation of T. vaginalis isolates 
 In vitro maintenance of stock cultures 
 Perform cell count to access the viability of isolates 
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Stage 3 
 Phenotypic characterization of amoeboid form of T. vaginalis based on: 
a. Generation of growth profiles of amoeboid forms 
b. Generation of growth profiles of trophozoites forms. 
c. Detection and morphological analysis using staining methods. 
d. Analyzing the effect of varying culturing parameters on the                
formation of amoeboid forms: - inoculums size, concentrations of 
horse serum and concentrations of metronidazole drug 
 
Stage 4 
 Further characterization of amoeboid form by observing the 
transformational  changes  from trophozoites to amoeboid under light 
microscopy 
 
Stage 5 
 Data analysis using SPSS to obtain data significance 
 Discussion and answers to the research questions 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Overview of T. vaginalis 
 T. vaginalis is a single-celled, flagellated protozoan parasite that was first 
identified and named by a French parasitologist, Alfred Francois Donné in 1836 
(Thorburn, 1974; Garber, 2005). Donné observed T. vaginalis as a motile 
microorganism isolated from frothy leucorrhea of women with vaginal discharge and 
genital irritation (Sood & Kapil, 2008). It is a microaerotolerant protist (Johnson et al., 
1993; Guschina et al., 2009; Sehgal et al., 2012) that requires human or animal host for 
survival and adaptation (Strous, 2008). As a primitive eukaryote, it lacks mitochondria 
and uses hydrogenosomes to accomplish fermentative carbohydrate metabolism (Sood 
& Kapil, 2008) under aerobic and anaerobic conditions(Petrin et al., 1998). 
 T. vaginalis is derived from the family Trichomonads; a large family of 
protozoan species that inhabits a variety of hosts ranging from humans and other 
primates to cattle and avians (Wang, 2000). Being among the three genuses of 
Trichomonas that infects human, T. vaginalis is the primary causative agent of the 
world’s most common non-viral sexually transmitted disease known as trichomoniasis 
with an annual rate of more than 170 million cases globally (Garber, 2005; Gehrig & 
Efferth, 2009). Potentially, T. vaginalis infects the urogenital tracts in both men and 
women with a high dominance in the latter (Garber, 2005).   
 Although curable, infected patients can be asymptomatic for the infection, thus 
increasing the risk of being untreated (Petrin et al., 1998). Presence of trichomoniasis in 
asymptomatic patients has been investigated by Valadkhani and team (2008). They 
concluded that asymptomatic patients are healthy carriers of T. vaginalis and are often 
associated with other STDs. Predispositions to other sexual infections such as cervical 
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inflammation (Shafir et al., 2009) which may progress into cervical cancer (Zhang et al., 
1995; Viikki et al., 2000; Pustan et al., 2010) if untreated, transmission of HIV (Moore, 
2007; Van Der Pol, 2007; Shafir et al., 2009) pelvic inflammatory disease (Petrin et al., 
1998) or infertility are other important characteristics of T. vaginalis that makes it an 
important parasite to be explored. Progress and challenges in the study of T. vaginalis 
has also been outlined in terms of infections in women infected with HIV, diagnosis and 
recurrent treatments with potential drugs (Bachmann et al., 2011). 
 Principal investigations on this parasite involved mainly biochemical tests and 
microscopic examinations to understand the growth profiles and behavior of the 
organisms (Sood & Kapil, 2008). Trussell and Johnson (1944) summarized few 
previous experimental studies relative to the parasite morphology, cultivation methods, 
biological properties, chemotherapy, epidemiology, pathogenicity and serology. In 
addition, Ovcinnikov et al. (1975) undertook an extensive study on T. vaginalis to 
identify the morphology, feeding mode mechanism, metabolism, life cycle and as well 
as host-parasite relationship using electron microscopy. 
 However, the growing infections of T. vaginalis has attracted many investigators 
to conduct extensive review and research ranging from morphological analysis up to 
immunological and molecular analysis to study the pathogenesis and clinical 
manifestations of this organism (Sood & Kapil, 2008). Klassen-Fischer and Ali (2011) 
have discussed trichomoniasis based on morphological description, clinical features, 
pathogenesis, diagnosis and treatments enhancing the understanding about this STD. 
Likewise, Petrin and members (1998) have given a general overview on the clinical and 
microbiological aspects of T. vaginalis through the compilation of studies from previous 
scientists.  
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2.2 Taxonomy classification   
The scientific name of this parasitic protozoan is Trichomonas vaginalis and the 
diseases are known as “trich”, “vaginitis” and “ureitis” (Strous, 2008). The complex 
structure and the large size of T. vaginalis have placed it under the most primitive 
eukaryotic domain of Eukarya (Strous, 2008) and Kingdom Protista. This is further 
supported by molecular phylogenetic studies using large and small ribosomal subunits 
by earlier studies (Pereira-Neves et al., 2003) indicating that these organisms might be 
among the earliest diverging eukaryotes (Pereira-Neves et al.,2003).  
Lower taxonomical classifications of T. vaginalis were reported from a different 
perspective in some studies that run parallel to recent updates on the genetic and 
phenotypic composition of this parasite. Being the most diverse parasitic protist of the 
human urogenital tracts with presence of flagella, it is stated to belong to the Phylum 
Zoomastiginia by Schwebke & Burgess (2004). Conversely, few other studies mention 
that T. vaginalis is well fitted into the Phylum Sarcomastigophora (Amany Mohammed, 
2000; Ramos, 2005) and subphylum Zoomastigosphora or Mastigophora (Ramos, 2005; 
Amany, 2000) since the members of this level contains non-photosynthetic flagellates 
from both free-living and parasitic organisms (Ramos, 2005).  
Presence of parabasal body such as Golgi associated kinetostomes, bundled 
microtubules and undulating membrane placed T. vaginalis under the Class Parabasalia 
(Schwebke & Burgess, 2004; Pereira-Never et al., 2003). However, review by Ramos 
(2005) categorized T. vaginalis under the Class Zoomastigophorea based on 
characteristics such as simple, flagellated and feeding mode by phagosytosis (Lackey, 
n.d.). 
Almost most of the scientists agreed on the ranking of T. vaginalis into the 
Order Trichomonadida, and Family Trichomonadidae (Ramos, 2005; Schwebke and 
Burgess, 2004; Amany, 2000). Members of these groups consist of protozoans generally 
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with three to five anteriorly directed flagella and one attached to undulating membrane 
supported by the costa with no true cysts such as T. vaginalis (Amany Mohammed, 
2000; Ackers, 2001; Schwebke & Burgess, 2004). 
The classification of this species is  continuously updated based on recent 
genetic findings (Goodman et al., 2011). Initially, this parasite was known to have 
originated from the genus Trichomonas by the founder of vaginale, Donné (1836) 
(Jamali et al., 2006). The name Trichomonas vaginalis was then based on the source of 
parasite from genital secretions of humans (Thorburn, 1974). However, recent findings 
highlighted that some strains of T. vaginalis might be from the genus Trichomonasvirus 
and family Totiviridae due to the presence of non-segmented double-stranded RNA 
(dsRNA) viruses in those strains.  
2.3  General morphology of T. vaginalis 
 Discovery of T. vaginalis from the genital discharge of human by Alfred Donné 
in 1836 (Thorburn, 1974) became the platform for many scientists to initiate and 
develop boundless study on this human protozoa beginning with the elucidation of 
morphology followed by other in depth studies on this parasite. The first morphological 
identification of T. vaginalis as flagellated protozoan was described by Donné (1836) 
based on wet mount study (as cited in Jamali et al., 2006; Trussell & Johnson, 1944). 
When Trussell performed axenic cultivation in 1940 (Clark & Diamond, 2002), pure 
cultures of T. vaginalis were obtained easily.  
Preliminary structural description of T. vaginalis was provided by Donné in 
1837 (Afzan, 2011a) as illustrated in Figure 2.1. The parasite is known to have an 
axostyle, chromatic basal and granules, cytosomal fiber, karyosome, nucleus and an 
undulating membrane with four external flagella (Afzan, 2011a). This primary 
morphological description of T. vaginalis initiated for a more detailed structural study 
of the parasite by subsequent scientists along with the advancement in technology such 
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as by using scanning electron microscopy, transmission electron microscopy or through 
fluorescent staining. As an example, Costamagna and Figueroa (2001) performed an 
ultrastructure study on T. vaginalis isolated from adult women and grown in liquid 
medium to define the morphology of its cytoskeleton, hydrogenosomes and endocytosis 
phenomena. 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: First morphological illustration of T. vaginalis by Donné (1837) 
Note: a = axostyle; b = blepharoplastic granules; cb = chromatic basal; cf = cytosomal 
fiber; cg = chromatic granule; k = karyosome; n = nucleus; u = undulating membrane 
(Adapted from Afzan, 2011a). 
 
T. vaginalis is typically described as free-swimming and actively motile parasite 
conforming to ellipsoidal, ovoidal or rounded shapes when observed under light 
microscopy (Petrin et al., 1998; Liang & Huang, 2009). In the absence of cell debris 
(Amany, 2006), T. vaginalis conforms to a more uniform, actively swimming pyriform 
or rounded shape (Honigberg & King, 1964; Ackers, 2001) with four anterior flagella at 
the arrangement of [9(2) + 2) and one attached to the undulating membrane (Schwebke 
& Burgess, 2004; Wang, 2000). Generally, T. vaginalis is quite robust in appearance 
and measures with an approximate length and width of 7-32 μm and 5-12 μm 
respectively (Costamagna & Figueroa, 2001; Klassen-Fischer & Ali, 2011; Afzan, 
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2011a). Internal organelles of T. vaginalis includes nucleus, axostyle and 
hydrogenosomes (Schwebke & Burgess, 2004), each with unique and significant 
functions in order to maintain the viability of the parasite. On the contrary, under 
unfavourable culture conditions (Petrin et al., 1998) or in the presence of site for 
attachment such as epithelial cells (Fiori et al., 1999), T. vaginalis appears abnormally 
different in shapes.   
T. vaginalis is known to be well-accustomed to the changing vaginal 
environment (Bhatt et al., 1996) and thus can be highly pleiomorphic (Jesus et al., 2004) 
with great variation in shapes and sizes depending on the in vitro or in vivo physical and 
physiochemical conditions (Smith, 2012; Jesus et al., 2004; Tasca & De Carli, 2002; 
Petrin et al., 1998). The capability to adapt and survive in changing environmental 
conditions either in vivo or in vitro (Jesus et al., 2004) has demonstrated T. vaginalis to 
have various morphologies to date which includes trophozoites as a more uniform shape 
when swimming freely (Trussell & Johnson, 1944; Petrin et al., 1998; Ryu & Min, 
2006), pseudocyst with a internalized flagella (Pereira-Neves et al., 2003; Afzan & 
Suresh, 2012b) and irregular amoeboid form upon contact with vaginal cells (Tasca & 
De Carli, 2002). 
In a study by Ryu and Min (2006) on T. vaginalis in Republic of Korea, 
trophozoite forms isolated from women with vaginal trichomoniasis was clearly defined 
based on structural appearances such as size, shape and internal organelles using 
electron microscopy.  Recently, Yusof and Kumar (2012) characterized trophozoite as 
phenotypic variant forms of T. vaginalis and compared the forms among cervical 
neoplasia isolates and non-cervical neoplasia isolates using electron microscopy and 
cytochemical staining methods. Meanwhile another notable form known as pseudocyst 
was reported by Pereira-Neves et al. (2003) and Afzan and Suresh (2012b) presenting 
contradictory data to previous study (Petrin et al., 1998) that reported formation of 
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pseudocysts under degenerative and unfavourable conditions. Significantly, another 
form of T. vaginalis known as amoeboid forms were also identified as an integral shape 
of the parasite and has been reported by few authors (John & Squires, 1978a; Arroyo et 
al., 1993; Jesus et al., 2004) based on their morphological appearance, pathogenicity 
and adherence mechanism. 
Studies have also suggested that virulence of T. vaginalis strains may play a role 
in the different morphologies of the parasite (Tasca & De Carli, 2002; Jesus et al., 2004; 
Adegbaju & Morenikeji, 2008). Apart from trophozoite, the other morphological forms 
that appear without flagella were assumed as part of developmental process of the 
parasite instead of being different stages in the life cycle of T. vaginalis (Malla et al., 
2001).  
2.3.1 Trophozoite form 
Trophozoites form is the initial and dominant shape identified in developing 
stages of T. vaginalis that has been structurally studied in detail using scanning electron 
microscopy and transmission electron microscopy by many investigators. Trophozoite 
of T. vaginalis was observed as free-swimming (Afzan, 2011a; Honigberg & King, 
1964), ovoid or pyriform in shape (Klassen-Fischer & Ali, 2011; Costamagna & 
Figueroa, 2001) with approximate length and width ranging within 7-30 µm and 5-15 
µm respectively (Ryu &Min, 2006; Costamagna & Figueroa, 2001). The overall 
structural appearance of T. vaginalis trophozoite is illustrated in Figure 2.2. 
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Figure 2.2: Trophozoite form of T. vaginalis. (Adapted from Strous, 2008). 
 
The trophozoite consists of five flagella contributing to its motility; four at the 
anterior portion and one incorporated within the undulating membrane at the posterior 
portion of the parasite (Petrin et al., 1998; Ryu & Min, 2006; Liang & Huang, 2009). 
An axostyle, a rigid structure located in the center of the tropozhoite holds part of the 
barbwire-like posterior flagellum (Strous, 2008; Smith, 2012). The axostyle is a slender 
hyaline, rod-like structure known to divide the protozoa longitudinally and protrudes 
through the posterior end to form a sharp point (Petrin et al., 1998; Adegbaju & 
Morenikeji, 2008) enabling the parasite to attach to vaginal epithelial cells (Petrin et al., 
1998).   
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A large single and round nucleus surrounded by porous nuclear envelope is 
positioned at the anterior part (Adegbaju & Morenikeji, 2008) of T. vaginalis along with 
prominent Golgi complex known as parabasal body attached by fibrils to the kinestome 
of the flagella (Klassen-Fischer & Ali, 2011; Petrin et al., 1998). The parasite is evenly 
distributed with nuclear chromatin and hydrogenosomes are found evidently along the 
axostyle and costa which supports the undulating membrane (Petrin et al., 1998; Ryu & 
Min, 2006; Adegbaju & Morenikeji, 2008). The hydrogenosomes are formerly known 
as siderophil granules and serve as mitochondria since trophozoite of T. vaginalis does 
not possess the latter in the cytoplasm (Ryu & Min, 2006; Petrin et al., 1998). Named 
after the ability to produce molecular hydrogen as end product of metabolism, 
hydrogenosomes plays an important role in energy production and drug activation to 
support the metabolic activity of T. vaginalis (Ryu & Min, 2006). Morphological 
description of trophozoite form of T. vaginalis has begun in late 1930s by Powell 
following the identification of the parasite by Donné in 1836. This was then further 
discussed by Trussell and Johnson (1944) in their review on experimental studies based 
on morphology, pure culture study, biology, chemotherapy, epidemiology, 
pathogenicity and serology of this protozoa. Further studies of T. vaginalis for fine and 
detail surface structure analysis were performed by Ovcinnikov and team (1975) using 
transmission and scanning electron microscopy. Recently, Ryu and Min (2006) reported 
the occurrence of only trophozoite stage in T. vaginalis from vaginal samples of women 
in Republic of Korea and detailed its structural components using electron microscope. 
In another study, Yusof and Kumar, 2012 demonstrated trophozoite as phenotypic 
“variant” forms of T. vaginalis by comparing its biological, biochemical and 
ultrastructure characteristics with isolates from cervical neoplasia and non-cervical 
neoplasia in Malaysia.  
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2.3.2 Pseudocysts form 
Another significant morphology of T. vaginalis that deforms the trophozoites 
under certain conditions is pseudocyst as proved by Pereira-Neves et al. (2003). Unlike 
trophozoite, the pseudocyst is defined as a compact, non-motile, without a true cyst 
wall, round in shape and lack of external flagella (Figure 2.3) (Pereira-Neves et al., 
2003). Initially, pseudocyst was reported as degenerative forms of T. vaginalis that 
appeared when the culture conditions were unfavourable (Petrin et al., 1998) and its 
formation remains uncertain.  
 
 
 
 
 
 
 
 
Figure 2.3: Epifluorescence image of pseudosyst of T. vaginalis stained with Acridine 
orange. Magnifications 400X (Yusof and Kumar, 2012).  
 
However, recent findings proved that pseudocyst plays a significant role in 
triggering trichomoniasis (Hussein & Atwa, 2008) and can be reversed to trophozhoites 
under certain circumstances (Afzan & Suresh, 2012b; Pereira-Neves et al., 2003). 
According to Pereira-Neves et al. (2003), pseudocyst can appear under natural 
conditions and also when induced using hydroxyurea methods. The study analysed the 
structural changes of pseudocyst using immunofluorescence and video microscopy. The 
team concluded that pseudocysts differs from trophozoites and are competent to divide  
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suggesting that it may play another role in sustaining trichomoniasis.  Similarly, study 
on mice injected intra-vaginally with T. vaginalis pseudocysts by Hussein and Atwa 
(2008) proved the occurrence of trichomoniasis in the infected mice and hence 
supporting the active contribution of pseudocsyts in causing the disease. 
2.3.3 Amoeboid form 
 Amoeboid form of T. vaginalis is another distinctive morphology of this 
mucosal protozoan that is currently being studied extensively. This form (Fig. 2.4) is 
known to be flattened, non-motile or slowly motile with an inactive flagella and a 
delicate outer layer projecting pseudopodia-like cytoplasmic extensions (Heath, 1981; 
Fiori, et al., 1999; Tasca & De Carli, 2002). 
 
 
 
 
 
 
Figure 2.4: Electron micrograph of amoeboid form of T. vaginalis. (Alderete, 2012).  
  
Amoeboid shape were observed only when the parasites adheres to the vaginal 
epithelial cells (Arroyo et al., 1993; Petrin et al., 1998; Fiori et al.,1999), attaches to 
erythrocytes (Tasca & De Carli, 2002) or onto glass cover slips (Brugerolle et al., 1996). 
However, a very recent and significant finding by Afzan and Suresh (2012a) found that 
amoeboid form of T. vaginalis can also appear naturally in axenic culture medium 
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without any attachments and was proved with growth profile study and ultrastructure 
analysis with electron microscopes.  
The primary factor that triggers the appearance of amoeboid form of T. vaginalis 
apart from trophozoite and pseudocysts is the ability of the parasite to conform 
adherence to the vaginal epithelial cells when opportunity arises, also known as host-
parasite relationship in order to maintain survivability of this extracellular parasite 
(Ryan et al., 2011). In conjunction to the adhesion properties of T. vaginalis that 
completely transforms the free-swimming trophozoites into immobile amoeboid, 
morphological description of this parasite takes a new deviation with focusing on the 
mechanisms involved in triggering this unusual shape (Fiori et al., 1999).  This 
adherence property of T. vaginalis also makes amoeboid strains to be the most virulent 
as elucidated by Brugerolle et al. (1996) with the presence of actin cytoskeleton in T. 
vaginalis compared to other trichomonads.   
Although abnormal shapes of T. vaginalis was reported as early as 1978 by John 
and Squires, however only recently the relation between the infective mechanisms of 
the parasite that destroys host cells was elucidated with great emphasis on cytotoxicity 
and cytopathogenicity (Rasmussen et al., 1986; Arroyo et al., 1998; Fiori et al., 1999; 
Adegbaju & Morenikeji, 2008; Alderete, 2012). Despite the findings that only 
trophozoite causes trichomoniasis, a biochemical analysis of amoeboid form conducted 
by Scott et al. (1995) concluded that amoeboid and flagellated form of T. vaginalis 
synthesizes similar proteinases that is also responsible in causing trichomoniasis in 
human. In a study conducted by Tasca and De Carli (2002), amoeboid form has been 
observed as abnormal form of T. vaginalis using scanning electron microscopy that 
appeared prior inoculation with McCoy cell monolayers and human erythrocytes. The 
amoeboid form was reported to have pseudopodia-like extensions used for feeding and 
22 
 
attachment to stationary objects but not for amoeboid movement (Tasca & De Carli, 
2002).  
Virulence of the T. vaginalis strain also plays an important role in triggering the 
amoeboid formation due to the changes that it causes to the microenvironment of the 
growth culture enhancing the secretion of adhesins protein responsible for the 
attachment properties of the parasite (Arroyo et al., 1998; Fiori et al., 1999; Liang 
&Huang, 2009). As reported by Jesus et al. (2004), freshly isolated strains of T. 
vaginalis presented higher percentage of amoeboid form with more virulence 
characteristics based on cytolytic activity compared to prolonged sub-cultured strains. 
The appearance of morphological variability among the strains highlighting the 
amoeboid form were determined using different environmental effects such as 
temperature, pH, oxygen tension, carbohydrates and contact with other cell types (Jesus 
et al., 2004). Likewise, Figueroa-Angulo and team (2012) revealed the effects of 
environmental factors on the virulence of T. vaginalis. They deduced amoeboid form as 
the key player of pathogenesis based on morphological transition observed under 
scanning electron microscope when the parasite attaches to cervical and prostatic cells.  
2.4 Reproduction and life cycle of T. vaginalis 
It is significant to understand the reproduction mechanism and life cycle of T. 
vaginalis in order to relate the formation of different morphology within this parasite as 
well as to understand the pathway of trichomoniasis infections. In the case of T. 
vaginalis, the life cycle is still poorly understood (Sood & Kapil, 2008; Petrin et al., 
1998) and is persistently being studied.  
The life cycle of this human pathogenic protozoan is simple (Schwebke & 
Burgess, 2004) such that it comprises only the infective trophozoite form and lacks the 
cyst stage (Strous, 2008; CDC, 2009). The overall diagrammatic overview on the 
reproduction stage of T. vaginalis adapted from CDC (2009) is shown in Figure 2.5.  
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Figure 2.5: The life cycle of T. vaginalis (Adapted from CDC, 2009). 
Trophozoites of T. vaginalis inhabits the female lower genital tract and the male urethra 
and prostate  , where it replicates by binary fission .  The parasite does not appear to 
have a cyst form, and does not survive well in the external environment. T. vaginalis is 
transmitted among humans primarily by sexual intercourse  (CDC, 2009). 
 
 The flagellated trophozoite of T. vaginalis is known to reproduce asexually 
(Afzan and Kumar, 2011a)  primarily by longitudinal binary fission and under natural 
infections, the parasite expand the population in the lumen and mucosal surfaces of the 
urogenital tracts of human (Sehgal et al., 2012; Schwebke & Burgess, 2004). During 
reproduction, the nuclear membrane surrounding the nucleus of T. vaginalis is retained 
throughout the dividing period giving rise to infective progeny (Adegbaju & 
Morenikeji, 2008). Petrin and team (1998) explained that apart from trophozoite, several 
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other oversized round forms of the trichomonad known to exist in dividing growth 
phase culture are not stages in the life cycle. Instead the shape was triggered due to 
certain unfavourable conditions.  
However, another mode of reproduction that has been identified recently is the 
multiple nuclear fission that gave rise to abnormal forms of T. vaginalis under 
favourable conditions (John & Squires, 1978a; Yusof and Kumar, 2011). One such 
example is proved by findings of Yusof and Kumar (2011) that observed multi-
nucleated T. vaginalis using cytochemical staining method and ultrastructural analysis 
to visualize the events taking place during the transformation of single nucleus to 
multinucleated T. vaginalis which eventually turned the ovoid trophozoite to an 
abnormally large and irregularly shaped amoeboid.  
2.5 Mode of transmission 
 Humans are the only natural host for T. vaginalis (Petrin et al., 1998). Since 
trichomoniasis is classified as a sexually transmitted disease, thus it is clear that the 
common mode of transmission is through sexual intercourse (Petrin et al., 1998; 
Coleman et al., 2013) between sexually different partners or within the same sexual 
partners (Coleman et al., 2013) with either one or both being infected. Moore (2007) 
reported that male-to-female transmission rates were higher than female-to-male rates 
with approximately 85% of exposed women were said to contract the disease. 
Moreover, prevalence of trichomoniasis was reported to be higher among women with 
multiple sexual partners and in women with other sexually transmitted infections 
(Soper, 2004). In a study conducted in Iran, trichomoniasis was proved to be prevalent 
among women involved actively in sexual activities compared to those of under-age or 
nearing menopause (Chalechale & Karimi, 2010) suggesting that sexual intercourse is 
the main cause of the disease.  
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Transmission is said to occur through the infective trophozoite stage found in the 
vaginal or urethral discharges of infected persons ("Trichomonas vaginalis," 2010). 
Trophozoite requires body fluids and moist surfaces for survival (Lewis, 2010) and dies 
at dried conditions (Ryu & Min, 2006). Once the trophozoites are transmitted through 
the urogenital tract of another individual, it then colonizes the epithelial surface of the 
tract to obtain nutrients and expand the growth through multiplication (Sehgal et al., 
2012) which later develops into infection. The incubation period of T. vaginalis before 
initiating an infection is between 4 to 28 days (Coleman et al., 2013; Klassen-Fischer & 
Ali, 2011; Moore, 2007).  
Conversely, non-sexual transmission of T. vaginalis has also been reported 
although this type of transmission is uncommon and occurs at rare circumstances 
(“Trichomonas vaginalis”, 2010). Crucitti and team (2011) postulated incidence of 
trichomoniasis among virgin girls in Zambia due to sharing of bathing water and 
inconsistent use of soap. Survivability of T. vaginalis besides in the body fluids of 
human was also proved by Pereira-Neves and Benchimol (2008) through the supportive 
data showing the viability and cytotoxicity of the strains grown in swimming pool 
indicating the possibility of acquiring trichomoniasis through non-sexual mode. 
Although the infection rate through non-sexual mode is low (Ryu & Min, 2006), yet 
transmission through formites such as contaminated douch nozzles, moist wash-clothes, 
specula or toilet seats (“Trichomonas vaginalis”, 2010; Moore, 2007; Petrin et al., 1998) 
were still possible if the parasite successfully find their way into the vagina.  
Transmission via non-sexual contact is possible due to the fact that T. vaginalis are able 
to survive persistently for a long time outside the body if the external environment is 
sufficiently moist (Ackers, 2001). 
Another probable mode of transmission identified was through vertical vaginal 
delivery (Coleman et al., 2013) when newborn acquires infection through infected 
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mother during delivery (Lewis, 2010; Petrin et al., 1998). Schwandt and team (2008) 
reported the occurrence of trichomoniasis in a newborn on day 19 after birth was 
hypothesized as perinatal transmission. Petrin and members (1998) also indicated that 
transmission to newborn infants occurred in 2 % to 17 % of cases resulting in urinary or 
vaginal infections.  
2.6  Etiology  
 Main etiologic agent of trichomoniasis is a parasitic protozoan known as T. 
vaginalis (Schwebke & Burgess, 2004; Petrin et al., 1998). Extensive studies have 
proved that T. vaginalis is the primary cause of trichomoniasis in women, however only 
few were conducted in men. One of the recent study confirmed the significant role of T. 
vaginalis and Mycoplasma genitalium as the main etiological agent of urethral 
discharge syndrome in West African men (Pépin et al., 2001). 
Risk factors associated with the occurrence of trichomoniasis due to sexual 
activity includes non-use of condoms or oral contraceptives, low socioeconomic classes 
(Lewis, 2010), use of injection drugs, constant change of sexual partners, history of 
STIs, and exchanging sex for drugs or money (Smith & Ramos, 2012). Based on the 
risk factors analysis carried out by Miller et al. (2008), it was proved that usage of drug 
for a past 30 days resulted in most cases of trichomoniasis among African-American 
women in New York City compared to having multiple male partners. A prospective 
study in China by Zhang (1996) were able to prove the relationship between  T. 
vaginalis and life style of women such as smoking, drinking alcohol and personal 
hygiene as associated risk factors of trichomoniasis with women indulged in multiple 
sexual partner reporting as high-risk populations of trichomoniasis.  
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2.7 Epidemiology 
 In recent years, human trichomoniasis prominently emerged as the most 
prevalent non-viral sexually transmitted disease of parasitic origin (Malla et al., 2001) 
with more than 170 million cases reported annually worldwide (Swygard et al., 2003; 
WHO, 2005; Smith & Ramos, 2012) of which 154 million cases occurs in resource-
limited areas (Johnston & Mabey, 2008). The estimations of global prevalence by WHO 
(2005) were made based on assumptions of wet mount sensitivity ranging from 60 % to 
80 % (Van Der Pol, 2007) with recent update suggesting the sensitivity using 
Polymerase Chain Reaction (PCR) maybe lower, ranging from 35 % to 60 %, thus 
underestimating the global prevalence data (Johnston & Mabey, 2008; Malla, 2012).  
Trichomoniasis has been reported with broad-based distribution in almost every 
region and climate and without seasonal variability regardless of races and 
socioeconomic levels (Sood & Kapil, 2008; Petrin et al., 1998). Although 
trichomoniasis is considered as most widespread STD, however it receives the least 
public attention (Van Der Pol, 2007) and is a non-reportable disease (Schwebke & 
Burgess, 2004) due to the facts that the infections accounts for almost half of all curable 
infections worldwide as presented by WHO (Van Der Pol, 2007; Schwebke & Burgess, 
2004).  
Prior to the global prevalence report presented by WHO (2005), one third of 
cases in females are thought to be asymptomatic with majority developing symptoms 
and signs of vaginal discharge, vulval irritation and inflammation (Johnston & Mabey, 
2008). Incidence in adolescent women were reported to be high with untreated 
infections remained undetected for three months or longer classifying them as high risk 
groups for STIs (Van Der Pol et al., 2005). Meanwhile, T. vaginalis infections in men 
tend to be less apparent (Smith & Ramos, 2012) with majority being asymptomatic 
(Johnston & Mabey, 2008). Approximately 90 % of men in a report were shown to be 
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asymptomatic (Wang, 2000) and often considered to be asymptomatic carriers but 
playing an important role in transmitting the disease (Soper, 2004). Another report 
presented that the rate of transmission from men to women were higher, approximately 
67 to 100% than women to men, approximately 14 % to 80 % suggesting the self-
limiting characteristic of the disease in men (Malla, 2012).  
Various investigators conducted different types of epidemiological studies based 
on geographical locations, age, races, socioeconomic status, sexual activity, number of 
sexual partners, other STDs, sexual customs, phase of menstrual cycle, techniques of 
examination (Klassen-Fischer & Ali, 2011) specimen collection and laboratory 
procedures (Petrin et al., 1998). A study by Sutton et al. (2007) revealed the prevalence 
of T. vaginalis infection among non-Hispanic black women in United States was 10.3 
times higher than that among non-Hispanic white and Mexican American women. 
Similarly, high prevalence of T. vaginalis infection was reported among socially-
marginalized young women from low income communities in coastal Peru with 
incidence rate of 9.1 % (Leon et al., 2009). Survey among pregnant women revealed 
that 12.6 % out of 13816 women from six urban clinic centers were colonized with 
trichomoniasis with majority having bad behavioral activities (Cotch et al., 1991). 
In normal populations, cases of trichomoniasis were approximated at about 10 % 
though it varies between 0 % to 65 % in different geographical locations (Malla, 2001), 
age groups and population studied (Malla, 2012). Annually in United States, 
trichomoniasis is identified as an extremely common cases (Schwebke & Burgess, 
2004) estimated at a rate of 8 million cases (Malla, 2012) with five million new cases 
among women exceeding the cases of other types of STIs such as chlamydia and 
gonococcal (Moore, 2007).  A review by Petrin et al. (1998) stated the prevalence of 
vaginal trichomoniasis among African populations between 11 and 25 % meanwhile an 
increasing rate of prevalence (approximately 10.4 %) have been reported among women 
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in Republic Korea since 1947 till recently (Ryu & Min, 2006). In United Kingdom, 
about 93 % women and 7 % men were infected with trichomoniasis (Lewis, 2010) 
meanwhile prevalence rate ranges between 15 to 20 % among tropical populations in 
Asia (Afzan, 2011a). In males attending STD clinics, T. vaginalis was reported as 
common especially in those 30 years or older accounting for as much as urethritis such 
as gonoccocal and chylamdia infections (Joyner et al., 2000). 
Despite the significantly high prevalence rates worldwide, cases of 
trichomoniasis reported were relatively low in Malaysia with most cases among women 
who attended local clinics for inspections (Amal et al., 2010). According to this report, 
no cases of trichomoniasis were reported in STD clinics and only 0.36 % was detected 
positive in Lembaga Penduduk dan Pembangunan Keluarga Negara (LPPKN) clinics. 
The study postulated that the low prevalence rates among Chinese women could be 
attributed to the use of herbal and traditional medicine washes for cleaning external and 
internal vaginal areas. Similarly, in the study undertaken by Afzan (2011c) in 695 
women who attended a local gynecology clinic, only 1.58 % of the patients were tested 
positive for T. vaginalis with 0.86 % diagnosed with cervical intraepithelial neoplasia.  
2.8  Clinical manifestation of T. vaginalis 
 Trichomoniasis presents a wide variety of clinical patterns both in males and 
females (Petrin et al., 1998). T. vaginalis is a well-known urogenital parasite that infects 
the squamous epithelium in the genital tract (Petrin et al., 1998). Once established, the 
infection persists for a long duration in females but only lasts for a short period in males 
(Petrin et al., 1998).  
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2.8.1 Clinical manifestation in women 
 The spectrum of trichomoniasis in women ranges from asymptomatic carrier 
state (Malla et al., 2001; Petrin et al., 1998) to flagrant vaginitis (Petrin et al., 1998), 
with one third of asymptomatic patients being symptomatic within six months of 
infection (Malla et al., 2001; Petrin et al., 1998). The parasite is normally isolated from 
the vaginal area with of urethra and Skene’s gland being the common infection site 
(Lewis, 2005, 2010). It is still unclear on the factors that influence the host 
inflammatory response to T. vaginalis, however probable causes identified includes 
hormonal levels, the coexisting vaginal flora, the strain and relative concentration of the 
organisms present in the vagina (Schwebke & Burgess, 2004). Severity of 
trichomoniasis infections in females are classified as acute, chronic or asymptomatic 
(Petrin et al., 1998).  
Females with acute infection experiences diffuse vulvitis due to copious 
leucorrhea (Petrin et al., 1998) with malodorous, frothy, yellow or green and 
mucopurulent discharge (Petrin et al., 1998). The discharge is typically pooled in the 
posterior vaginal formix with bubble formation around 10 to 33 percent as observed 
through perspeculum examination (Malla, 2012). These bubbles are characteristics of 
the infection which appears as a result of carbohydrate metabolism which produces 
carbon dioxide and hydrogen gases (Moore, 2007). Likewise, small punctate 
hemorrhagic spots also known as “strawberry appearance” (Figure 2.6) were found on 
the vaginal and cervical mucosa in two percent of patients (Malla, 2012; Petrin et al., 
1998). These signs and symptoms in women infected with acute trichomoniasis are 
rotational and worsen during menstruation period (Petrin et al., 1998). A study by Dan 
and Sobel (1996) determined the presence of florid inflammation with high numbers of 
polymorphonuclear leukocytes and parasitic load in symptomatic women who attended 
a chronic vaginitis clinic. A prevalence study in Nigerian women also identified the 
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common features of vaginal discharge in T. vaginalis as 69.8 % being white, 20.1 % as 
yellow and 28.2 % as clear with heavy and malodorous leakage (Anorlu et al., 2001). 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: Frothy vaginal discharge of trichomoniasis with strawberry spots. (Adapted 
from Lewis, 2010). 
 
 
Females with chronic infections were the major source of the parasite 
transmission with major mild symptoms and scanty vaginal secretion (Petrin et al., 
1998). Complains of vaginal discharge (50 % to 75 %), pruritus (25 % to 50 %), dysuria 
(30 % to 50 %), dyspareunia (10 % to 50 %) and lower abdominal pain in small 
percentage were very common among infected females with chronic onset (Malla, 2012; 
Malla et al., 2001). Occurrence of dysuria and vaginal discharge were caused by a 
urethral infection whereas dyspareunia generally resulted from the inflamed and friable 
cervix (Moore, 2007).  
Majority of women, around 25 to 50 % display asymptomatic state of infection 
with normal vaginal pH of 3.8 to 4.2 and normal vaginal flora (Petrin et al., 1998). This 
figure increased greatly during pregnancy while menstruation also was thought to 
worsen the symptoms in infected women (Malla et al., 2001). Infection during 
pregnancy can also be associated with premature rupture of membrane, preterm 
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delivery, low birth weight babies and as well respiratory infection in infants (Malla, 
2012). Cotch et al. (1997) confirmed the relationship of T. vaginalis with adverse 
outcome of pregnancy by providing statistical significance on the number of low birth 
weight infant, preterm delivery and preterm low birth weight infant in pregnant infected 
women.  
Complications such as adnexitis, pyosalpinx, endometritis, infertility, cervical 
erosion (Petrin et al., 1998) with predisposition to malignant transformation (Malla et 
al., 2001) were also associated with trichomoniasis. A study between 240 infertile 
women and 40 pregnant women revealed a clinically significant data on the role of T. 
vaginalis in causing female infertility (El-Shazly et al., 2001). Increased risk to 
acquisition of HIV infection was also possible with the presence of genital inflammation 
in infected women (Malla et al., 2001; Petrin et al., 1998). In all cases, trichomoniasis in 
women is suggested to continue causing infection for three to five years if untreated 
earlier (Swygard et al., 2003). 
2.8.2 Clinical manifestation in men 
 Although trichomoniasis is a dominant disease in women, however infection in 
males still persist but in less probability, approximately five percent (Swygard et al., 
2003; Petrin et al., 1998) with 70 % (Harp & Chowdhury, 2011) of them being 
asymptomatic carrier (Petrin et al., 1998). Symptomatic men usually exhibit non-
specific urethritis (Lewis, 2010) with slight scanty, clear to mucopurulent discharge, 
irritation inside the penis and mild burning sensation immediately after sexual 
intercourse or urination (Petrin et al., 1998). Severe symptoms were also reported in 
cases with infections that involves the prostate or seminal vesicles (Moore, 2007). 
Besides, men with T. vaginalis as a cause of nongonococcocal urethritis also 
experienced symptoms for almost twice longer than men with other causative agents 
(Moore, 2007). However, the amount of discharge in men were usually far less then in 
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women as mentioned by Rein and Queiroz (as cited in Afzan, 2011a). The duration of 
infection is 10 days or less (Petrin et al., 1998) suggesting the less frequency of this 
disease in males than in females.  
T. vaginalis mainly infects the urethra, epididymis and prostate gland in men 
(Lewis, 2010). At rare circumstances, the parasite causes clinically evident syndromes 
such as balanitis, epididymitis, prostatitis (Lewis, 2010), urethral disease, infertility 
(Petrin et al., 1998) and epidymo-orchitis (Harp & Chowdhury, 2011). Other types of 
complications in men associated with T. vaginalis infections include HIV transmission 
and infectivity (Soper, 2004), impaired sperm mobility and reduced sperm viability 
(Lewis, 2005).  
 Urogenital trichomoniasis in men are classified into three categories namely 
asymptomatic carrier state caused by sexual contact with infected women, acute 
trichomoniasis identified by profuse purulent nongonococcal urethritis and mild 
symptomatic disease (Petrin et al., 1998). A high prevalence of urethritis was found in 
rural men in Tanzania according to a community based study conducted with majority 
of them being asymptomatic for the infections (Watson-Jones et al., 2000). Similarly, 
another prospective study of T. vaginalis infection conducted in male sexual partners 
found that majority of them acquired the disease from their infected women partner 
(Seña et al., 2007). The study also revealed that 76.8 % out of 177 men examined were 
asymptomatic for the disease with minority of them having other symptoms such as 
penile discharge, penile tingling and painful urination.  
2.9 Pathogenesis 
 Despite the mild to severe infections imposed by T. vaginalis causing different 
kinds of clinical signs and symptoms in both men and women, yet the actual 
pathogenesis mechanism underlying this disease has not been clearly explained (Petrin 
et al., 1998). The insufficient evidence to reveal the pathogenecity of T. vaginalis 
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infection is probably due to lack of good animal model in order to perform a 
standardized and controlled research on transmission, pathogenesis, immunity and 
vaccine development related to trichomoniasis (Adegbaju & Morenikeji, 2008). It was 
known that T. vaginalis damages the host tissue by direct contact and by cytotoxicity 
through proteins found on this parasite (Klassen-Fischer & Ali, 2011). 
Different clinical spectrums identified in males and females were reported to be 
contributed by the multi-faceted interplay of virulence factors between parasite and host 
(Malla, 2012; Malla et al., 2001). However, the relationship between the putative 
virulence factors and the observed signs and symptoms remains unclear (Ackers, 2001). 
Infected men usually serve as vector to spread the disease such as urethritis and 
prostatitis as well as act as a co-factor to increase predisposition to HIV infection 
(Afzan, 2011; Soper, 2004) by disrupting the prostate epithelial cells (Afzan, 2011). 
Conversely, Cook (2009) mentioned that in women, T. vaginalis preferably attaches to 
squamous epithelial cells without invading the tissue in order to cause the disease (as 
cited in Afzan, 2011a).  
Many strains of T. vaginalis were widely recognized as inherently pathogenic 
and can potentially cause serious illness to human (Heath, 1981). In addition, the host-
parasite relationship is very complex (Sood & Kapil, 2008; Petrin et al., 1998) and 
single pathogenic mechanisms is unlikely to cause the broad range of clinical symptoms 
in male and female (Sood & Kapil, 2008). Cytopathogenecity of T. vaginalis has been 
well proved by Gilbert and team (2000) through the cytotoxicity tests conducted in 
which the human vaginal epithelial cells were destroyed as results of infection with the 
parasite. The study also hypothesized the significance of host-parasite relationship for 
the pathogenesis to occur. Following that, initial events leading to successful invasion of 
T. vaginalis have been well linked to the existence of several virulence mechanisms 
(Figueroa-Angulo et al., 2012) such as cell-to-cell adhesions (Lewis, 2010; Adegbaju & 
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Morenikeji, 2008; Petrin et al., 1998), hemolytic activity (Malla, 2012; Malla et al., 
2001; Petrin et al., 1998), trichomonad proteinase activity (Ryu & Min, 2006; Petrin et 
al., 1998), contact-independent mechanisms and cell-detaching factor (Sood & Kapil, 
2008; Petrin et al., 1998) phagocytosis (Figueroa-Angulo et al., 2012; Harp & 
Chowdhury, 2011)  and host immune system evasion (Harp & Chowdhury, 2011; Ryu 
& Min, 2006; Petrin et al., 1998).  
2.9.1 Cell-to-cell adhesion mechanisms 
 One of the initial steps in the infection process of T. vaginalis is through 
adherence mechanisms by colonization of the vaginal tract (Harp & Chowdhury, 2011). 
Protein components found on the cell surfaces of trichomonads is essential for adhesion, 
host-parasite interaction, nutrient absorption as well as exhibiting virulence property 
(Petrin et al., 1998). As an extracellular parasite, T. vaginalis needs to adhere to the 
epithelial cells of the urogenital tract for survival purposes (Ryan et al., 2011). Hence, 
adherence molecules are fundamentally important in exerting trichomonal infection 
(Moreno-Brito et al., 2005). Four types of adhesion proteins is known to be responsible 
in triggering the adhesion of the parasite to the epithelial cells; AP65, AP51, AP33 and 
AP23 (Alderete & Garza, 1985; Petrin, et al., 1998).  
Upon attachment, the ovoid trophozoite transforms into amoeboid form that can 
be highly adherent (Ryan et al., 2011). Arroyo and team (1993) has clearly 
demonstrated the rapid amoeboid transformation of T. vaginalis during cytoadherence 
activity. The formation of cytoplasmic-like projections through the amoeboid form 
increases the cell-to-cell surface contact (Harp & Chowdhury, 2011) and simultaneously 
destroys the normal host cell, causing it to be infected. The morphological 
transformation leads to tight association between the parasite and host cell, thus 
isolating the space between membrane and the environment (Gonzàles-Robles et al., 
1995). Expression of several genes in the target cells was known as the key factors to 
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initiate the adherence mechanism of the parasite. This was hypothesized by a study that 
observed the gene expression in human vaginal epithelial cells due to complex signaling 
cascade in response to trichomonal adherence (Kucknoor et al., 2005).  
2.9.2 Hemolytic activity 
 T. vaginalis lacks the ability to synthesize many pyrimidines and lipids required 
for a more stable infection (Adegbaju & Morenikeji, 2008; Petrin et al., 1998). In return, 
these nutrients are acquired from erythrocytes found in the host cells which are rich in 
fatty acids (Petrin et al., 1998). Iron on the other hand is an essential nutrient required 
by T. vaginalis for growth in high concentration (Sehgal et al., 2012). In order to 
achieve this, T. vaginalis lyses the erythrocytes via protein receptors found on the 
surfaces of both the red blood cells and the parasites (Petrin et al., 1998). This hemolytic 
activity is said to be correlated to the virulence of the parasite (Sood & Kapil, 2008; 
Petrin et al., 1998).  Study by Rosset et al. (2002) revealed the hemolytic activity of T. 
vaginalis as an important mechanisms in causing injury to the erythrocytes of the host 
cell. Electron microscopy studies (Gonzàles- Robles et al., 1995; Arroyo et al., 1993) 
have shown that during infection, there is a close association between the parasite and 
target cell whereby amoeboid morphology take control. This induces the balancing of 
the microenvironment by the parasite by means of increasing the concentration of pore-
forming proteins needed to achieve lysis activity.  
2.9.3 Proteinase activity 
 Trichomonad proteinases have been related to various types of pathogenesis 
which includes nutrients absorption, immune system invasion, cytotoxicity, 
cytoadherence and hemolysis (Alvarez-Sanchez et al., 2000). Cysteine proteinases 
(CPs) have been implicated with lytic and adherence factors, thus aiding the hemolysis 
of erythrocytes as well as the adherence of T. vaginalis to the epithelial cells (Petrin et 
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al., 1998). CPs possesses the ability to degrade the host immunoglobulin and is 
pathogenic (Petrin et al., 1998). Study by Mendoza-Lòpez et al. (2000) explained the 
involvement of CP30, a cysteine proteinase in attachment to host epithelial cells. The 
attachment subsequently caused the degradation of proteins found on the female 
urogenital tract. Similarly, CPs was known to induce cell death in human vaginal 
epithelial cells (HVEC) as demonstrated through Cell Death ELISA assay and flow 
cytometry analyses (Sommer et al., 2005). 
2.9.4 Contact-independent mechanisms and cell detaching factor 
 Contact-independent cytolytic mechanisms have been identified and major 
cytolytic effects have been related to substances released by the parasite in the culture 
medium (Ryan et al., 2011; Sommer et al., 2005). Therefore, contact-independent 
factors of T. vaginalis are also important in triggering pathogenesis (Bhatt et al., 1996). 
Contrary to contact-dependent mechanisms of T. vaginalis such as cytocidal and 
haemolytic properties, Pindak et al. (1993) proved that cell death of the host cells still 
occurs without the addition of erythrocytes through the production of acidic metabolites 
and other factors by the living parasite alone which causes apoptosis of the host. One of 
these factors is known as cell detaching factor (CDF), a cell-free product of T. vaginalis 
with significant cytopathic effect (Petrin et al., 1998). CDF is 200 kDa glycoprotein, 
heat and acid labile and exert a pH dependent activity (Sood & Kapil, 2008). This is 
clinically important since the normal pH of vagina is 3.9 to 4.2 but becomes more than 
pH 5 during trichomoniasis, suggesting that rise of vaginal pH during infection 
contributes to pathogenesis (Sood & Kapil, 2008; Adegbaju & Morenikeji, 2008). One 
earlier study has successfully isolated CDF from T. vaginalis and explained a trypsin-
like activity in the parasite that can disrupt the monolayer of cells (Garber et al., 1989). 
Levels of CDF have also been shown to exert different severity of clinical symptoms of 
vaginitis with high concentration of CDF having chronic infection (Petrin et al., 1998).  
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2.9.5 Phagocytosis 
 Extensive studies using light and electron microscopy have demonstrated the 
phagocytic activity of T. vaginalis as being able to efficiently ingest and degrade 
lactobacilli, vaginal and cervical epithelial cells, leukocytes, erythrocytes (Rendón-
Maldonado et al., 1998), yeast cells (Pereira-Neves & Benchimol, 2007), prostatic cell 
(Vazquez-Carrillo et al., 2011) and spermatozoids (Benchimol et al., 2008; Midlej & 
Benchimol, 2010). Although the exact mechanism has not been fully elucidated, 
however two types of phagocytic pathways have been described by Pereira-Neves and 
Benchimol (2007) based on their study on phagocytosis of T. vaginalis on yeast cells. 
These pathways include extension of pseudopodia towards target cells and sinking 
process without the extension of membrane cell of T. vaginalis (Figueroa-Angulo et al., 
2012; Pereira-Neves & Benchimol, 2007). Amoeboid morphology is a significant 
structure observed during phagocytosis process which can be highly virulent as 
observed by few investigators (Pereira-Neves & Benchimol, 2007; Rendón-Maldonado 
et al., 1998). Therefore, it can be concluded that phagocytosis contributes to the 
virulence mechanism of T. vaginalis apart from other mechanisms used to acquire iron, 
lipids, nucleotides and relevant nutrients (Figueroa-Angulo et al., 2012).   
2.9.6 Immune evasion mechanisms 
 Chronic vaginal infections and constant changing microenvironment 
encountered during the menstrual cycle enabled T. vaginalis to evolve defensive system 
against host immune responses using a variety of immune evasion mechanism 
(Figueroa-Angulo et al., 2012).  T. vaginalis was able to overcome the host immune 
system using complement avoidance strategy (Adegbaju & Morenikeji, 2008; Petrin et 
al., 1998). This means that T. vaginalis take advantage on minimal complement 
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situation present in infected areas such as cervical mucus surrounded with deficiency in 
complement substances (Petrin et al., 1998).  
To date, iron was found as a major contributing attribute in complement 
resistance of T. vaginalis (Petrin et al., 1998). The resistance to complement iron-rich 
conditions considerably induces microbial pathogenesis (Petrin et al., 1998).  In a study 
conducted by Ryu and Min (2006), T. vaginalis was noted to exhibit cell-capping 
mechanisms in which antibody-induced membrane antigen modulated by the parasite 
can resist host immune responses.  
 Host humoral immune responses to T. vaginalis are also known to play a 
significant role as determinant of virulence (Malla, 2012). IgG, IgM and IgA are human 
immunoglobulins which can be easily degraded by the cysteine proteinases secreted by 
the parasite thus allowing the parasite to survive antibody response (Min et al., 1998). T. 
vaginalis also can coat itself with host plasma proteins, disallowing host immune 
system from recognizing the parasite as foreigners (Malla, 2012). The continuous 
release of antigens also may neutralize antibody or cytotoxic T lymphocytes, thus 
inhibiting specific anti-T. vaginalis defense mechanisms by host immune system 
(Alderete & Garza, 1985). Identification of antigenic proteins on the surface of T. 
vaginalis has also been suggested to stimulate immune responses by human cells (Lee et 
al., 2012). 
Other invasion mechanisms applied by T. vaginalis includes molecular mimicry 
mechanism by decorating the parasite membrane with molecules homologous to host 
proteins (Alderete et al., 2001), induction of neutrophil recruitment via interleukin 
pathways in response to activation by live T. vaginalis (Cudmore et al., 2011) and 
surface immunogens activity (Petrin et al., 1998).  
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2.10 Predisposition of T. vaginalis infection to other complications 
 Growing incidence of infections with T. vaginalis reversed the initial 
acknowledgement as minor STD into major STD based on the increasing number of 
associated complications (Schwebke & Burgess, 2004; McClelland, 2008) with 
trichomoniasis. Examples of these complications include preterm delivery, low birth 
weight, premature rupture of membranes, acquisition of HIV, tendency to cervical 
cancer, pelvic inflammatory disease and infertility (Schwebke & Burgess, 2004; Petrin 
et al., 1998). Among these, predisposition to HIV and cervical cancer became the highly 
concerned associated diseases due to the significant health drawbacks it sets to T. 
vaginalis infected patient.  
2.10.1 T. vaginalis and cervical cancer  
Cervical cancer is classified as one of the most common malignant disease 
worldwide (Yap et al., 1995). Many of the earlier studies correlated human 
papillomavirus (HPV) as the major risk factor for cervical neoplasia (Viikki et al., 
2000). However, it has been clearly proved by recent studies that T. vaginalis can also 
be major contributor for this disease. One of them is the cohort study conducted to 
determine other predictors beside HPV in causing cervical cancer (Viikki et al., 2000). 
The study proposed two possible risk determinants of subsequent cervical neoplasia 
with T. vaginalis as the major contributor to cervical cancer. It has also been reported 
that live T. vaginalis has been found to induce higher degree of immunosuppression by 
the more virulent strains suggesting the possible activation of carcinogenic viruses (Yap 
et al., 1995).  
One possible mechanism identified in T. vaginalis infections progress into 
cervical cancer is that the parasite adheres to the wall of cervicovaginal cells and 
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through an effective enzyme systems, it interferes with host metabolism and generates 
toxins which finally leads to cell necrosis (Pustan et al., 2010).  
A prospective study conducted by Yap et al. (1995) revealed high titre of 
antibodies in serum of patients with invasive cervical carcinoma marking a significant 
association of T. vaginalis infection with cervical cancer. Similarly, Zhang et al. (1995) 
was able to prove the association of T. vaginalis with cervical cancer among women 
subjects in China although the proportion rate was low. Afzan (2011b) were also able to 
screen for T. vaginalis from clinical patients in Malaysia with 0.86 % out of 1.58 % 
were diagnosed with cervical intraepithelial neoplasia.  
2.10.2 T. vaginalis and acquisition of HIV 
 T. vaginalis has emerged as a co-factor for HIV transmission regardless of 
gender (Coleman et al., 2013). Almost all the studies conducted mentioned the close 
association of T. vaginalis with HIV infection. Four potential mechanisms have been 
identified for increased susceptibility for predisposition to HIV which includes 
(Coleman et al., 2013); 
a. Recruitment of HIV target cells such as CD4+ T cells to the genital tract as a 
result of the host immune response to T. vaginalis. 
b. Degradation of HIV-protective factors such as secretory leukocyte protease 
inhibitor. 
c. Direct and indirect cytotoxic effects of the parasite itself. 
d. Disrupted or abnormal vaginal flora (Cudmore et al., 2011). 
Cell-detaching factor is a contact-independent mechanism of T. vaginalis that 
aids transmission of HIV by releasing epithelial cells from tissues and weakening the 
defense barrier against HIV invasion (Coleman et al., 2013). Besides, the discharge of 
punctuate micro hemorrhages in infected mucosal genital tract tissue also known to aid 
the transmission by acting as portal for HIV entry (Coleman et al., 2013).  
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Studies by Van Der Pol et al. (2008) and Miller et al. (2008) highlighted that T. 
vaginalis infection may be epidemic in populations at risk for HIV-1 transmission in 
resource limited countries and in the developed world taking the complications to a 
general population cohort. Based on a review study conducted, it was evident that 
amplifying effect of T. vaginalis is fundamental in increasing the HIV infections among 
African-Americans especially those with low-income (Shafir et al., 2009).   
Rates of trichomoniasis associated-HIV infections were prominently higher in 
women. A recent review study confirmed the interactions of trichomoniasis and HIV by 
providing strong evidence on the increased risk of transmission and acquisition of HIV 
among women (Kissinger & Adamski, 2013). The association of trichomoniasis with 
HIV transmission was also seen among men (Soper, 2004). Hobbs et al. (1999) 
performed a prevalence study among Malawian men and concluded that symptomatic 
inflammatory trichomoniasis may cause the increased incidence of HIV excretions in 
semen.  
Co-infection is another phenomenon in which HIV-positive patients become 
prevalent to other infections such as trichomoniasis and bacterial vaginosis. Incidence of 
co-infection with HIV and T. vaginalis in women has been reported to vary between 16 
% to 30 % (Allsworth et al., 2009; Gatski et al., 2011). However, it is difficult to 
estimate the rate of co-infection in men due to asymptomatic characteristics of T. 
vaginalis infection (Cudmore et al., 2011). 
2.11 Growth requirements and survival of T. vaginalis 
Studies on the nutritional requirements of T. vaginalis progressed with the 
advent of axenic culture by Trussell in 1940 (as cited in Clark & Diamond, 2002). 
Axenic culture of T. vaginalis incorporates antifungal and antibacterial antibiotics into 
medium to prevent growth of any other metabolizing cells (Clark & Diamond, 2002). It 
is an obligate parasite, lacking the ability to synthesize many macromolecules de novo 
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such as purines, pyrimidines and lipids (Petrin et al., 1998; Sood & Kapil, 2008). In 
vagina, these nutrients are acquired through secretions or via phagocytosis of host and 
bacterial cells (Petrin et al., 1998; Sood & Kapil, 2008). However, under in vitro growth 
conditions, these nutrients are supplemented in the culture media to ensure efficient 
growth of T. vaginalis (Kostara et al., 1998; Sood & Kapil, 2008). 
Being a fastidious organism, T. vaginalis can only be cultured in medium 
containing sufficient growth requirements such as yeast extract, trypticase soy broth, 
maltose, minerals and vitamins (Wang, 2001). Serum is an important supplement in the 
culture media as it contains lipids, fatty acids, amino acids and trace metals (Sood & 
Kapil, 2008). Examples of axenic medium used for the successful growth of T. vaginalis 
includes Diamond medium  (Schmid et al., 1989), Modified Hollander medium (Afzan, 
2011b), Feinberg and Whittington medium (Kostara et al., 1998), TYI-33 and YI-S 
medium (Clark & Diamond, 2002).  
T. vaginalis is a microaerotolerant flagellate (Sehgal et al., 2012) that tolerates 
low level of oxygen and are anaerobic (Guschina et al., 2009). An optimum growth 
temperature suggested by Trussell and Johnston (1944) which has been maintained to 
date is 35ºC to 37ºC. Outside the host, the parasite can survive up to six to 24 hours in 
swimming pool water, in urine and semen whereas lasts up to 30 minutes when exposed 
to air  (“Trichomonas vaginalis”, 2010). T. vaginalis can grow over a wide range of pH 
(Wang, 2001) with optimum level between pH 6 to 6.3 (Sood & Kapil, 2008). 
2.12 Diagnosis 
 Diagnosis for trichomoniasis cannot be readily made solely based on clinical 
signs and symptoms since T. vaginalis holds a broad spectrum of infection with several 
STDs possessing similar clinical features (Sood & Kapil, 2008). Hence, laboratory 
diagnosis methods are significant in detecting the infection accurately so that 
appropriate treatment and management of the disease can be applied (Petrin et al., 
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1998). These diagnostic tests varies from some old techniques such as direct 
microscopic examination and Pap smear to newer techniques such as culturing method 
and RNA analysis up to recent methods such as rapid antigen and nucleic acid 
amplification (Harp & Chowdhury, 2011). Different investigators use various kinds of 
diagnostic tools depending on the resource and cost availability therefore presenting a 
range of sensitivity and specificity to diagnose trichomoniasis (Patel et al., 2000). 
Significance of rapid diagnosis of T. vaginalis infection has been reported by Mitchell 
and Hussey (2010) using a case of vulval ulceration in a 41-year old female that 
remained unnoticed for five years. In male, urine specimens were used as diagnostics 
samples whereas in females, endocervical and vaginal swab specimens were more 
common (Harp & Chowdhury, 2011).  
2.12.1 Direct microscopy 
Preparation of saline wet mount from the vaginal swab or urine specimen and 
screening them under light microscopy is one of the conventional methods used. It is 
one of the cost-effective and prompt diagnostic methods known. Although highly 
specific (Wiese et al., 2000), however, this techniques became less reliable due to the 
low sensitivity (30 % to 80 %) and requirement of trained microscopists reported (Adu-
Sarkodie et al., 2004). Direct microscopy observation (Figure 2.7) requires visualization 
of viable, motile trophozoite indicating that the specimens must be examined 
immediately (Hobbs & Sena, 2007). 
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Figure 2.7: Example of wet mount preparation of T. vaginalis. Magnification 400X. 
(Ng, 2007). 
 
Most of the comparative studies done to evaluate the efficiency of different 
diagnostic methods revealed direct microscopy as less preferred method mainly due to 
the low sensitivity in detecting T. vaginalis in large number of women populations 
(Jamali et al., 2006; Fernando et al., 2011; Sadek & Gammo, 2012). Most men are 
asymptomatic for trichomoniasis and direct microscopy diagnosis has been reported to 
produce a less productive results compared to other latest techniques used (Chapin, 
2013). Nevertheless, sensitivity of wet mount examination has been reported to increase 
when coupled with other diagnostic techniques such culture method (Cohen et al., 2006; 
Patullo et al., 2009; Patil et al., 2012). 
2.12.2 Staining method 
 Various kinds of staining methods have been implied to detect T. vaginalis such 
as using Gram stain (Stefanski et al., 2010) Giemsa stain (Akujobi & Ojukwu, 2006; 
Radonjic et al., 2006; Karaman et al., 2008), Papanicolaou (PAP) smear stain  (Karaman 
et al., 2008), periodic acid-Schiff stain (Sood & Kapil, 2008), fluorescent staining (Van 
Der Schee et al., 1999; Radonjic et al., 2006)and Modified Field’s stain (Afzan et al., 
2010). Despite the relative easiness of performing staining diagnostic method, yet it 
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remained as the least preferred due to the time-consuming and tediousness of preparing 
the specimens. Figure 2.8 illustrates examples of Gram stain, Modified Field Stain and 
Giemsa stain performed by Afzan et al. (2010) for diagnosis of T. vaginalis in infected 
women.  
 
Figure 2.8: Three different types of staining method; A) Giemsa stain B) Modified 
Field’s stain C) Gram stain performed for the diagnosis of T. vaginalis. Magnification 
x400 (Afzan et al., 2010). 
 
A comparative study between wet mount, Giemsa stain and culture method of 
vaginal swabs found that the culture method provides more positive results of 9.04 % 
with Giemsa staining giving only 6.7 % of positive results (Akujobi & Ojukwu, 2006). 
However, in resource limited countries such as Sri Lanka, Giemsa stain was known to 
give 100 % sensitive and 99 % specific results compared to culture and wet smear 
examination (Fernando et al., 2011). Radonjic et al. (2006) reported that the sensitivity 
of Giemsa and acridine orange staining was 52 % and 71 % respectively compared to 
wet mount examination.  This study concluded that although staining method is easier 
to perform, however it requires fluorescence microscopy and longer preparation time.  
2.12.3 Culture method 
 The broth culture method is known as the gold standard and has been recognized 
as the most sensitive for routine diagnosis of T. vaginalis (Malla, 2012; Petrin et al., 
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1998). InPouch (Hobbs et al., 2006; Sadek & Gammo, 2012) and cell culture technique 
(Bhatt et al., 1996) has also been implemented with added advantages such as being 
portable and requires small volume of inoculums respectively (Malla, 2012; Sood & 
Kapil, 2008). However, the high cost involved, greater risk of contamination and 
inconvenience for rapid diagnosis in using these two techniques made broth culture 
method as the most reliable method (Malla, 2012; Garber, 2005).  In men, optimal 
sensitivity is said to be obtained using culture technique using urethral swab and urine 
specimen (Sood & Kapil, 2008).  
 Examples of broth cultures used includes Diamond’s Trypticase-yeast medium 
(Radonjic et al., 2006), Kupferg medium (Jamali et al., 2006; Van Der Schee et al., 
1999) and Hollander medium (Afzan, 2011). In a study to detect T. vaginalis by 
different methods in women from Iraq found that diagnosis with Diamond modified 
culture medium yielded higher rate of infection (Al-Saeed, 2011). Culture method is 
known to detect as few as 1-10 organisms in a specimen and sensitivity range is 
between 92 to 95 % (Wang, 2001). One limitation of culturing technique is the need to 
incubate samples for several days prior to detection which is time-consuming (Lewis, 
2010). In a study by Akujobi and Ojukwu (2006), cultivation technique was reported as 
most sensitive though costly and slow. The study also suggested that the culture method 
can be used to complement wet mount method in order to achieve higher rate of T. 
vaginalis isolation.  
 Another type of culture method used was solid medium which has also been 
proved to be effective. Example is the use of Modified Columbia Agar which was able 
to identify 98 % of positive samples and is categorized as reliable, sensitive, time-
saving and suitable medium to detect infection in asymptomatic and symptomatic 
individuals (Stary et al., 2002). 
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2.12.4 Molecular method 
 In conjunction to the limitations possessed by wet mount, staining and culture 
methods, a more specific and improved sensitivity molecular assays for the detection of 
T. vaginalis DNA known as Polymerase Chain Reaction (PCR) was developed 
(Caliendo et al., 2005). Review of reports indicated that DNA detection in clinical 
samples by PCR yielded a fast and higher sensitivity results compared to wet mount and 
culture (Schwebke & Burgess, 2004). Diagnosis of trichomoniasis by PCR has been a 
widely accepted method based on the many clinical studies performed (Madico et al., 
1998; Van Der Schee et al., 1999; Lawing et al., 2000; Jamali et al., 2006; Valadkhani 
et al., 2010; Lee et al., 2012). Trichomoniasis detection in males has also been improved 
with the use of PCR methods (Schwebke & Lawing, 2002; Seña et al., 2007; Lee et al., 
2012). 
In a study, 100 % sensitivity and 99 % specificity in detecting T. vaginalis from 
vaginal swabs was achieved using Real-time PCR compared to culture method, 
suggesting the reliability of molecular method compared to conventional diagnosis 
(Caliendo et al., 2005).  In a case study performed by Bellanger et al. (2008) for a 
trichomonal empyema adult woman and T. vaginalis infected infant, the PCR method 
was known to complement the weak sensitivity of wet mount and low viability of T. 
vaginalisby providing a rapid and consistent identification of the trichomonad species. 
Wendel et al. (2002) proposed PCR as an ultimate solution to diagnose T. vaginalis 
infection in high-risk group women especially those with perinatal morbidity and HIV-
positive. One potential strength of PCR is its usefulness in mass screening of 
trichomoniasis (Patel et al., 2000).  
Diverse PCR types have been implemented for a better and improved diagnosis 
of T. vaginalis infections. This includes PCR–enzyme-linked immunosorbent assay 
(PCR-ELISA) used for detection of T. vaginalis in urethral swabs, urine, and semen of 
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male sexual partners of women (Hobbs et al., 2006). Others include random amplified 
polymorphic DNA analysis (RAPD) (Jamali et al., 2005) to detect T. vaginalis DNA 
polymorphism, multiplex PCR (Diaz et al., 2010) and restriction fragment length 
polymorphism (RFLP) (Crucitti et al., 2008). 
Many different primers have been developed with regard to refining and 
improving the sensitivity of PCR method (Schwebke & Burgess, 2004; Swygard et al., 
2003). Although obtaining significant results were assertive with PCR methods, 
however high costs and technical complexity have limited the method to research 
settings (Soper, 2004).  
2.12.5 Other diagnostic methods 
 Additional diagnostic methods which have been invented and evaluated to 
enhance diagnosis of T. vaginalis includes fluroscent taxoid FLUTAX (Lecke et al., 
2003), latex agglutination (Adu-Sarkodie et al., 2004), antigen-based diagnostic tests 
(Soper, 2004), Food and Drug Adminisration (FDA)-approved point-of-care tests (i.e. 
OSOM, rapid antigen test and Affirm VP III, nucleic acid probe-hybridization) 
(Bachmann et al., 2011; Hobbs & Sena, 2007), XenoStrip-Tv rapid assay (Kurth et al., 
2004), antibody based technique (i.e. complement fixation, hemagglutination, gel 
diffusion, fluorescent antibody and ELISA) (Garber, 2005), and Transcription-Mediated 
Amplification-Based Analyte-Specific-Reagent Testing (Munson et al., 2008). Huppert 
et al. (2007) reported that the sensitivities of rapid antigen tests and transcription-
mediated assay were comparable with 92 % and 97 % respectively making these tests 
superior to wet mount examination. Although rapid tests can overcome the weakness of 
in vitro culture methods, however, these tests are seldom used in clinical settings due to 
the limited availability of sensitivity and specificity data (Wang, 2001).  
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2.13 Treatment and Control 
 Knowledge of clinical features, the virulence mechanisms, diagnosis methods 
and the epidemiological distributions of T. vaginalis enhance the effective treatment and 
management of this infection. Introduction of nitroimidazoles in 1960 for the systemic 
treatment of trichomoniasis became the turning point to the therapeutic approach of this 
infection (Wang, 2001). Derivative of nitroimidazoles includes metronidazole, 
tinidazole, ornidazole and secnidazole have been assessed for therapeutic effects in T. 
vaginalis infections (Ryu & Min, 2006).  Among these, metronidazole has been widely 
used in the treatment (Afzan, 2011a) especially in the United States (Soper, 2004) since 
it is highly effective and approved by WHO (1995) (Ryu & Min, 2006; Workowski & 
Berman, 2010) Metronidazole is a 5-nitroimidazole, a heterocyclic compound derived 
from Streptomyces antibiotic azomycin (Sood & Kapil, 2008). Metronidazole enters 
trichomonads by passive diffusion (Sood & Kapil, 2008; Ryu & Min, 2006).  
The recommended regimen of metronidazole consumption by CDC is 2 g orally 
in a single dose or alternatively 500 mg orally twice a day for seven days (Workowski 
& Berman, 2010). If an infected woman’s male partner is also treated, then the cure 
rates in women were reported similar, approximately 95 % with both regimens (Ackers, 
2001). However, if the male partner is not treated, the cure rates were lower with single-
dose regimen (Ackers, 2001). Despite the excellent cure rate, treatment failure is often 
encountered probably due to non-compliance or reinfection with T. vaginalis (Petrin et 
al., 1998). However, extensive studies proposed that the main cause of the treatment 
failure is due to resistance mechanisms of T. vaginalis strains to metronidazole (Petrin 
et al., 1998).  
Resistance towards metronidazole by T. vaginalis strains is an emerging 
problem with this drug (Wendel & Workowski, 2004; Harp & Chowdhury, 2011). 
Failure of drug resistance by T. vaginalis have been clinically studied by Dunne and 
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team (2003) giving other prospective therapeutic agents as an alternative treatment for 
the infection. Likewise, Meri et al. (2000) reported three cases of metronidazole- 
resistance of T. vaginalis in Finland and suggested a relatively simple method of 
identifying resistant strains through in vitro susceptibility testing. According to a source, 
CDC estimated that 5 % of clinical isolates of T. vaginalis demonstrated certain degree 
of resistance towards metronidazole (Swygard et al., 2003). In a study, metronidazole 
treatment of asymptomatic pregnant women infected with T. vaginalis was found to 
successfully eliminate the parasite but could not prevent preterm delivery suggesting 
that this drug may not be appropriate for asymptomatic women (Klebanoff et al., 2001). 
Similar to metronidazole, another derivative of 5-nitroimidazole known as 
tinidazole has also been widely accepted for treatment of trichomoniasis (Schwebke & 
Burgess, 2004). T. vaginalis strains that are resistant to metronidazole have been said to 
react effectively with tinidazole (Cudmore et al., 2004) with a plasma elimination half-
life of metronidazole (Harp & Chowdhury, 2011). Moreover, tinidazole penetrates 
better into male reproductive tissues compared to metronidazole (Harp & Chowdhury, 
2011) making it a better choice of treatment. Nonetheless, T. vaginalis is also known to 
exhibit resistance towards tinidazale but relatively in smaller number, 0.56 % compared 
to 9.6 % by metronidazole (Schwebke & Barrientes, 2006). 
Potential side effects such as metallic taste, headache, insomnia, drowsiness, dry 
mouth and nausea have been reported with the use of metronidazole or tinidazole 
(Moore, 2007; Cudmore et al., 2004). Alternative therapeutic approaches in treating T. 
vaginalis infections include nonoxynol-9 vaginal derivatives, clotrimazole derivatives, 
acetarsol derivatives, sulfimidazole, vaginal paromomycin preparations, combination of 
borad-spectrum antibitiocs and metronidazole (Cudmore et al., 2004; Lewis, 2010) as 
well as natural products (Gehrig and Efferth, 2009).  
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Treatment and control is an important aspect in the study T. vaginalis because 
untreated infections may remain “silent” leaving millions of men and women at 
increased risk of reproductive health complications and HIV transmission (Van Der Pol, 
2007). Control of risk associated factors such as smoking, frequent change of sexual 
partner, sharing of needles and other contagious materials must be taken care to prevent 
severity of the infections.  
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CHAPTER 3 
METHODOLOGY 
3.1  Source of T. vaginalis isolates 
This study was conducted using the samples collected by Afzan (2011b). The 
samples had been screened and identified for positive isolates. The screening was based 
on routine PAP smears and vaginal swabs of females seen at the Obstetric and 
Gynecology clinic. It was collected from patients from a local hospital complaining of 
vaginal discharges and itching. Actively growing T. vaginalis from CN isolates and 
NCN isolates were obtained from the culture maintained in Department of Parasitology, 
University Malaya. A total of three NCN isolates (NCN2 –NCN4) and six CN isolates 
(CN1 – CN6) were used in this study. NCN1 isolate died while maintaining in the in 
vitro culture. The identity of each isolates and their respective symptoms as obtained by 
Afzan (2011b) is shown in Appendix A. 
3.2 In vitro cultivation for maintenance of isolates 
The positive isolates were maintained axenically in Hollander medium 
(Appendix B) supplemented with 10% heat inactivated Horse serum (Gibco, Life 
Technologies) and 2 % Penicillin-Streptomycin-Neomycin (Gibco, Life Technologies) 
antibiotic mixture. All the isolates were grown in 15 ml screw-capped falcon tubes and 
incubated at 37ºC. Sub-culturing were performed every three days once by adding the 
Hollander medium up to 10 ml per isolate and screened once a week using light 
microscope to ensure the viability of the parasite. Isolates with active motile 
trophozoites were used for the phenotypic analysis of amoeboid forms in this study.  
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3.3 Trophozoites counts of T. vaginalis 
 The parasites of each isolate from day three culture were centrifuged at 2000 
rpm for 10 minutes and the supernatant was discarded up to 1 ml. The pellets were then 
suspended well before the count was taken. 10 µl of the suspension was mixed with 10 
µl of 0.4 % Trypan blue dye exclusion (Sigma-Aldrich Corp. USA). The trophozoite 
count was done using haemacytometer chamber (Improved Neubauer, Hausser 
Scientific). The chamber was then observed under light microscope at 400X 
magnification prior to counting. The blue dye acted as viability indicator and only 
viable cells that did not take up trypan blue stain was counted. Trophozoites were 
identified by observing their motile movements and twitching flagella.  
3.4 Growth profiling of amoeboid forms of T. vaginalis 
Prior initiating the growth profiles of amoeboid forms of T. vaginalis, initial 
counts of trophozoites were performed as mentioned in Section 3.3. Based on the 
numbers of trophozoite counted, a final inoculum  size of 1 x 10
4 
T. vaginalis per ml 
was made from the day three culture and inoculated into 3 ml culture tubes containing 
Hollander medium supplemented with 10 % heat inactivated horse serum and 2 % 
Penicillin-Streptomycin Neomycin antibiotic mixture. All cultures were kept in airtight 
screw-capped tubes and incubated at 37ºC until all the cells became non-viable. All 
experiments were done in triplicates. Amoeboid forms were identified by observing 
their non-motile movements with none or inactive flagella and delicate outer layer 
showing pseudopodia-like cytoplasmic extensions. Trophozoites and pseudocysts forms 
were excluded in this particular growth profile study. Growth profile and the percentage 
of amoeboid forms in the isolates were generated. Data significance were analysed 
using SPSS. The parasite concentration per ml (a) and initial inoculum concentration 
per ml (b) was calculated according to the given formulae;  
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(a) T. vaginalis concentration (T. vaginalis/ml): 
 
Average number of trophozoites in 5 squares x dilution factor x 10
4
 
Where; 
Dilution factor = 2 (1:1 dilution with trypan blue) 
10
4 
= count in 10 squares from large four squares 
 
(b)  Initial inoculum concentration (µl/ ml): 
 
                x     =   1 x 10
4
 
            1000             y 
 Where;  
 x   = Initial inoculum concentration (µl/ ml) 
 y   = T. vaginalis concentration (T. vaginalis/ml) 
 
3.5 Growth profiling of trophozoite forms of T. vaginalis 
Based on the number of trophozoites counted (Section 3.3), a final concentration 
of 1 x 10
4  
T. vaginalis/ml was made from the day three culture and inoculated in 3 ml 
culture tubes containing Hollander medium supplemented with 10 % heat inactivated 
horse serum and 2 % Penicillin-Streptomycin Neomycin antibiotic mixture. All cultures 
were kept in airtight screw-capped tubes and incubated at 37ºC. Counts of viable 
trophozoites detected using trypan blue were recorded up to 11 days until all the 
parasites became non-viable. Any other morphology besides trophozoites was excluded 
in this specific growth profile study. All experiments were done in triplicates. Growth 
profiles of trophozoites in CN isolates and NCN isolates were generated. Data 
significance were analysed using SPSS. The parasite concentration per ml and initial 
inoculum concentrations per ml was calculated using the formula shown in Section 
3.4(a) and (b).  
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The parasite concentration was increased to 10
5 
T. vaginalis/ml and the methods 
mentioned in Section 3.5 were repeated for CN isolates to generate the growth profile 
of trophozoites.  
3.6 Giemsa Stain method for detection of amoeboid forms  
Clean glass slides were smeared with drop of the T. vaginalis culture sediment 
of all the isolates showing amoeboid forms as detected from the growth profile study in 
Section 3.5. The smears were air dried and fixed with methanol for 30 seconds and 
stained with Giemsa stain at (Merck) dilution rate of 1:1 following the protocol of 
Sivanandam and Joon-Wah (as cited in Afzan et al., 2010) and allowed to air dry at 
room temperature for 10 – 30 minutes. The completely dried slides were then rinsed 
with distilled water and allowed to dry to room temperature prior to mounting with 
DPX. The slides were observed under 400X magnification using a light microscope. 
Similarly, trophozoites detected from growth profile study in Section 3.5 were stained 
with Giemsa for comparison with the amoeboid forms.  
3.7 Modified Fields’ Stain method for detection of amoeboid forms  
A small drop of the culture sediment from all the isolates showing amoeboid 
forms as detected from the profile study in Section 3.4 were smeared on clean glass 
slides. The smear was allowed to dry at room temperature for approximately 15-20 
seconds. Subsequently, six drops of Fields’ stain B (0.2 % solution of eosin Y (Sigma 
Aldrich) in methanol) and 10 drops of Fields’ stain A (LabChem Sdn Bhd) were 
immediately added. The slides were tilted to right and left for 10 – 20 seconds until a 
golden scum appeared on the surface of the smear. The slides were then rinsed for two 
seconds under brisk stream of tap water and allowed to dry to room temperature and 
mounted using DPX. The slides were observed under light microscope at 400X 
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magnification. Similarly, trophozoites detected from growth profile study in Section 3.5 
were stained with Modified Fields’ stain for comparison with amoeboid forms.  
3.8 Assessing the effect of different stress conditions in triggering amoeboid 
forms 
Three types of stress conditions were applied to the suspension culture as 
mentioned in the subsequent sub-methods to observe the formation of amoeboid forms 
in the positively detected isolates. The protocol to study the effect of these stress 
conditions were performed similarly as the growth profiling methods mentioned in 
Section 3.3 and Section 3.4 except for the parameters studied as described in the 
following sub-methods. The cultures were observed for amoeboid formation and 
numbers of viable amoeboid T. vaginalis were counted using the haemacytometer 
chamber until all the parasites became non-viable. All the following experiments were 
done in triplicates. The growth profiles were generated and analyzed. 
3.8.1  Effect of different parasite concentrations on amoeboid formation 
The protocol to study the effect of varying concentrations of T. vaginalis per ml 
on the development of amoeboid forms was similar as mentioned in Section 3.4 except 
that the final inoculum size was made to 1 x 10
3 
T. vaginalis/ml, 1 x 10
5 
T. vaginalis/ml 
and 1 x 10
6 
T. vaginalis/ml. Control in this specific growth profile study was the 
parasites concentration of 1 x 10
4 
T. vaginalis/ml. All experiments were conducted in 
triplicates. The cultures were observed for amoeboid formation and numbers of viable 
amoeboid T. vaginalis were counted until all the parasites became non-viable using the 
haemacytometer chamber. The results obtained were recorded and data significance 
were analysed using SPSS.  
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3.8.2 Effect of different horse serum concentrations on amoeboid formation 
      The protocol to study the effect of varying the concentrations of horse serum on 
the development of amoeboid forms was performed as mentioned in Section 3.4. 
However, the concentration of horse serum added to the Hollander medium prior to 
culturing is varied from 1 %, 5 %, 10 %, 15 % and 20 %. The final inoculum size of T. 
vaginalis were maintained at 1 x 10
4 
 T. vaginalis/ml. Control in this specific growth 
profile study was the horse serum concentration of 10 %. All experiments were 
conducted in triplicates. The cultures were observed for amoeboid formation and 
numbers of viable amoeboid forms of T. vaginalis were counted until all the parasites 
became non-viable using the haemacytometer chamber. The results obtained were 
recorded and data significance were analysed using SPSS. 
3.8.3  Effect of different metronidazole drug concentrations on amoeboid 
formation  
The protocol to study the effect of metronidazole drug (Sigma Aldrich) on the 
development of amoeboid forms was performed as mentioned in Section 3.4. Different 
concentrations of metronidazole drug ranging from 1 mg/ml, 0.1 mg/ml, 0.01 mg/ml, 
0.001 mg/ml and 0.0001 mg/ml were introduced into the culture containing the isolates. 
The final inoculum size was maintained at 1 x 10
4 
T. vaginalis/ml. Control in this 
specific growth profile study was without the addition of metronidazole drug for each 
isolate. All experiments were conducted in triplicates. The cultures were observed for 
amoeboid formation and numbers of viable amoeboid T. vaginalis were counted until all 
the parasites became non-viable using the haemacytometer chamber. The results 
obtained were recorded and data significance were analysed using SPSS. 
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3.9 Transformational changes of T. vaginalis from trophozoites to amoeboid 
forms  
    The parasites of each isolate from day three culture were centrifuged at 2000 
rpm for 10 minutes and the supernatants discarded up to 1 ml. The pellets were then 
suspended well before the count was taken. 10 µl of the suspension was mixed with 10 
µl of 0.4 % Trypan blue dye exclusion and amoeboid count was done using 
haemacytometer chamber. The chamber is then observed under a light microscope at 
400X magnification prior to counting. The blue dye acts as a viability indicator and only 
viable trophozoites that did not take up trypan blue stain were counted. Based on the 
number of parasites counted, a final inoculum size of 1 x 10
5 
T. vaginalis per ml was 
made from the day three culture and inoculated in 3 ml culture tubes containing 
Hollander medium supplemented with 10 % heat inactivated horse serum, 2 % 
Penicillin-Streptomycin Neomycin antibiotic mixture. All cultures were kept in airtight 
screw-capped tubes and incubated at 37ºC. The transformational change that took place 
in terms of size and shape from trophozoites to amoeboid forms was measured and 
recorded every day until no amoeboid forms were observed using a light microscope.  
3.10  Statistical analysis 
Statistical analysis was performed using SPPS version 20 (IBM SPSS Statistics). 
Significance of trophozoites count between days and between CN isolates in 10
4 
T. 
vaginalis/ml and 10
5 
T. vaginalis/ml respectively were tested using multiple comparison 
method meanwhile Mann-Whitney Test was used to compare the average trophozoites 
count between 10
4 
T. vaginalis/ml and 10
5 
T. vaginalis/ml. The significance between 
days of average amoeboid forms in CN isolates (CN1 – CN6) was calculated using 
Dunnett’s T3. Positive mean differences and the significance value were used to 
determine the days with higher counts. Mann-Whitney Test was used to determine the 
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significant difference in the number of amoeboid forms observed between 10
4 
T. 
vaginalis/ ml and 10
5 
T. vaginalis/ml. The effect of different concentrations of horse 
serum and metronidazole drug on amoeboid formation in suspension culture were 
analysed using Dunnett’s T3 and Tukey HSD respectively. In all cases, results with p < 
0.05 were considered as statistically significant. 
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CHAPTER 4 
RESULTS 
4.1 Light micrograph of amoeboid forms 
 Amoeboid forms of T. vaginalis are a unique and distinguishable morphological 
form of the parasite. Unlike the trophozoites and pseudocysts form of T. vaginalis, the 
amoeboid forms were observed with pseudopodia-like cytoplasmic extension 
surrounding the parasites, non-motile, none or inactive flagella, more inclusion–like 
bodies, flattened, bigger and irregular in shape under a light microscope (Fig. 4.1). The 
amoeboid forms were easily detected with their larger and non-motile morphology 
compared to actively swimming trophozoite forms. This shape was significant for the 
present study in order to obtain the targeted results. 
 
 
 
 
 
 
 
Figure 4.1: Light micrograph showing comparison of (a) round trophozoite form and (b) 
pseudocyst form with (c - d) amoeboid forms of T. vaginalis in suspension culture of 
CN isolates. Magnifications at 400X.  
Note: Arrows indicate the pseudopodia-like cytoplasmic extensions in the amoeboid 
forms. 
 
 
c. d. 
a. b. 
20 µm 
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4.2 Growth profiles of amoeboid forms of T. vaginalis 
The growth profile of amoeboid forms in CN and NCN isolates was performed 
for five consecutive days. Transformation of the motile trophozoites to non-motile 
amoeboid forms was only observed in CN isolates (Table 4.1) and none in NCN 
isolates. The growth pattern of amoeboid form of T. vaginalis followed a steady 
logarithmic growth phase from day 1 then peaked on day 3 and reached the death phase 
thereafter (Fig. 4.2a).  
The average number of amoeboid forms was significantly different between the 
days (p < 0.05) with highest count on day three of the culture, 19.34 ± 0.65 x 10
4 
T. 
vaginalis/ml for all the CN isolates (CN1 – CN6). Data on the significant difference 
were presented in Table 4.2 meanwhile the raw data were shown in Appendix C. 
Amoeboid forms remained viable only for 96 hours in all the CN isolates. The total 
number of amoeboid forms observed in all the CN isolates from day 1 to day 5 was 28.7 
± 7.93 x 10
4 
T. vaginalis/ml with highest count of 19.34 ± 0.65 x 10
4 
T. vaginalis/ml on 
day 3. Lowest number of amoeboid forms were observed on day 1 with total count of 
0.66 ± 0.17 x 10
4 
T. vaginalis/ml. Amoeboid forms were detected after 24 hours of 
incubation from isolate CN3 and isolate CN5 but in lower number of 0.33 ± 0.58 x 10
4 
T. vaginalis/ml respectively.  
Based on percentages of amoeboid forms detected in each isolate (Fig. 4.2b), it 
can be concluded that all CN isolates had almost similar amount of these forms. The 
most number of amoeboid formations from day 1 to day 4 were observed in isolate CN6 
with total average count of 6.00 ± 1.69 x 10
4 
T. vaginalis/ml (20.9 %), meanwhile the 
least was in isolate CN1 with an average of 13.9 %. Although every isolate reported 
different percentage of amoeboid counts, there was no significant preference among the 
CN isolates in triggering amoeboid forms (p > 0.05). Different types of the amoeboid 
forms of T. vaginalis were detected throughout the growth profile study in CN isolates 
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(Figure 4.3). Most of the amoeboid forms were observed with projections of cytoplasm, 
with none or inactive flagella and irregularly shaped. 
 
Table 4.1: Average amoeboid count of T. vaginalis in CN isolates from day 1 to day 5 
 
Note: Values in bold and highlighted were the optimum amoeboid forms obtained on 
day three culture. 
 
Table 4.2: Significance analysis between days using Dunnett T3 for average amoeboid 
forms of T. vaginalis in CN isolates at 10
4 
T. vaginalis/ml. 
 
 
*. The mean difference is significant at the 0.05 level 
 
Note: Comparison of average amoeboid form on day 3 with the rest of the days yielded 
all positive values with p-value less than 0.05 (bold). The 95 % confidence interval does 
not contain the value 0. Thus, there is a significant difference of average amoeboid 
count between days with day 3 having significantly higher count.  
Isolates 
Average count (No of amoeboid x 10
4 
T. vaginalis
 
/ ml) 
Day 0 Day 1 Day 2 Day 3  Day 4 Day 5 
CN 1 0.00          0.00 0.67 ± 0.58 3.00 ± 1.00 0.33 ± 0.58 0.00 
CN 2 0.00          0.00 1.00 ± 1.00 3.67 ± 1.15 0.33 ± 0.58 0.00 
CN 3 0.00      0.33 ± 0.58 1.33 ± 0.58 2.67 ± 0.58 0.33 ± 0.58 0.00 
CN 4 0.00          0.00 1.00 ± 1.00 2.67 ± 2.08 0.67 ± 1.15 0.00 
CN 5 0.00      0.33 ± 0.58  1.00 ± 1.00 3.00 ± 0.00   0.33 ± 0.58 0.00 
CN 6 0.00 0.00  0.67 ± 1.15 4.33 ± 1.53   1.00 ± 1.00 0.00 
Multiple comparisons 
Dependent Variable: Average amoeboid count x 10
4
 T. vaginalis/ ml 
Dunnett T3 
(I) 
Days of 
count 
(J) Days of 
count 
Mean 
difference     
(I – J) 
Std. 
error 
Sig. 
95% confidence interval 
Lower bound 
Upper 
bound 
Day 3 
Day 1 3.11333
*
 .27577 .000 1.9849 4.2417 
3.3958 Day 2 2.27833
*
 .28548 .001 1.1609 
Day 4 2.66833
*
 .28941 .000 1.5522 3.7844 
Day 5 3.22333
*
 .26685 .000 2.0728 4.3739 
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Figure 4.2a: Growth profiles of amoeboid forms of T. vaginalis in CN isolates (CN1 – CN6) at 104 T. vaginalis/ml inoculated in 
Hollander medium supplemented with 10 % Horse serum and 2 % Penicillin-Streptomycin Neomycin antibiotic mixture with 
optimum growth on day 3 of culture for all CN isolates.  
    Note: The values were expressed as average ± S.D. 
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Figure 4.2b: Percentages of amoeboid forms of T. vaginalis in CN isolates (CN1 – CN6) grown in Hollander medium  
from day 1 to day 4 of culture. Highest percentage of amoeboid forms was observed in isolate CN6 which had a total  
of 20.9 %. 
 
 
13.9% 
17.4% 
16.3% 
15.1% 
16.3% 
20.9% 
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
CN 1 CN 2 CN 3 CN 4 CN 5 CN 6
P
er
ce
n
ta
g
es
 (
%
) 
Isolates 
Percentages of Amoeboids in Six CN isolates 
Amoeboid forms
66 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Light micrograph showing different types of amoeboid forms of T. vaginalis observed on day 3 of suspension culture 
in cervical neoplasia (CN) isolates; (a-b) CN1, (c-d) CN2, (e-f) CN3, (g-h) CN4, (i-j) CN5, (k-l) CN6. 
Note: pseudopodia-like cytoplasmic extensions (arrows) with more inclusion-like bodies (black dots) on the cytoplasm of 
amoeboid forms. Magnifications 400X.   
20 µm 
a 
k j i 
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4.3 Growth profiles of trophozoite forms 
 4.3.1 Growth trend in 10
4 
T. vaginalis/ml 
 Generation of growth profiles of trophozoite forms of T. vaginalis for nine 
isolates consisting of three NCN isolates (NCN2 – NCN4) and six CN isolates (CN1 - 
CN6) with initial inoculum concentration of 1 x 10
4 
T. vaginalis/ml showed two 
distinctive and different growth curves (Fig 4.4 and Fig 4.5). The growth profile was 
generated based on mean count of three replicates (Appendix D). The growth pattern of 
trophozoites of both CN and NCN isolates started with logarithmic growth phase (log 
phase) in which the organisms divided continuously until each isolate reached its peak 
number of parasites. This was then followed by a continuous decrease in the 
trophozoites count until it reached the death phase where each isolate recorded a zero 
count of trophozoites.  
Presence of motile trophozoite forms were detected in almost all isolates up to 
10 days of culture except for CN2 and CN6 which remained viable only up to nine days. 
Although all the CN isolates were positive for trophozoites form, however there was no 
significant difference (p > 0.05) in average counts between each CN isolates (CN1 – 
CN6).  
All CN isolates exhibited optimum average count of trophozoite forms on day 3 
of cultures meanwhile it varied in NCN isolates with NCN2 and NCN3 having peak 
count on day 4 whilst day 3 for NCN4 isolate (Table 4.3). A gradual increase on the 
number of trophozoite were observed for all CN isolates and NCN isolates from day 1 
to day 3 (NCN4, CN1 – CN6) and day 4 (NCN2 – NCN3) which then decreased greatly 
upon reaching the optimal count until all parasites become non-viable.  
Total average number of trophozoite from day 1 to day 10 counted in CN 
isolates (CN1 – CN6) and NCN isolates (NCN2 – NCN4) was 3615.04 ± 67.69 x 104 T. 
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vaginalis/ml and 1060.63 ± 30.07 x 10
4 
T. vaginalis/ml respectively. The total average 
count of trophozoites in NCN isolates was relatively lower than CN isolates. Highest 
trophozoite count obtained from both types of isolate, CN and NCN was on day 3 with 
average count of 240 ± 13.89 x 10
4 
T. vaginalis/ml in CN4 and 92.33 ± 4.93 x 10
4 
T. 
vaginalis/ml in NCN4. The lowest trophozoite count recorded was on day 1 for NCN2 
with mean count of 5.33 ± 1.53 x 10
4 
T. vaginalis/ml and day 10 for CN5 with mean 
count of 0.67 ± 1.15 x 10
4 
T. vaginalis/ml.  
Average trophozoite count on day 3 in all CN isolates were observed to be 
significantly different (p < 0.05) and highest with mean average of 224.22 ± 2.18 x 10
4 
T. vaginalis/ml compared to other incubation days that at least has one pair that are not 
significant (Table 4.4). Further data analysis using multiple comparison method 
(Appendix E) found that mean difference of trophozoite count on day 3 with other days 
was significant (p <0.05, Dunnett’s T3). Based on the growth curve observed for 
trophozoite in CN isolates (CN1 – CN6), it is evident that the optimal count was on day 
3 for all isolates ranging between 210 ± 21.52 x 10
4 
T. vaginalis/ml for CN2 to 240 ± 
13.89 x 10
4 
T. vaginalis/ml in CN4. This is followed by isolate CN5 with second highest 
trophozoite count of 238 ± 26.66 x 10
4 
T. vaginalis/ml. In isolate CN1, there was a rapid 
increase from day 1 with average count of 16.67 ± 3.06 x 10
4 
T. vaginalis/ml to day 3 
with average count of 221 ± 11.59 x 10
4 
T. vaginalis/ml. In both types of isolate, 
trophozoites count started to decrease tremendously after day 7 and none were detected 
on day 11 of observation.  
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Table 4.3: The number of trophozoites of T. vaginalis in all isolates from day 1 of inoculation up to day 11 where no trophozoites 
were detected in the cultures. 
Note: Values in bold were peak count of trophozoites based on isolates 
          Values in grey highlighted boxes were significantly different (Dunnett T3). 
Isolates 
Average no. of trophozoites of T.vaginalis x 10
4 
T. vaginalis/ ml  ± standard deviation 
Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10 Day 11 
NCN 2 1.00 5.33          
± 1.53 
11.00    
± 2.00 
41.33    
± 3.21 
89.00    
± 9.17 
86.33    
± 11.85 
63.33     
± 5.69 
45.33    
± 4.04 
19.33    
± 5.86 
14.33    
± 6.51 
8.00        
± 2.00 
0.00 
NCN 3 1.00 6.00          
± 1.00 
10.00     
± 3.46 
50.33    
± 8.74  
87.00 
±9.54 
54.00    
± 5.29 
51.33 
±18.23 
27.00    
± 3.46 
10.67    
± 2.52 
5.33      
± 2.08  
3.00        
± 2.00 
0.00 
NCN 4 1.00 13.00        
± 1.73 
28.00 
±7.94 
92.3     
± 4.93  
74.33 
±4.04 
63.67 
±6.66 
46.00 
±10.15 
32.33 
±2.52 
11.33 
±1.53 
8.00      
± 1.00 
3.67        
± 1.15 
0.00 
CN 1 1.00 16.67        
± 3.06 
103.00    
± 6.08 
221.00   
± 11.59 
88.00    
± 2.65 
64.00    
± 5.29 
54.67     
± 3.79 
25.33    
± 0.58 
15.33    
± 3.51 
1.67      
± 2.89 
0.33        
± 0.58 
0.00 
CN 2 1.00 16.00        
± 4.58 
99.00 
±8.19 
210.00  
± 21.52 
94.33    
± 8.14 
75.00    
± 11.14 
24.67     
± 4.51 
15.33    
± 3.21 
8.67      
± 1.53 
3.00      
± 2.65 
0.00 0.00 
CN 3 1.00 43.67        
± 7.37  
85.67    
± 6.66 
209.67  
± 10.26 
149.67  
± 19.04 
77.67    
± 3.21 
26.33     
± 5.51 
20.33    
± 5.51 
13.67    
± 4.73 
7.33      
± 3.21 
2.33        
± 3.21 
0.00 
CN 4 1.00 17.00        
± 3.46 
144.67 
±14.50 
240.00  
± 13.89 
170.33  
± 18.23 
68.67    
± 8.62 
40.67    
± 4.73 
25.00    
± 5.00 
12.33    
± 4.16 
4. 33     
± 3.21 
1.67        
± 2.89 
0.00 
CN 5 1.00 22.00        
± 6.56 
116.00  
± 16.52 
238.00  
± 26.66 
95.00    
± 7.81 
58.00    
± 2.65 
36.67     
± 5.77 
27.33    
± 5.69 
16.67    
± 4.93 
7.00      
± 3.61 
0.67        
± 1.15 
0.00 
CN 6 1.00 23.67        
± 7.09 
67.67    
± 12.86 
226.00  
± 11.36 
92.67    
± 4.73 
33.67    
± 2.08 
27.00     
± 1.73 
17.00    
± 1.00 
10.67    
± 0.58 
1.67      
±  0.58 
0.00 0.00 
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Table 4.4: Significance analysis between days using Dunnett T3 for average trophozoite 
count of CN isolatesin 10
4 
T. vaginalis/ml. 
  
Note: Comparison of average trophozoite count on day 3 with the rest of the days 
yielded all positive values with p-value less than 0.05 (bold). The 95 % confidence 
interval does not contain the value 0. Thus, there is a significant difference of average 
trophozoite count between days with day 3 having significantly higher count.  
Multiple Comparisons 
Dependent Variable: Average trophozoites count in 10
4 
T. vaginalis/ml 
Dunnett T3 
(I) Days 
of count 
(J) Days 
of count 
Mean 
Difference (I-J) 
Std. Error Sig. 95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Day 3 Day 0 
Day 1 
Day 2 
Day 4 
Day 5 
Day 6 
Day 7 
Day 8 
Day 9 
Day 10 
223.22333
*
 
201.05500
*
 
121.55500
*
 
109.22333
*
 
161.38833
*
 
189.22167
*
 
202.50333
*
 
211.33333
*
 
220.05667
*
 
223.39000
*
 
5.36184 
6.87041 
12.01630 
15.47124 
8.44575 
7.14190 
5.72359 
5.49660 
5.46006 
5.37614 
.000 
.000 
.000 
.008 
.000 
.000 
.000 
.000 
.000 
.000 
193.6285 
171.0052 
64.7365 
32.1207 
124.5406 
158.2293 
174.0276 
182.3122 
190.9010 
193.8667 
252.8181 
231.1048 
178.3735 
186.3260 
198.2361 
220.2140 
230.9791 
240.3545 
249.2123 
252.9133 
 
*. The mean difference is significant at the 0.05 level 
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Figure 4.4: Growth profiles of trophozoite forms in CN isolates (Isolates 1 – Isolates 6) at 104 T. vaginalis/ml inoculated in 
Hollander medium containing 10 % heat inactivated horse serum and 2 % PSN antibiotic mixture and incubated at 37ºC. All CN 
isolates exhibited peak count of trophozoite forms on day 3 culture. 
          Note: The values were expressed as the means ± S.D.  
 
 
 
Isolates 
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Figure 4.5: Growth profiles of trophozoite forms in NCN isolates (Isolates 2 – Isolates 4) at 104 T. vaginalis/ml inoculated in Hollander 
medium containing 10% heat inactivated horse serum and 2% PSN antibiotic mixture and incubated at 37ºC. NCN4 showed peak 
count on day 3 meanwhile NCN2 and NCN3 showed peak count on day 4. 
 Note: The values were expressed as the means ± S.D. 
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4.3.2 Growth trends in 10
5 
T. vaginalis/ml 
 Growth profile of average trophozoite counts of T. vaginalis for CN isolates in 
10
5 
T. vaginalis/ml showed a similar curve with 10
4 
T. vaginalis/ml but with increased 
trophozoite counts (Table 4.5 and Fig 4.6). The growth profile generated was based on 
mean count of three replicates (Appendix F). There was no significant difference in 
mean trophozoite counts between each CN isolate tested as well as between the days (p 
> 0.05). However, the average trophozoites count was the highest on day 3 with mean 
total of 429.22 ± 11.19 x 10
5 
T. vaginalis/ml. In all CN isolates, the trophozoites were 
observed to be viable only for six days. Among all the CN isolates, CN6 produced the 
most trophozoite forms with the count of 512.67 ± 12.74 x 10
5 
T. vaginalis/ml on day 3 
cultures. There was a rapid growth of trophozoites from day 1 to day 3 and decreased 
tremendously thereafter.  
Table 4.5: The average number of trophozoites of T. vaginalis in all CN isolates at 
inoculum concentrations of 10
5 
T. vaginalis/ml. 
 
Note: Values highlighted in grey were highest for trophozoites count. 
Isolate
s 
Average count (No of trophozoites x 10
5 
T. vaginalis/ ml ± S.D. 
Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
CN 1 1.00 
62.67 
±11.02 
121.00    
± 14.53 
361.67    
± 32.52 
237.00    
± 8.00 
65.33      
± 18.50 
3.00     
± 1.00 
0.00      
CN 2 1.00 
31.67  
±11.02 
150.00 
±19.7 
370.33   
± 43.02 
221.33  
±21.01 
34.00     
± 14.11 
6.33     
± 3.21 
0.00 
CN 3 1.00 
41.33  
± 4.04 
139.67   
± 23.97 
510.33   
± 63.14 
267.33   
± 19.04 
41.00     
± 3.61 
13.67  
± 6.43 
0.00 
CN 4 1.00 
78.67   
± 9.61 
141.67    
± 8.08 
421.33   
± 51.64 
227.67   
± 21.08 
91.00     
± 13.89 
23.67 
±10.07 
0.00 
CN 5 1.00 
35.00  
± 4.58 
167.67   
± 14.47 
399.00   
± 19.00 
218.00   
± 16.82 
53.33     
± 21.73 
0.33    
± 0.58  
0.00 
CN 6 1.00 
51.00 
±17.09 
127.33   
± 26.16 
512.67   
± 12.74 
230.67   
± 28.01 
109.67   
± 12.06 
33.33  
± 9.07 
0.00 
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Figure 4.6: Growth profiles of trophozoite forms in CN isolates (Isolates 1 – Isolates 6) at 105 T. vaginalis/ml inoculated in 
Hollander medium containing 10 % heat inactivated horse serum and 2 % PSN antibiotic mixture and incubated at 37ºC. All the CN 
isolates showed peak count on day 3 culture. 
    Note: The values were expressed as the means ± S.D. 
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4.3.3 Combined growth profiles of CN isolates for 10
4 
T. vaginalis/ml and 10
5 
T. 
vaginalis/ml 
The combined average growth rate of trophozoites in all CN isolates in 10
4 
T. 
vaginalis/ml and 10
5 
T. vaginalis/ml were shown in Table 4.6. The average growth rate 
of trophozoites from day 1 to day 4 was significantly higher (p < 0.05) when parasite 
concentration was 10
5 
T. vaginalis/ml and the growth was overtaken by parasite 
concentration of 10
4 
T. vaginalis/ml from day 6 onwards (Table 4.7). Trophozoite count 
was approximately the same on day 5, thus no significant difference were produced 
between the two concentrations. 
The mean average trophozoite form observed in all CN isolates (CN1-CN6) was 
597.51 ± 8.93 x 10
4 
T. vaginalis/ml for 10
4 
T. vaginalis/ml and 933.28 ± 18.71 x 10
5 
T. 
vaginalis/ml for 10
5 
T. vaginalis/ml. The trophozoite count was constantly higher in 10
5 
T. vaginalis/ml from day 1 to day 4 of culture and decreased steadily from day 5 until 
all the parasites attained senescence. Based on the graph (Fig. 4.7), it can be observed 
that trophozoite forms became totally non-viable first in culture with concentration of 
10
5 
T. vaginalis/ml on day 7 followed by trophozoites in 10
4 
T. vaginalis/ml on day 10.   
 
Table 4.6: The average growth of trophozoites in all CN isolates (CN1-CN6) at10
4 
T. 
vaginalis/ml and 10
5 
T. vaginalis/ml.
 
Note: 
x 
represents the concentration of the parasites. 
 
 
Isolates 
Total Average count (No of trophozoites x 10
x 
T. vaginalis/ ml ± S.D. 
Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 
10
4
 T. 
vaginalis/ml 1.00 
23.17   
± 1.75 
102.67    
± 4.39 
224.22    
± 2.18 
115.00    
± 5.92 
62.84      
± 2.66 
35.00   
± 1.93 
21.72   
± 0.82 
12.89  
±0.82 
10
5
 T. 
vaginalis/ ml 1.00 
50.06   
± 3.00 
141.22   
± 2.77 
429.22    
± 11.19 
233.67    
± 2.97 
 65.72  
± 4.92 
13.39   
± 2.15 0.00 0.00 
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Table 4.7: Significant difference of growth rates of trophozoites in CN isolates between 
inoculum size of 10
4 
T. vaginalis/ml and 10
5 
T. vaginalis/ml using Mann-Whitney Test. 
 
Test Statistics
a
 
 Day1 Day2 Day3 Day4 Day5 Day6 Day7 Day8 
Mann-Whitney U 3.000 4.000 .000 .000 18.000 3.000 .000 .000 
Wilcoxon W 24.000 25.000 21.000 21.000 39.000 24.000 21.000 21.000 
Z -2.402 -2.242 -2.882 -2.882 .000 -2.402 -3.077 -3.077 
Asymp. Sig. (2-
tailed) 
.016 .025 .004 .004 1.000 .016 .002 .002 
Exact Sig. [2*(1-
tailed Sig.)]       
 
.015
b
 .026
b
 .002
b
 .002
b
 1.000
b
 .015
b
 .002
b
 .002
b
 
 ** **  ** **  *** *** *** 
         
a. Grouping Variable: Parasites concentrations 
b. Not corrected for ties. 
 
Note: Comparison of growth rates of trophozoites in CN isolates (CN1-CN6) between 
parasite concentration of 10
4 
T. vaginalis/ml and 10
5 
T. vaginalis/ml. Trophozoites count 
were significantly higher from day 1 to day 4 in 10
5 
T. vaginalis/ml (** p < 0.005, 
Mann-Whitney Test) and from day 6 to day 8 in 10
4 
T. vaginalis/ml (*** p < 0.005, 
Mann-Whitney Test).  
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  Figure 4.7: Comparison of combined growth profiles of average trophozoite forms of T. vaginalis between 10
4 
T. vaginalis/ml and 10
5 
T.     
vaginalis/ml in all CN isolates (CN1-CN6). Total average trophozoite form found in all CN isolates of 10
5 
T. vaginalis/ml from day 1 to 
day 4 culture was significantly higher than in 10
4 
T. vaginalis/ml (** p < 0.05, Mann-Whitney Test).  
Note: The values were expressed as mean average ± S.D. 
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4.4 Assessment of amoeboid morphology by staining method 
 Once the amoeboid forms were detected using light microscopy and further 
confirmed with growth profile study, the positive isolates were subjected to staining 
methods to detect and analyze the morphological characteristics of the amoeboid forms. 
In this study, the positive isolates were CN isolates (CN1-CN6).  The two types of 
staining methods used were the Giemsa stain and the Modified Field’s Stain.
 Nucleus and cytoplasm of the amoeboid forms of T. vaginalis were stained dark 
purple and light purple respectively with Giemsa stain. Meanwhile with Modified 
Field’s Stain the nucleus and cytoplasm were stained with bright purplish red and light 
purplish red respectively. Inactive flagella although was observed attached to the 
cytoplasm of amoeboid forms did not pick up the stains by both methods. 
Morphological differences between trophozoite and amoeboid forms of T. vaginalis 
were highlighted through the staining methods (Fig 4.8a & Fig. 4.8b). Giemsa stained 
the flagella of trophozoites light purple while Field’s stain showed reddish purple. This 
was absent in the amoeboid forms. 
Despite the significant colour contrast of amoeboid forms observed using both 
the stains, staining with Field’s stain was found to be more rapid (15 seconds) compared 
to 30 minutes for the Giemsa stain. Field’s stain was better than Giemsa stain as it gave 
better and noticeable contrast of the amoeboid morphological features. The nucleus, 
cytoplasm and the pseudopodia-like projections were more clearly seen in Field’s stain. 
Other morphological features such as single or multi-nucleus as well rough surfaces 
were clearer when stained with Field’s stain (Figure 4.9).  
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Figure 4.8a: Morphological comparison between Giemsa stained (a-b) trophozoites and 
(c-d) amoeboid forms. Note the evident differences between ovoid trophozoites and 
abnormal amoeboid. The arrows indicate the flagella (a-b) and pseudopodia-like 
cytoplasmic projections (c-d). Magnifications 400X. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8b: Morphological comparison between Modified Field’s stained (e-f) 
trophozoites and (g-h) amoeboid forms. Note the evident differences between ovoid 
trophozoites and abnormal amoeboid.  The arrows indicate the flagella (e-f) and 
pseudopodia-like cytoplasmic projections (g-h). Magnifications 400X.
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Figure 4.9: Comparison of staining method between (a-c) Modified Field’s Stain and 
(d-f) Giemsa stain of amoeboid forms in CN isolates of T. vaginalis.  
 
20 µm  
Clear contrast between nucleus ( ) and cytoplasm (  ) stained bright 
purplish red and light purplish red respectively. Not the prominent pseudopodia-
like cytoplasmic extensions ( ), uneven surfaces and multi-nucleated. 
Nucloelus (  ) stained with very dark purple can also be seen (b). 
Magnifications 400X. 
  
 
 
c. 
 
b. 
 
a.
.. 
 
Modified Field’s Stain 
Nucleus ( ) and cytoplasm ( ) stained dark and light purple respectively. 
Poor identification of other morphological appearance of amoeboid forms. 
(Magnifications 400X).  
 
 
Giemsa stain 
e. d. f. 
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4.5 Effect of different stress conditions in triggering amoeboid forms 
Based on the three different stress conditions applied to the suspension culture, 
formation of amoeboid forms in T. vaginalis was observed to be significantly higher (p 
< 0.05) when the growth conditions were stressed than in normal conditions in all the 
CN isolates (CN1 – CN6). Although the mean counts of amoeboid forms were different 
in each CN isolate for the three respective stress conditions, yet there was no significant 
relationship (p > 0.05) between each isolate in triggering this form. Raw data on the 
average count of the amoeboid forms for the three stress conditions tested are shown in 
Appendix G – Appendix I. 
4.5.1  Effect of different sizes of inoculum 
Among the three different types of T. vaginalis concentrations compared, 
amoeboid forms of T. vaginalis were only seen in culture with inoculum size of 10
5 
T. 
vaginalis/ml. No amoeboid forms were present in culture with 10
3 
T. vaginalis/ml and 
10
6 
T. vaginalis/ml. Appearance of amoeboid forms were found to be similar with the 
growth profile of amoeboid form at 10
4 
T. vaginalis/ml but with increased number of 
trophozoites and amoeboid forms were detected on day 1 itself for all the CN isolates 
(Table 4.8 and Fig. 4.10).  All CN isolates (CN1 – CN6) reported significantly higher 
number of amoeboid forms (p < 0.05) from day 1 to day 4 when the number of T. 
vaginalis was increased ten-fold from the standard concentration of 10
4 
T. vaginalis/ml 
(Table 4.9 and Fig. 4.11). Data on statistical significance between average amoeboid 
counts between 10
4 
T. vaginalis/ml and 10
5 
T. vaginalis/ml were shown in Appendix J.  
Total number of amoeboid forms detected in culture of 10
5 
T. vaginalis/ml was 
116.65 ± 3.96 x 10
5 
T. vaginalis/ml with peak count of 59.33 ± 3.03 x 10
5 
T. 
vaginalis/ml on day 3 of culture in all CN isolates (CN1-CN6). Lowest amount of 
amoeboid forms were detected on day 4 with total count of 7.67 ± 0.53 x 10
5 
T. 
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vaginalis/ml. Despite statistical insignificance between CN isolates, isolate CN4 
recorded highest numbers of amoeboid forms with mean average of 4.61 ± 0.91 x 10
5 
T. 
vaginalis/ml. Only mean average of 2.22 ± 0.46 x 10
5 
T. vaginalis/ml of amoeboid were 
detected in isolate CN1. Overall, all the CN isolates developed amoeboid forms only up 
to 96 hours of incubation. 
Table 4.8: Average amoeboid forms of T. vaginalis in CN isolates from day 1 to day 5 
in 10
5 
T. vaginalis/ml. 
 
Note: Values in bold and highlighted were peak count of amoeboid forms on day 3. 
 
 
Table 4.9: The significant difference between growth profiles of amoeboid forms of at 
10
4 
T. vaginalis/ml and 10
5 
T. vaginalis/ml using Mann-Whitney test. 
Note: Comparison of growth rates of amoeboid forms in CN isolates (CN1-CN6) 
between 10
4 
T. vaginalis/ml and 10
5 
T. vaginalis/ml. Amoeboid forms were significantly 
higher from day 1 to day 4 in 10
5 
T. vaginalis/ml (** p < 0.05, Mann-Whitney Test).  
Isolates 
Average count (No of amoeboid x 10
5 
T. vaginalis/ ml ± S.D) 
 
Day 0 Day 1 Day 2 Day 3  Day 4 Day 5 
CN 1 0.00 1.33 ± 0.58 3.00 ± 0.00   7.33 ± 3.06 1.67 ± 0. 58 0.00 
CN 2 0.00 2.00 ± 1.73 5.33  ± 0.58 14.33 ± 4.93 1.33  ± 0.58 0.00 
CN 3 0.00 1.33 ± 0.58            7.00  ± 1.00 7.67 ± 2.52 0.33  ± 0.58 0.00 
CN 4 0.00 3.33 ± 1.53 9.67  ± 1.53 13.00 ± 3.46 1.67 ± 1.53 0.00 
CN 5 0.00 3.00 ± 1.73 7.33 ± 3.79 9.33 ± 3.79 1.67  ± 1.15 0.00 
CN 6 0.00 2.00 ± 0.00 4.33 ± 1.15 7.67 ± 1.15 1.00  ± 1.00 0.00 
Test Statistics
a
 
 Day 1 Day 2 Day 3 Day 4 
Mann-Whitney U .000 .000 .000 4.500 
Wilcoxon W 21.000 21.000 21.000 25.500 
Z -2.950 -2.908 -2.898 -2.263 
Asymp. Sig. (2-tailed) .003 .004 .004 .024 
Exact Sig. [2*(1-tailed Sig.)] .002
b
 .002
b
 .002
b
 .026
b
 
 ** ** ** ** 
a. Grouping Variable: Cell concentrations b. Not corrected for ties. 
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 Figure 4.10: Growth profiles of amoeboid forms of T. vaginalis in CN isolates (CN1 – CN6) at 105 T. vaginalis/ml inoculated in    
 Hollander medium supplemented with 10 % Horse serum and 2 % Penicillin-Streptomycin Neomycin antibiotic mixture with   
 optimum growth on day 3 of culture for all CN isolates.  
 
 Note: The values were expressed as average ± S.D. 
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Figure 4.11: Comparison of combined growth profiles of average amoeboid forms of T. vaginalis between inoculum size of 10
4 
T. vaginalis/ml and 10
5 
T. vaginalis/ml in all CN isolates (CN1-CN6). Total average amoeboid found in all CN isolates of 10
5 
T. 
vaginalis/ml from day 1 to day 4 culture was significantly higher than in 10
4 
T. vaginalis/ml (** p < 0.05, Mann-Whitney Test).  
Note: The values were expressed as mean average ± S.D. 
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4.5.2 Effect of different concentrations of horse serum  
All six isolates of CN responded well to different concentrations of horse serum 
ranging from the lowest concentration of 1 % to highest concentration of 20 % (Table 
4.10). Horse serum concentrations of 10 % were used as the reference standard to 
evaluate the formation of amoeboid forms of T. vaginalis. Percentages of amoeboid 
forms in CN isolates of T. vaginalis were observed to vary greatly when the 
concentrations of horse serum were increased from 1 % to 20 % (Fig.4.12). Amoeboid 
forms were not observed in any of CN isolates when the horse serum concentrations 
were the lowest (1 %), thus reported a significantly lowest count (p < 0.05) compared to 
other concentrations. 15 % of horse serum triggered the highest formation of amoeboid 
in all CN isolates with mean average of 9.95 ± 0.47 x 10
4 
T. vaginalis/ml and was 
significantly higher (p < 0.05) than the amoeboid forms identified in horse serum 
concentrations of 1 %, 5 % and 10 %. When the concentration was further increased to 
20 %, amoeboid forms were still observed in the culture, however the count decreased 
slightly to mean average of 6.33 ± 0.27 x 10
4 
T. vaginalis/ml with no significant 
difference with 5 %, 10 % and 15 % concentrations. Data on statistical significance 
were presented in Appendix K.  
Table 4.10: Average amoeboid forms between different horse serum concentrations in 
CN isolates. 
 
Note: Horse serum concentrations of 15 % reported highest count of amoeboid forms 
(bold and highlighted). 
Isolates 
Average amoeboid forms ± S.D  x 10
4 
T. vaginalis/ml  
1 % 5 % 10 % 15 % 20 % 
 CN 1 0.00 4.00 ± 1.26 5.00 ± 1.37 11.00 ± 2.49 5.67 ± 1.59 
CN 2 0.00 3.00 ± 0.83 4.33 ± 1.19 7.33 ± 1.80 8.00 ± 2.39 
CN 3 0.00 3.67 ± 0.98 3.67 ± 1.06 7.33 ± 2.14 6.33 ± 1.77 
CN 4 0.00 3.00 ± 0.89 3.00 ± 0.72 8.67 ± 2.23 5.67 ± 1.66 
CN 5 0.00 4.00 ± 1.26 4.00 ± 1.03 14.67 ± 4.02 8.33 ± 2.29 
CN 6 0.00 6.00 ± 1.79 6.00 ± 1.16 10.67 ± 3.35 4.00 ± 1.10 
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Figure 4.12: Effect of different horse serum concentrations in triggering amoeboid forms in CN isolates (CN1 – CN6) grown in 
Hollander medium.  
Note: Horse serum concentration of 15 % reported higher count of amoeboid in all CN isolates while none in 1 %.   
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4.5.3 Effect of different concentrations of metronidazole drug 
In the final evaluation of the effects of growth environment on the development 
of amoeboid forms, the culture conditions of CN isolates was put under stress by 
introducing different concentrations of metronidazole drug. Effects of metronidazole 
drug  was observed to trigger amoeboid forms under certain circumstances (Fig.4.13) 
and CN isolates were found to be susceptible to high concentrations of the drug. Among 
the five different metronidazole drug concentrations tested, amoeboid forms were only 
observed at the two lowest concentrations of 0.001 mg/ml and 0.0001 mg/ml with 
significantly higher count in 0.0001 mg/ml (p < 0.05). The mean average of amoeboid 
forms detected in 0.001 mg/ml and 0.0001 mg/ml was 1.56 ± 0.08 x 10
4 
T. vaginalis/ml 
and 3.61 ± 0.07 x 10
4 
T. vaginalis/ml respectively. However, when compared with the 
control (without metronidazole drug), the amoeboid forms in all the six CN isolates 
were seen to be significantly higher (p < 0.05) using Tukey HSD compared to 0.001 
mg/ml and 0.0001 mg/ml with mean average amoeboid forms of 5.66 ± 0.13 x 10
4 
T. 
vaginalis/ml (Table 4.11).  Data on statistical analysis were presented in Appendix L. 
Although there was no significant preference between CN isolates in developing 
amoeboid forms, highest amoeboid forms in control and 0.0001 mg/ml was in isolate 
CN2 meanwhile in 0.001 mg/ml was in isolate CN3.  
Table 4.11: Comparison of average amoeboid forms in CN isolates between control and 
different concentrations of metronidazole drug. 
Isolates 
Average amoeboid forms ± S.D  x 10
4 
T. vaginalis/ml 
Control 0.001 mg/ml 0.0001 mg/ml 
CN 1 6.00 ± 1.30 1.67 ± 0.26 3.33 ± 0.26 
CN 2 7.00 ± 1.52 1.67 ± 0.26 4.33 ± 0.46 
CN 3 5.00 ± 1.00 2.33 ± 0.26 3.67 ± 0.67 
CN 4 5.00 ± 1.41 1.67 ± 0.26 3.33 ± 0.52 
CN 5 5.00 ± 1.41 1.00 ± 0.45 3.67 ± 0.26 
CN 6 6.00 ± 1.30 1.00 ± 0.00 3.33 ± 0.87 
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Figure 4.13: Effects of different concentrations of metronidazole drug against control in CN isolates (CN1-CN6). Highest 
amoeboid forms were observed in conditions without metronidazole drug followed by in 0.0001 mg/ml.   
Note: Values were expressed as mean ± S.D.  
Standard bar = Standard error. 
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4.6 Transformational changes analysis from trophozoites to amoeboid forms 
 Transformational changes in CN isolates of T. vaginalis were successfully 
demonstrated using light microscopy. There were significant modifications of the ovoid 
trophozoite forms when changing into irregular amoeboid forms. The changes were 
observed under two types of conditions namely stress-free and stressed culture 
environments. Comparison of the morphological changes from trophozoites to 
amoeboid forms between these two conditions revealed remarkable variations to the 
size and shapes of CN isolates with evident observations in stressed culture conditions 
(Fig 4.14 & Fig 4.15).  
 When the growth medium was retained in its standard conditions with inoculum 
size of 10
4 
T. vaginalis/ml, amoeboid forms were detected. The size and shapes of the 
amoeboid forms were slightly smaller and irregular. Maximum length and width of 
amoeboid forms achieved in a non-stress condition was approximately 17.5 µm and 
12.5 µm respectively. Within 24 hours of culture, the trophozoites were observed to 
move freely and were actively twitching the flagella which had an approximate length 
of 10 µm. When the incubation period increased to 24 hours, the ovoid trophozoites 
slowly turned into irregular shape with small part of the cell membrane seen to protrude 
from one end of the cell. Motility of trophozoite decreased gradually after 24 hours with 
slow twitching of flagella. The shape became irregular, measuring about 15 µm in 
length. At 72 hours, the trophozoites transformed into larger, flattened and thin 
amoeboid forms with inactive flagella. At this point, more trophozoites were observed 
to be in close contact but in a relaxed state. Slight protrusion of the cytoplasm occurred 
forming small pseudopodia-like cytoplasmic extensions with few inclusion-like bodies 
in the cytoplasm.  
 In contrast, when the growth medium was inoculated with 10
5 
T. vaginalis/ml, a 
rapid and significant formation of amoeboid forms was seen. Numbers of trophozoite 
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forms increased immensely within few hours of culture and were seen to move in 
groups. Although the trophozoite was seen to move actively, however their movement 
became restricted with the large number of T. vaginalis aggregating into clumps of 
trophozoites which showed slow motility when observed at six hours of culture.  At 12 
hours, trophozoites were observed to attach with each other. Few irregular shaped forms 
were noted to attach with one another and these parasites were motile with slow moving 
inactive flagella. Amoeboid forms with extensive projection of cytoplasm forming 
pseudopodia around the membrane were seen. These forms had more inclusion-like 
bodies and inactive flagella. Fully non-motile amoeboid forms measured approximately 
27.5 µm in length and 25 µm in width which was relatively larger than those observed 
in stress-free medium were only observed in 72 hours culture. The pyriform shaped 
trophozoites were seen to transform into thin and flattened amoeboid forms. The 
morphological structure of amoeboid form complete with the pseudopodia-like 
cytoplasmic extensions and inclusion-like bodies disintegrated after 96 hours and were 
totally absent in 120 hours culture.   
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Figure 4.14: a-f Light micrograph showing transformational changes of T. vaginalis 
from trophozoite to amoeboid forms in non-stressed culture conditions. Observation 
taken from six hours (day 0) up to 120 hours (day 5) in CN isolates. Magnifications 
400X. 
a Trophozoite of T. vaginalis. Note the tear-drop shaped, with active flagella at the 
anterior end of the cell with length about 8µm at six hour. 
b Trophozoite tend to become irregular in shape after 24 hours in the suspension 
culture. Note that the cell membrane protrudes at one end giving the trophozoite a 
slightly irregular shape measuring about 10 µm in length. 
c Amoeboid forms were seen to form after 36 hours in culture with more irregular in 
shape. Note that the tear-drop trophozoite has taken a new shape with less active 
flagella and measuring about 15.5 µm in length. 
d Complete formation of viable amoeboid shape was seen at 72 hours. Note the 
pseudopodia-like cytoplasmic projections (arrows), no flagella, and few inclusion-like 
bodies (black dots) within the amoeboid cells. The shape was observed to be flattened 
and larger than the trophozoite and measuring about 17.5 µm in length. 
e-f Amoeboid forms with an approximate length of 12 µm start to disintegrate after 96 
hours and are totally absent from the suspension culture at 120 hours. 
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Figure 4.15: a-i Light micrograph showing the transformation of T. vaginalis from 
trophozoite to amoeboid form in the suspension culture under the effect of increased 
cell concentration (10
5
 T. vaginalis/ml) from one hour (day 0) up to 120 hours (day 5) in 
CN isolates. Magnifications 400X.  
a-d Trophozoites with an average length of 10 µm was observed to come into close 
proximity due to high number of parasites with increasing culture time (zero hour to 
six hours) and was completely attached to one another forming big clumps at 12 
hours. 
e Trophozoites start to change into larger and irregular and seen as partial amoeboid 
forms with an approximate length of 22.5 µm after 24 hours culture .  
f-g Full formation of amoeboid forms  with approximate length of 27.5 µm was 
observed after 48 hours in culture  with distinct amoeboid forms showing 
pseudopodia-like cytoplasmic projections (arrows), flattened, appeared larger with 
more inclusion-like bodies (black dots) at 72 hours culture.  
h-i Amoeboid forms was still observed at 96 hours culture but with the cell membrane 
losing the integrity of the ovoid shape and inclusion-like bodies became less visible. 
These forms measured an approximate length of 22.5 µm. Amoeboid form was 
completely absent from the suspension culture after 120 hours culture.  
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CHAPTER 5 
DISCUSSION 
5.1 General discussion 
 In this research, a total of nine symptomatic isolates of T. vaginalis consisting of 
three non-cervical neoplasia (NCN2-NCN4) and six cervical neoplasia (CN1-CN6) 
were investigated for formation of amoeboid forms under laboratory conditions. The 
isolates were consistently maintained in axenic Hollander medium to prevent 
contamination with bacteria or fungi that can interfere with the growth rate of T. 
vaginalis. All the isolates were subjected for growth profiling studies by measuring the 
number of trophozoite and amoeboid forms. Isolates without amoeboid forms were 
eliminated for the subsequent component of the study where assessment of the effects 
on the parasite by changing the culture conditions was carried out. Growth curve is 
defined as a measurement to study the growth of microorganisms in terms of parasite 
number (Willey et al., 2009). Therefore, in this study, growth curve reflecting the 
number of trophozoite and amoeboid forms of T. vaginalis was generated to measure 
the number of these organisms developed with increasing incubation period in order to 
determine the optimal growth conditions required to produce the maximum number of 
parasites. All the CN (CN1-CN6) and NCN (NCN2-NCN4) isolates showed a 
significant growth pattern for the trophozoite forms, however only CN isolates (CN1-
CN6) were observed to have the amoeboid forms which will be discussed in the 
following sub-sections. Variation of growth conditions such as parasites concentration, 
horse serum concentration and metronidazole concentration were analyzed to determine 
the effects towards the development of amoeboid forms. Each of these factors is known 
to have significantly contributed towards the transformational changes of trophozoites 
to amoeboid forms. 
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5.2 Observation of amoeboid forms of T. vaginalis in suspension culture   
 The morphology of the amoeboid forms has long been observed as an inherent 
form of T. vaginalis associated with the pathogenic mechanisms (Heath, 1981). 
Previous studies have shown the appearance of amoeboid forms upon attachment with 
vaginal cells, blood cells or on cover slips (Arroyo et al., 1993; Brugerolle et al., 1996; 
Fiori et al., 1999; Tasca & De Carli, 2002). Amoeboid forms were also said to have 
been triggered upon contact with laminin and fibronectin suggesting a common 
signaling mechanism through adhesions (Crouch & Alderete, 1999). In axenically 
grown cultures, Honigberg and Brugerolle have only observed ellipsoid and spheroid 
forms of T. vaginalis (as cited in Jesus et al., 2004). During the phagocytosis process, 
the virulent strain of T. vaginalis changed into the amoeboid shape during 
internalization of yeast cells (Pereira-Neves & Benchimol, 2007). However, only 
recently Afzan and Suresh (2012a) proved the formation of this distinctive 
morphological form of T. vaginalis in a suspension culture using transmission and 
scanning electron microscopy. This study also observed the formation of amoeboid 
forms in an axenic suspension culture without any types of attachments.  
Morphologically, the amoeboid forms were observed as flattened, non-motile or 
slowly motile with inactive flagella and a delicate outer layer with projecting 
pseudopodia-like cytoplasmic extensions when attached to epithelial or vaginal cells 
(Heath 1981; Fiori et al., 1999; Tasca & De Carli, 2002). Abnormal forms of T. 
vaginalis has also been identified with larger size compared to normal cell size with 
spiky projections on irregular surfaces and multiple stumps and a fragmented undulating 
membrane (John & Squires, 1978b). Rasmussen et al. (1986) observed an amoeboid 
form with a pseudopodium projected into the cytoplasm of disintegrated epithelial cells. 
The present study concurred with previous findings which showed  that the amoeboid 
forms had multiple projections of the pseudopodia, non-motile or slow motile, none or 
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inactive flagella, higher numbers of  inclusion–like bodies, flattened, bigger and 
irregular in shape. However, these forms only occurred under stressed conditions in 
suspension cultures as identified by Afzan and Suresh (2012a). Nevertheless, there has 
been no report on the numbers of amoeboid forms in cultures and factors elucidated to 
trigger these forms to exist in suspension cultures. Thus, this study is the first to identify 
factors that contribute to the formation of amoeboid forms under certain culture 
conditions.   
5.3 Growth profiles of amoeboid forms of T. vaginalis 
The maximum count of amoeboid forms was seen on day 3 in suspension 
cultures of CN isolates.  No amoeboid forms were seen in NCN isolates of T. vaginalis. 
The results concurred with findings of Afzan and Suresh (2012a). However the  present 
study observed amoeboid forms on day 1 for CN3 and CN5, day 2 and day 4 for all  CN 
isolates with a lower count of 0.66 ± 0.17 x 10
4 
T. vaginalis/ml, 5.67 ± 0.25 x 10
4 
T. 
vaginalis/ml and 2.99 ± 0.28 x 10
4 
T. vaginalis/ml respectively. Although the amount of 
amoeboid forms detected in the culture was relatively low, it was indeed higher 
compared to the findings by Afzan and Suresh (2012a). This could be due to the 
prolonged cultivation of the CN isolates that enabled them to adapt to the growth 
medium.   
Amoeboid forms were seen to appear along with the trophozoites of T. vaginalis 
and were at optimum when the numbers of trophozoites peaked on day 3 in all CN 
isolates. The formation of amoeboid forms corresponds to the number of trophozoites of 
T. vaginalis. The higher the number of trophozoites, greater is the probability of seeing 
amoeboid forms in the culture.  This is because as more numbers of trophozoites are 
produced in the culture medium, the limited space and the overcrowding facilitates 
contact with one another which could be a factor to trigger the formation of amoeboid 
forms. 
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 Amoeboid forms have been persistently observed in subsequent sub-cultures 
following first or second passage but in inconsistent numbers and always intermixed 
with pyriform trophozoite (Tasca & De Carli, 2002). Afzan and Suresh (2012a) reported 
that amoeboid forms were detected only on day 3 when the parasites were overcrowded 
and in frequent contact with each other. The present study also observed optimum 
numbers of amoeboid forms on day 3 when the trophozoites were high in number. 
However, the amoeboid forms were still detected on day 1, day 2 and day 4 of certain 
CN isolates suggesting that other factors such as cultivation period and adherence effect 
to glass surface as well as unfavourable culture conditions could have triggered the 
formation of the amoeboid forms in these isolates.  
 Amoeboid forms were not observed after 96 hours (day 4) of culture but viable 
and motile trophozoites were seen instead but in lower numbers. Present findings 
indicate that the amoeboid forms are an integral part of the life cycle of T. vaginalis and 
they appear to emerge in crowded cultures where the parasites are forced to be in close 
contact with one another. In another study the virulence factor was said to be significant 
in triggering amoeboid forms more in prolonged isolates than fresh isolates (Tasca and 
De Carli et al., 2002). 
Some studies have shown that well-established T. vaginalis strains when 
maintained for years under laboratory conditions were less adherent (Rasmussen et al., 
1986), had low virulence and without amoeboid morphology (Jesus et al., 2004). Tasca 
and De Carli (2002) have reported that more virulent strains tend to settle on and adhere 
to the culture cells compared to less virulent strains due to prolonged cultivation. In 
spite of these observations, the present study has shown that the amoeboid forms of T. 
vaginalis from CN isolates that has been cultured for a long time can be found in vitro 
and without induced attachments to vaginal epithelial cells or human erythrocytes. Jesus 
et al. (2004) have also observed amoeboid forms in fresh culture medium without 
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incubation of host cells but in freshly isolated strains of T. vaginalis. Therefore, the 
present finding has opened a new prospect of finding amoeboid forms in vitro in 
medium free of host cells and in prolonged cultivated state. Amoeboid forms in 
trichomonasis patients with cervical cancer could play a role in exacerbating the 
cervical cancer condition.  
5.4 Growth profile of trophozoite forms of T. vaginalis 
Study on growth patterns of the trophozoite forms of T. vaginalis have been 
performed by many investigators (Lehker & Alderete, 1990; Kostara et al., 1998; El-
Okbi et al., 2004; Boulos et al., 2012). Most of the growth profile studies conducted 
were as a part of phenotypic characterization studies to evaluate the viability of the 
trophozoites in in vitro growth conditions (Cox & Nicol, 1973; Lehker & Alderete, 
1990), to elucidate the growth rate of trophozoites in different growth media (Gelbart et 
al., 1990; Ryu et al., 1998) as well as to understand the metabolic activities based on the 
growth profile of T. vaginalis from CN isolates and NCN isolates (Yusof and Kumar 
2012). However, the present study on growth profile of trophozoites was performed 
from the same samples obtained from the study carried out by Yusof and Kumar (2012) 
with an inoculum size of 10
4 
T. vaginalis/ml and 10
5 
T. vaginalis/ml. Inoculum size of 
10
4 
T. vaginalis /ml was used as the base line to compare growth rates with other 
inoculum sizes.  
The present study concurred with the finding of Yusof and Kumar (2012) that  
significant optimal growth rate of parasites in all CN isolates on day 3 of culture were 
seen with trophozoite number to be  224.22 ± 2.19 x 10
4 
T. vaginalis/ml. However, the 
results differed with NCN isolates as NCN2 and NCN3 showed peak growth on day 4 
while NCN4 was on day 3 with mean trophozoites count of 88 ± 1.41 x 10
4 
T. 
vaginalis/ml and 92.33 ± 4.93 x 10
4 
T. vaginalis/ml respectively. The peak growth on 
day 3 in the present study was  comparable to a study carried out on five clonal strains 
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of T. vaginalis which observed a similar pattern of growth profile for trophozoites with 
highest count on 72 hours of culture (Chaudhari & Singh, 2011).  
The average trophozoites count obtained for both CN and NCN isolates in this 
study was relatively higher than that shown in the study of Yusof and Kumar (2012). 
This could be due to the good adaptation of the isolates to the growth conditions using 
Hollander medium. There were great variation between the average count of 
trophozoites in CN and NCN isolates with the former having higher trophozoites count. 
This could be due to the difference in biological and metabolic activities. Trophozoites 
from CN isolates could be more vibrant and active than NCN isolates because of a 
higher virulence nature of the cells. The growth rate of trophozoites in CN and NCN 
isolates were dependent on the growth conditions such as nutrient composition, 
temperature and pH (Kostara et al., 1998). 
Combined growth profile of trophozoites for CN isolates with initial inoculum 
of 10
4 
T. vaginalis/ml and 10
5 
T. vaginalis/ml observed no significant mean difference 
of trophozoites detected in cultures with 10
4 
and 10
5 
T. vaginalis/ml. However the 
growth rate was observed to be higher in culture medium with higher inoculum size of 
parasite. Both types of inoculum sizes reported a peak growth for all CN isolates on day 
3 with mean count of 224.22 ± 2.19 x 10
4 
T. vaginalis/ml (37.22 %) and 429.22 ± 11.19 
x 10
5 
T. vaginalis/ml (45.99 %) respectively. The numbers of trophozoites detected in 
cultures with inoculum size of 10
5 
T. vaginalis/ml were higher in cultures from day 1 to 
day 4 than cultures with inoculum size of 10
4 
T. vaginalis/ml probably observed during 
the same period. This is due to the higher propagation rate seen in cultures with larger 
inoculum size. Similarly, Kulda et al. (1970) using higher initial inoculum of 7 x 10
5 
T. 
vaginalis/ml reported that fast growing strains of  T. vaginalis reached maximum 
growth after 32 hours compared to 48 to 52 hours for slow growing strains (Boulos et 
al., 2012).  
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Growth profile study of trophozoite forms has been show to imply that essential 
growth conditions are essential for the prolonged survival of T. vaginalis (Kostara et al., 
1998). Besides, the growth profile of trophozoites was comparable with the growth 
profile of amoeboid forms in CN isolates. This is because, for both type of inoculum 
sizes, when the trophozoites count were optimum on day 3, the amoeboid forms are also 
optimum.
 
5.5 Assessment of staining methods for the detection of amoeboid forms  
Modified Fields’ staining  have been shown to be a good rapid assay for the 
detection of T. vaginalis and was preferred over Giemsa and Gram stain (Afzan et al., 
2010) for this study . The staining of trophozoites of T. vaginalis following the method 
of Afzan et al. (2010) showed that the nucleus and cytoplasm stained reddish purple and 
light purple respectively and was detected in 20 seconds. The amoeboid forms detected 
in the present study using Modified Field’s stain stained the nucleus and cytoplasm with 
brighter and lighter reddish purple and was effectively seen when stained within 15 
seconds. The small differences in the colour of the organelles and time could be due to 
the large size of amoeboid forms which caused them to be stained with intense 
colouration. The easy and reliable preparation of Fields’ stain was preferred over time-
consuming Giemsa stain. Besides being useful for the detection of amoeboid forms of T. 
vaginalis, Modified Fields’ stain elucidated greater morphological details especially the 
biology of the multiple nuclei formation seen in some of the amoeboid forms 
(unpublished observation). 
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5.6 Effect of different stress conditions on the development of amoeboid forms 
 Based on the study conducted to analyze the effects of varying the culture 
conditions in triggering the formation of amoeboid forms of T. vaginalis, the present 
results have verified the assumptions made by Afzan and Suresh (2012a). This is on the 
possible role of the stress applied on the culture conditions to trigger the transformation 
of the motile trophozoites to non-motile amoeboid forms. All the three culture 
conditions studied were able to induce amoeboid forms in the CN isolates of T. 
vaginalis to a certain extent. T. vaginalis is an opportunistic organism that takes 
advantage of the changing surrounding conditions in the human genitourinary tract for 
continual survival.  The efficient growth potential of T. vaginalis in an in vitro condition 
is primarily due to the availability of sufficient nutrients and suitable growth 
environment in the suspension culture that allows the parasite to proliferate and expand 
its infection (Figueroa-Angulo et al., 2012).  
A deviation from the standard growth conditions in terms of varying the nutrient 
supply, increasing the parasites count in the medium and introducing growth 
suppressing drug affected the adaptability and survival rate of T. vaginalis, thus 
signaling the development of the amoeboid forms. Present study analysed three different 
growth conditions based on number of parasites, horse serum concentrations and effect 
of metronidazole drug which showed significant formation of amoeboid forms in six 
CN isolates for the respective conditions. Previous studies have analyzed the effects of 
growth environment on the virulence and survival rate of T. vaginalis but only on the 
trophozoite forms (Lehker & Alderete, 1990; Kostara et al., 1998; Figueroa-Angulo et 
al., 2012). Present study was the first to demonstrate the effects of growth conditions 
manipulation in triggering amoeboid forms of T. vaginalis.  
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5.6.1 Effect of different inoculum sizes 
Increasing the inoculum size from 10
4 
T. vaginalis/ml to 10
5 
T. vaginalis/ml 
caused a significant difference in triggering amoeboid form (p < 0.05). Concurrently, 
the amount of trophozoites was significantly higher in inoculums size of 10
5
T. 
vaginalis/ml than in 10
4  
T. vaginalis/ml. Amoeboid forms were not seen in culture of 
CN isolates with parasite concentrations of 10
3 
T. vaginalis/ml and 10
6 
T. vaginalis/ml. 
This could mean that too low or too high inoculum sizes fail to facilitate the triggering 
of these forms. A very low amount of inoculum size reduces the opportunity for cell 
contact  between the cells whereas the  higher  inoculum size may use up the nutrients 
faster and thereby  prevent the triggering of T. vaginalis to form amoeboid forms. Only 
inoculum between 10
4 
T. vaginalis/ml and 10
5 
T. vaginalis/ml showed a significant 
number of amoeboid forms. Hence it appears that there is a balance requirement 
between the numbers of trophozoites in the media and availability of sufficient nutrients 
to create frequent collision between each parasite to form the amoeboid forms. 
Boulos et al. (2012) showed that in their study the fast growing isolates had 
higher rate of division. When the growth conditions were stressed with overcrowding of 
parasites in one ml, the motility of trophozoites were inhibited due to limited space for 
growth resulting in more frequent contact between the parasites leading to the 
appearance of more number of amoeboid forms as seen in cultures with inoculum sizes 
of 10
5 
T. vaginalis/ml when compared to 10
4 
T. vaginalis/ml. As the number of 
trophozoites reduced with increasing incubation period, the amoeboid forms were also 
reduced implying that overcrowding is a factor in triggering this abnormal shape of T. 
vaginalis.    
The situation can be extrapolated to a human urogenital system infected with 
trichomonas infection. In the initial stages, the parasites multiply and colonize a wide 
area and in cases with patients having CN, the parasites might reproduce rapidly due to 
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changes in the environment and potentially give rise to pathogenic amoeboid forms. 
Eventually, the infection could be exacerbated with these forms contributing to the 
complication in infected women. 
5.6.2 Effects of different horse serum concentrations  
Nutritional compositions in the growth medium of CN isolates of T. vaginalis 
also played an important role in triggering amoeboid forms as seen from the results 
obtained from the effects of different horse serum concentrations. Inside the host, T. 
vaginalis acquires the essential growth factors from vaginal secretions or through 
phagocytosis of the vaginal microflora (Petrin et al., 1998). Likewise, T. vaginalis must 
be supplied with the necessary nutrients in order to maintain the survivability. Thus this 
experiment assessed if nutrient depletion in the in vitro condition can trigger amoeboid 
forms. In this study, the Hollander medium used for growth of T. vaginalis was 
supplemented with heat-inactivated horse serum as the main source of nutrients. Horse 
serum is a donor-herd collected serum that contains higher protein concentration with 
essential growth factors, vitamins, co-factors, hormones, attachment factors, transport 
factors, nutrients and trace elements to support an effective growth rate in T. vaginalis 
("Sera for cell culture," n.d). A number of studies have described the possible effects of 
nutrients such as iron (Kim et al., 2006) and polyamines (Figueroa-Angulo et al., 2012) 
in regulating the growth metabolism of T. vaginalis.  
Varying the concentration of horse serum in the growth media of T. vaginalis 
was observed to significantly affect the growth potential of trophozoite forms in CN 
isolates which indirectly influenced the development of amoeboid forms. Lowest 
concentration of horse serum of 1 % reported zero formation of amoeboid forms due to 
limited-availability of nutrients to support the growth of T. vaginalis. The mobility and 
viability of trophozoites in this medium was extremely poor and deteriorated within 24 
hours of incubation. Since amoeboid forms were associated with trophozoites, therefore 
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lower nutrients contents affected their potential development. The findings on the role 
of nutrient deficiency in controlling the cell viability concurred with the study by 
Lehker and Alderete (1992) on the fact that the depletion of a nutrient source primarily 
iron can affect the growth rate of T. vaginalis. They concluded that iron limitations 
resulted in decrease in protein synthesis and cell densities of T. vaginalis. Virulence of 
T. vaginalis was also reported to be reduced with reduction of iron in the growth 
medium (Ryu et al., 2001).  
As the horse serum concentration was increased to 5 %, calculated mean average 
amoeboid forms was 3.95 ± 0.18 x 10
4 
T. vaginalis/ml and increased slightly to 4.33 ± 
0.18 x 10
4 
T. vaginalis/ml with 10 % of horse serum. Optimal amoeboid count was 
obtained when the horse serum was 15 % and decreased gradually when the horse 
serum concentration was increased to 20 %, reflecting the role of adequate protein 
content in triggering this shape. Higher hyrogenosomal activity of T. vaginalis have 
been reported in iron enriched medium compared to iron depleted medium, thus 
indicating the importance of having sufficient nutrients for optimal growth of parasites 
(Kim et al., 2006). Horse serum concentration of 15 % was the impulse for active 
formation of amoeboid forms of T. vaginalis by providing sufficient amount of nutrients 
for the growth of trophozoites which then proliferated rapidly and vigorously until they 
gained opportunities to transform into amoeboid forms.  
5.6.3 Effects of different concentrations of metronidazole drug  
 In the final evaluation of stress conditions on amoeboid formation, effects of 
metronidazole drug were tested against CN isolates to determine if metronidazole can 
trigger the amoeboid forms. Metronidazole was chosen as the drug of choice due to its 
effectiveness in treating T. vaginalis infection although few cases of metronidazole 
resistance have been reported (Meri et al., 2000; Chaudhari & Singh, 2011). The 
findings revealed that the first three highest concentration of metronidazole drug used; 1 
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mg/ml, 0.1 mg/ml and 0.01 mg/ml reported no formation of amoeboid forms because all 
the trophozoites were highly susceptible to these concentrations and died immediately 
within hours after cultures were treated. This clearly explains the close association of 
amoeboid forms with trophozoites whereby the dominant pyriform must be present in 
order for the irregular amoeboid form to develop.   
When the concentration was slightly lowered to 0.001 mg/ml and 0.0001 mg/ml, 
amoeboid forms were observed to appear in the suspension culture with the highest 
count seen in cultures treated with 0.0001 mg/ml. This suggests that the CN isolates of 
T. vaginalis at lower doses of the drug triggered steady growth of trophozoites which 
then lead to the formation of amoeboid forms. The higher resistance of CN isolates to 
metronidazole drug up to 100 µg/ml in a previous study reflected the parasite from CN 
isolates were robust (Afzan, 2011d). This caused the parasites to divide rapidly and 
transformed into non-motile amoeboid forms again pointing to the idea that close 
contact with cells could be a factor in inducing the parasite to form amoeboid forms.   
In cervical cancer patients the parasites can attach to vaginal cells or epithelial 
cells and transform into amoeboid forms which can increase the severity of the 
infections with T. vaginalis. Formation of amoeboid forms upon attachment to cover 
slips have been demonstrated with actin cytoskeleton activity  contributing to the 
adhesion and phagocytic ability (Brugerolle et al., 1996).  
Lower drug concentration of 0.001 mg/ml and 0.0001 mg/ml triggered a 
proliferation of the parasite compared to the untreated culture (control) and produced 
significant high parasite count (p < 0.05). Higher concentration of metronidazole 
however killed T. vaginalis. This suggests that if patient stops their medication half way 
during treatment or if the drug dose is insufficient this can be more harmful as it can 
trigger higher parasite number. High dosage of 2.6 g of metronidazole/day has been 
given for a period of nine days to patients with refractory vaginal trichomoniasis but 
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reported a number of failure cases due to resistance effect (Lossick et al., 1986). 
Conversely, a regimen of 400 mg metronidazole twice daily for seven days were found 
to be effective when taken in prescribed dosage (Keighley, 1971). The present study is 
crucial as it contributes to the idea that correct treatment dose is of paramount 
importance in treating Trichomonas-infected patients with cervical cancer.  
5.7 Significance on the effects of stress factors in triggering amoeboid forms 
In all the three culture conditions studied, it was anticipated that stress factors in 
the growth culture medium of T. vaginalis will most likely trigger amoeboid forms 
when culture conditions become unfavourable. Although stress-free cultures still report 
the presence of amoeboid forms, however the numbers were far less when compared 
with stressed cultures. Overall, amoeboid forms are triggered when the trophozoites 
grow in high numbers causing a lack of nutrients as well as enhancing contact with one 
another due to overcrowding. However, it must be noted that in every stressed condition 
tested, as long as the numbers of trophozoite significantly increase there is likelihood 
that amoeboid forms can be triggered. Factors such as different concentrations of horse 
serum and metronidazole merely facilitated the propagation of parasites in culture. 
Higher numbers of trophozoite increased cell contact and this triggered higher number 
of amoeboid forms seen in cultures. 
Previous studies have shown that the amoeboid forms seen when the 
cytoadherence mechanisms aided by adhesin proteins got triggered when attaching to 
surfaces (Arroyo et al., 1993; Fiori et al., 1999; Moreno-Brito et al., 2005; Ryan et al., 
2011). There have been previous studies to suggest that a virulence property in T. 
vaginalis in triggering amoeboid forms was achieved when culture conditions were 
changed (Arroyo et al., 1993; Fiori et al., 1999; Liang & Huang, 2009).  
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5.8 Transformational changes analysis 
 In the description of phenotypic characteristics of amoeboid forms, the 
transformation of the trophozoites into the amoeboid forms were measured based on 
size and shape. Transformational changes of pseudocysts forms were shown revert to 
trophozoites when lysed with distilled water (Afzan and Suresh, 2012b). However, this 
is the first study to show the morphological changes from actively swimming 
trophozoites into non-motile amoeboid forms. Based on the present findings, it can be 
further confirmed that the amoeboid forms of T. vaginalis do appear in suspension 
cultures unlike previous reports where these forms were only seen when grown on cover 
slips containing epithelial or erythrocytes cells.  
The significant difference seen between the amoeboid formation in a stress-free 
and stressed culture medium described the role of culture conditions in influencing the 
formation of these life cycle stages.  
Trophozoites in stressed-culture lose  their motility earlier (within 48 hours) 
compared to trophozoites in control tubes (after 48 hours)  due to the probable dense 
parasite numbers  in cultures which restrict their movements. The irregular shape of 
amoeboid structures could be formed to gain attachment. The pseudopodia-like 
cytoplasmic extensions were also observed to appear on day 3. Similar to the present 
observation, Arroyo et al. (1993) captured a similar transformation of globular shape 
parasites into thin, flat amoeboid forms when in contact with vaginal epithelial cells. 
Ryan et al. (2011) also visualized the transition of ovoid free-swimming forms of T. 
vaginalis into amoeboid forms upon binding to a host epithelial cell.  
Conversion of trophozoites to amoeboid forms saw the development of more 
inclusion-like bodies suggesting that there is an active process involved during the 
transformation.  These inclusion-like bodies could be glycogen granules found in the 
cytoplasm of T. vaginalis since evidence have shown rich contents in these vesicles  in 
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the parasite as observed through electron microscopy (Costamagna & Figueroa, 2001). 
The name itself reflects the role of these granules as food storage. It is possible that 
inclusion-like bodies in amoeboid forms may play role in synthesizing energy to trigger 
activities.  
 The present study confirmed that stressful conditions can trigger amoeboid 
forms in culture. More molecular studies need to be carried out to better understand the 
role of the amoeboid forms. 
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CHAPTER 6 
CONCLUSION  
Isolates of T. vaginalis diagnosed from patients with cervical neoplasia are 
potential for the development of amoeboid forms as they are more likely to be triggered 
under various growth conditions. High number of trophozoites is the critical factor for 
the formation of amoeboid forms.  At normal culture condition, highest numbers of 
amoeboid forms was seen in day 3 culture. The study for the first time detected 
amoeboid forms in suspension culture using Modified Fields’ stain with significant 
extensions of cytoplasm to form the pseudopods, rough surfaces and with single or 
multiple nuclei. The study also for the first time demonstrated the phenotypic 
characteristics of amoeboid forms in suspension cultures obtained from stressed and 
non-stressed conditions.   
 A potential application of this study would be to identify the dietary intake of 
patients diagnosed with cervical neoplasia and trichomoniasis, and ascertain the severity 
of symptoms with the type of food intake.  An in depth understanding of the disease 
may help to lower the clinical symptoms of the infection and prevent further 
complications.  Other potential growth parameters such as temperature and pH can also 
be varied to identify their effects in triggering amoeboid forms. A prospective study by 
looking at the gene and protein expression of the amoeboid forms can also be initiated 
to determine if these forms can be identified in suspension cultures. In addition, a better 
observation on the transformational changes taking place from trophozoite to amoeboid 
forms must be performed to better understand the process taking place.  
 Based on the findings of this study, the following conclusions were drawn: 
1. The cultures used in the present study were four years old indicating that the 
isolates can be maintained for a long time without the parasite losing its ability to 
trigger amoeboid forms.  
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2. Amoeboid forms were only detected in CN isolates with higher count on day 3 
with average amoeboid of 28.66 ± 7.93 x 10
4 
T. vaginalis/ml. The amoeboid forms 
were observed with pseudopodia-like cytoplasmic extension, none or inactive 
flagella, non-motile, irregular in shape, were larger than trophozoites, flattened 
and with more inclusion-like bodies. 
3. Cultures of CN showed higher growth rate of trophozoites than those of NCN 
isolates in inoculum concentration of 10
4 
T. vaginalis/ml with total average count 
of 3615.04 ± 67.69 x 10
4 
T. vaginalis/ml. 
4. Total average number of trophozoites was higher in culture with inoculum size of 
10
5 
T. vaginalis/ml compared to inoculum size of 10
4 
T. vaginalis/ml. The 
numbers of trophozoite in culture with 10
5 
T. vaginalis/ml for all CN isolates were 
933.28 ± 18.71 x 10
5 
T. vaginalis/ml. 
5. Modified Fields’ stain can be efficiently used to detect amoeboid forms of T. 
vaginalis with clear morphological details such as multiple or single nuclei as well 
other cellular details.  
6. 15 % horse serum and an inoculum size of 105 T. vaginalis/ml yielded the highest 
amoeboid forms with average count of 59.67 ± 2.80 x 10
4 
T. vaginalis/ml and 
116.65 ± 3.96 x 10
5 
T. vaginalis/ml respectively showing that the interaction 
between the parasites and the correct nutrient amount appears to be  key factors 
for triggering amoeboid forms. 
7. Lowest drug concentration of 0.0001 mg/ml (21.66 ± 0.39 x 104 T. vaginalis/ml) 
triggered these forms implying that metronidazole used for the treatment of 
trichomoniasis  when not taken at the right dose can trigger more  amoeboid forms 
to develop.  
8. The study confirmed that amoeboid forms were triggered due to stress response 
when culture conditions were altered. There is a possibility that chemotherapy 
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drugs and different food intake during treatment of cervical cancer patients 
infected with the parasite can trigger these forms. The exact role of these forms 
has yet to be elucidated but the possibility of cell invasion cannot be ruled out 
which in turn can exacerbate the already complicated condition.  The summary of 
comparison of amoeboid forms in stress and non-stress conditions is presented in 
Table 4.12. 
9. Clumping of trophozoites was observed as the first step leading to amoeboid 
formation in suspension culture under stress conditions.  Parasite clumping is due 
to the high number of trophozoites. This facilitated contact with one another which 
eventually triggers to form as amoeboid forms.  
Overall, the present findings were able to answer the research questions 
asked at the beginning of the study. There are as follows: 
i. The present study concurs with the findings of Afzan and Suresh (2012a) that 
amoeboid forms do exist and they are found in CN isolates predominantly on 
day 3 cultures. Despite 4 years of age the cultures were consistent in producing 
the amoeboid forms.  
ii. Stressing the conditions of the growth medium does trigger the formation of 
amoeboid forms in suspension culture. 
iii. The morphology that differentiates amoeboid forms are the pseudopodia-like 
cytoplasmic extension, none or inactive flagella, non-motile, irregular in shape, 
larger than trophozoites, flattened and more inclusion-like bodies. 
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Table 4.12: Summary of comparison of amoeboid forms between stressed conditions 
and normal conditions. 
 
Features 
Amoeboid forms 
Stressed conditions Normal conditions 
(stress-free) 
Size Larger, 27.5 µm (length) and 25 
µm (width) 
Smaller, 17.5 µm (length) 
and 12.5 (width) 
Shape Irregular with more pseudopodia-
like cytoplasmic extensions 
Irregular with less 
pseudopodia-like 
cytoplasmic extensions 
Number of 
inclusion bodies 
More (25 to 30 granules in one 
cell) 
Less (15 to 17 granules in 
one cell) 
Number of 
amoeboid forms 
Higher, 116.65 ± 3.96 x 10
5 
T. 
vaginalis/ml 
Lower, 28.66 ± 7.93 x 10
4 
T. vaginalis/ml 
Arrangements 
of trophozoites 
Appeared in clumps Loosely or individually 
distributed 
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Appendix A 
Clinical identity of each isolates from CN and NCN cultures as obtained by Afzan (2011c). 
Table 1: Clinical identity of the samples 
T.vaginali
s positive 
Race Age  
(years old) 
Marital 
status 
Multiple/single 
partner 
Inflammation Cervical  
neoplasia 
(CIN3) 
Reported symptoms of 
patients 
NCN1 Malay 32 Single Multiple Moderate No Heavy discharge 
NCN2 Malay 30 Married Single Moderate No Heavy discharge 
NCN3 Chinese 48 Single Multiple Moderate No Heavy discharge 
NCN4 Malay 25 Married Single Moderate No Heavy discharge 
CN1 Chinese 49 Married Single Moderate Yes Heavy discharge, punctate 
strawberry spots 
CN2 Chinese 52 Married Single Moderate Yes Abdominal distension, 
punctate strawberry spots 
CN3 Chinese 52 Married Single Moderate Yes Creamy discharge, 
abdominal distension, 
punctate strawberry spots 
CN4 Chinese 45 Married Single Moderate Yes Frothy discharge, punctate 
strawberry spots 
CN5 Chinese 31 Single Multiple Moderate Yes Greenish yellowish 
discharge, abdominal 
distension, punctate 
strawberry spots 
CN6 Malay  52 Married Single Moderate Yes Heavy discharge, itching 
abdominal distension, 
punctate strawberry spots 
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Appendix B 
Hollander medium preparation for cultivation of T. vaginalis 
 
Tryptic Soy Broth (TSB)   20.0 g 
Yeast extract    10.0 g 
Maltose    5.0 g 
Ascorbic acid    1.0 g 
KCl     1.0 g 
KH2PO4    1.0 g 
 
All the ingredients mentioned above are dissolved in 900 ml of distilled water and 
autoclave for 15 minutes at 121 ºC. Once cooled, the medium is stored at 4ºC. Prior use, 
100 ml of heat inactivated horse serum and 20 ml of Penicillin-Streptomycin Neomycin 
is added to the medium and mixed well.  
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Appendix C 
Statistical analysis results to test the significance of amoeboid forms in CN isolates of 
T.vaginalis between days. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Output: 
a. Test of homogeneity of variances : equality of variances not assumed 
b. Kruskal-Wallis: p <0.05 – at least one pair of days of average trophozoites forms 
differs.  
Hence, Post-hoc test using Dunnett T3 was performed to identify the days that differ 
significantly (Table 4).   
 
 
Test of Homogeneity of Variances 
Average amoeboid count x 10
4
 T. vaginalis/ml 
Levene 
Statistic 
df1 df2 Sig. 
7.448 4 25 .000 
Test Statistics
a,b
 
 Average amoeboid 
count x 10
4
 T. 
vaginalis/ml 
Chi-Square 26.479 
Df 4 
Asymp. Sig. .000 
a. Kruskal Wallis Test 
b. Grouping Variable: Days of count 
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Table 4: Average amoeboid forms in CN isolates of T. vaginalis at 10
4 
T. vaginalis/ml 
 
 
Output: 
Based on the multiple comparison made, it can be concluded that average trophozoite 
count on day 3 is significantly higher compared average trophozoites count on day 1, 
day 2, day 4 and day 5.  
 
 
 
Multiple Comparisons 
Dependent Variable: Average amoeboid count x 10
4
 T. vaginalis/ml  
 Dunnett T3 
(I) Days of 
count 
(J) Days 
of count 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Day 1 
Day 2 -.83500
*
 .12298 .001 -1.2735 -.3965 
Day 3 -3.11333
*
 .27577 .000 -4.2417 -1.9849 
Day 4 -.44500 .13185 .071 -.9220 .0320 
Day 5 .11000 .06957 .702 -.1900 .4100 
Day 2 
Day 1 .83500
*
 .12298 .001 .3965 1.2735 
Day 3 -2.27833
*
 .28548 .001 -3.3958 -1.1609 
Day 4 .39000 .15110 .200 -.1350 .9150 
Day 5 .94500
*
 .10141 .002 .5077 1.3823 
Day 3 
Day 1 3.11333
*
 .27577 .000 1.9849 4.2417 
Day 2 2.27833
*
 .28548 .001 1.1609 3.3958 
Day 4 2.66833
*
 .28941 .000 1.5522 3.7844 
Day 5 3.22333
*
 .26685 .000 2.0728 4.3739 
Day 4 
Day 1 .44500 .13185 .071 -.0320 .9220 
Day 2 -.39000 .15110 .200 -.9150 .1350 
Day 3 -2.66833
*
 .28941 .000 -3.7844 -1.5522 
Day 5 .55500
*
 .11200 .029 .0721 1.0379 
Day 5 
Day 1 -.11000 .06957 .702 -.4100 .1900 
Day 2 -.94500
*
 .10141 .002 -1.3823 -.5077 
Day 3 -3.22333
*
 .26685 .000 -4.3739 -2.0728 
Day 4 -.55500
*
 .11200 .029 -1.0379 -.0721 
*. The mean difference is significant at the 0.05 level. 
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Appendix D 
Raw data of trophozoite counts in NCN and CN isolates (10
4 
T. vaginalis/ml). 
Isolates : Non-cervical neoplasia (NCN) 2  
Days 
No of trophozoites x 10
4 
T. vaginalis/ml Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 7 5 4 5.33 1.53 -1.53 
2 9 13 11 11.00 2.00 -2.00 
3 45 40 39 41.33 3.21 -3.21 
4 91 79 97 89.00 9.17 -9.17 
5 100 80 79 86.33 11.85 -11.85 
6 57 65 68 63.33 5.69 -5.69 
7 41 49 46 45.33 4.04 -4.04 
8 26 17 15 19.33 5.86 -5.86 
9 14 8 21 14.33 6.51 -6.51 
10 8 6 10 8.00 2.00 -2.00 
11 0 0 0 0.00 0.00 0.00 
       
Isolates : Non-cervical neoplasia (NCN) 3 
Days 
No of trophozoites x 10
4 
T. vaginalis/ml Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 7 6 5 6.00 1.00 -1.00 
2 12 6 12 10.00 3.46 -3.46 
3 48 60 43 50.33 8.74 -8.74 
4 97 86 78 87.00 9.54 -9.54 
5 60 52 50 54.00 5.29 -5.29 
6 35 48 71 51.33 18.23 -18.23 
7 25 25 31 27.00 3.46 -3.46 
8 11 13 8 10.67 2.52 -2.52 
9 6 7 3 5.33 2.08 -2.08 
10 1 5 3 3.00 2.00 -2.00 
11 0 0 0 0.00 0.00 0.00 
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Isolates : Non-cervical neoplasia (NCN) 4 
Days 
No of trophozoites x 10
4 
T. vaginalis/ml Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 12 15 12 13.00 1.73 -1.73 
2 22 25 37 28.00 7.94 -7.94 
3 98 90 89 92.33 4.93 -4.93 
4 78 75 70 74.33 4.04 -4.04 
5 67 56 68 63.67 6.66 -6.66 
6 55 48 35 46.00 10.15 -10.15 
7 32 35 30 32.33 2.52 -2.52 
8 13 11 10 11.33 1.53 -1.53 
9 9 8 7 8.00 1.00 -1.00 
10 5 3 3 3.67 1.15 -1.15 
11 0 0 0 0.00 0.00 0.00 
       
Isolates : Cervical neoplasia (CN) 1 
Days 
No of trophozoites x 10
4 
T. vaginalis/ml Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 16 20 14 16.67 3.06 -3.06 
2 99 100 110 103.00 6.08 -6.08 
3 211 220 234 221.67 11.59 -11.59 
4 89 90 85 88.00 2.65 -2.65 
5 70 60 62 64.00 5.29 -5.29 
6 52 53 59 54.67 3.79 -3.79 
7 25 25 26 25.33 0.58 -0.58 
8 15 12 19 15.33 3.51 -3.51 
9 5 0 0 1.67 2.89 -2.89 
10 1 0 0 0.33 0.58 -0.58 
11 0 0 0 0.00 0.00 0.00 
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Isolates : Cervical neoplasia (CN) 2 (Repeated on 3/11/2012) 
  No of trophozoites x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Days Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 11 17 20 16.00 4.58 -4.58 
2 106 101 90 99.00 8.19 -8.19 
3 209 189 232 210.00 21.52 -21.52 
4 100 85 98 94.33 8.14 -8.14 
5 87 73 65 75.00 11.14 -11.14 
6 2 20 29 24.67 4.51 -4.51 
7 19 14 13 15.33 3.21 -3.21 
8 10 9 7 8.67 1.53 -1.53 
9 5 4 0 3.00 2.65 -2.65 
10 0 0 0 0.00 0.00 0.00 
11 0 0 0 0.00 0.00 0.00 
Isolates : Cervical neoplasia (CN) 3 
No of trophozoites x 10
4 
 T. vaginalis/ml Standard 
Deviation (±) Days Replicate 1 Replicate 2 Replicate 3 Average counts  
1 41 52 38 43.67 7.37 -7.37 
2 78 89 90 85.67 6.66 -6.66 
3 201 221 207 209.67 10.26 -10.26 
4 130 168 151 149.67 19.04 -19.04 
5 80 79 74 77.67 3.21 -3.21 
6 30 29 20 26.33 5.51 -5.51 
7 26 20 15 20.33 5.51 -5.51 
8 19 12 10 13.67 4.73 -4.73 
9 11 6 5 7.33 3.21 -3.21 
10 6 0 1 2.33 3.21 -3.21 
11 0 0 0 0.00 0.00 0.00 
 
Isolates : Cervical neoplasia (CN) 4 
No of trophozoites x 10
4 
 T. vaginalis/ml Standard 
Deviation (±) Days Replicate 1 Replicate 2 Replicate 3 Average counts  
1 15 21 15 17.00 3.46 -3.46 
2 145 130 159 144.67 14.50 -14.50 
3 256 233 231 240.00 13.89 -13.89 
4 154 167 190 170.33 18.23 -18.23 
5 78 67 61 68.67 8.62 -8.62 
6 46 37 39 40.67 4.73 -4.73 
7 30 25 20 25.00 5.00 -5.00 
8 17 11 9 12.33 4.16 -4.16 
9 3 8 2 4.33 3.21 -3.21 
10 0 5 0 1.67 2.89 -2.89 
11 0 0 0 0.00 0.00 0.00 
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Isolates : Cervical neoplasia (CN) 5 
No of trophozoites x 10
4 
 T. vaginalis/ml Standard 
Deviation (±) Days Replicate 1 Replicate 2 Replicate 3 Average counts  
1 16 21 29 22.00 6.56 -6.56 
2 100 115 133 116.00 16.52 -16.52 
3 268 217 229 238.00 26.66 -26.66 
4 99 86 100 95.00 7.81 -7.81 
5 60 55 59 58.00 2.65 -2.65 
6 30 40 40 36.67 5.77 -5.77 
7 21 32 29 27.33 5.69 -5.69 
8 11 20 19 16.67 4.93 -4.93 
9 3 10 8 7.00 3.61 -3.61 
10 0 2 0 0.67 1.15 -1.15 
11 0 0 0 0.00 0.00 0.00 
Isolates : Cervical neoplasia (CN) 6 
No of trophozoites x 10
4 
 T. vaginalis/ml Standard 
Deviation (±) Days Replicate 1 Replicate 2 Replicate 3 Average counts  
1 25 16 30 23.67 7.09 -7.09 
2 77 53 73 67.67 12.86 -12.86 
3 221 218 239 226.00 11.36 -11.36 
4 89 98 91 92.67 4.73 -4.73 
5 36 32 33 33.67 2.08 -2.08 
6 28 25 28 27.00 1.73 -1.73 
7 17 18 16 17.00 1.00 -1.00 
8 11 10 11 10.67 0.58 -0.58 
9 2 2 1 1.67 0.58 -0.58 
10 0 0 0 0.00 0.00 0.00 
11 0 0 0 0.00 0.00 0.00 
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Appendix E 
Statistical analysis results for average trophozoite counts between days of CN isolates 
(CN 1- CN 6) in 10
4 
T. vaginalis/ml 
1. One-Way ANOVA was performed to test the equality of variances between 
different days of trophozoite observation 
 
Table 2: ANOVA table  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Output: 
a. Test of homogeneity of variances: p < 0.05, equality of variances not assumed  
b. Kruskal-Wallis: p-value is 0.000, which is less than 0.05. Hence, at least one 
pair of means between the days differs significantly 
Hence, to identify the pairs that differ significantly, post-hoc test was performed using 
Dunnett T3 since equality of variances cannot be assumed. 
Test of Homogeneity of Variances 
Average trophozoites count in 10
4 
T. 
vaginalis/ml 
Levene 
Statistic 
df1 df2 Sig. 
7.586 10 55 .000 
Test Statistics
a,b
 
 Average 
trophozoites count 
in 10
4
 T. 
vaginalis/ml 
Chi-
Square 
62.630 
df 10 
Asymp. 
Sig. 
.000 
a. Kruskal Wallis Test 
b. Grouping Variable: Days of    
    count 
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Table 3: Statistical comparison between days for average trophozoite counts of CN isolates in 10
4 
T. vaginalis/ml 
Multiple Comparisons 
Dependent Variable: Average trophozoites count in 10
4 
T. vaginalis/ml 
Dunnett T3 
(I) Days of count (J) Days of count Mean Difference 
(I-J) 
Std. Error Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
Day 0 Day 1 -22.16833 4.29572 .065 -45.8787 1.5420 
Day 2 -101.66833
*
 10.75371 .005 -161.0237 -42.3129 
Day 3 -223.22333
*
 5.36184 .000 -252.8181 -193.6285 
Day 4 -114.00000
*
 14.51240 .011 -194.1016 -33.8984 
Day 5 -61.83500
*
 6.52545 .005 -97.8524 -25.8176 
Day 6 -34.00167
*
 4.71778 .016 -60.0416 -7.9617 
Day 7 -20.72000
*
 2.00254 .003 -31.7731 -9.6669 
Day 8 -11.89000
*
 1.20969 .004 -18.5669 -5.2131 
Day 9 -3.16667 1.03100 .371 -8.8573 2.5240 
Day 10 .16667 .39196 1.000 -1.9968 2.3301 
Day 1 Day 0 22.16833 4.29572 .065 -1.5420 45.8787 
Day 2 -79.50000
*
 11.57996 .009 -136.4845 -22.5155 
Day 3 -201.05500
*
 6.87041 .000 -231.1048 -171.0052 
Day 4 -91.83167
*
 15.13483 .023 -169.6081 -14.0553 
Day 5 -39.66667
*
 7.81247 .024 -74.7762 -4.5571 
Day 6 -11.83333 6.38049 .898 -39.4697 15.8030 
Day 7 1.44833 4.73956 1.000 -21.2459 24.1425 
Day 8 10.27833 4.46280 .672 -12.7890 33.3457 
Day 9 19.00167 4.41771 .115 -4.2016 42.2049 
Day 10 22.33500 4.31357 .063 -1.2871 45.9571 
Day 2 Day 0 101.66833
*
 10.75371 .005 42.3129 161.0237 
Day 1 79.50000
*
 11.57996 .009 22.5155 136.4845 
Day 3 -121.55500
*
 12.01630 .000 -178.3735 -64.7365 
Day 4 -12.33167 18.06245 1.000 -92.0708 67.4075 
Day 5 39.83333 12.57870 .276 -17.5001 97.1667 
Day 6 67.66667
*
 11.74307 .020 10.8127 124.5206 
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Day 7 80.94833
*
 10.93857 .012 22.4262 139.4704 
Day 8 89.77833
*
 10.82153 .008 30.7533 148.8033 
Day 9 98.50167
*
 10.80302 .005 39.3894 157.6139 
Day 10 101.83500
*
 10.76085 .005 42.5158 161.1542 
Day 3 Day 0 223.22333
*
 5.36184 .000 193.6285 252.8181 
Day 1 201.05500
*
 6.87041 .000 171.0052 231.1048 
Day 2 121.55500
*
 12.01630 .000 64.7365 178.3735 
Day 4 109.22333
*
 15.47124 .008 32.1207 186.3260 
Day 5 161.38833
*
 8.44575 .000 124.5406 198.2361 
Day 6 189.22167
*
 7.14190 .000 158.2293 220.2140 
Day 7 202.50333
*
 5.72359 .000 174.0276 230.9791 
Day 8 211.33333
*
 5.49660 .000 182.3122 240.3545 
Day 9 220.05667
*
 5.46006 .000 190.9010 249.2123 
Day 10 223.39000
*
 5.37614 .000 193.8667 252.9133 
Day 4 Day 0 114.00000
*
 14.51240 .011 33.8984 194.1016 
Day 1 91.83167
*
 15.13483 .023 14.0553 169.6081 
Day 2 12.33167 18.06245 1.000 -67.4075 92.0708 
Day 3 -109.22333
*
 15.47124 .008 -186.3260 -32.1207 
Day 5 52.16500 15.91199 .265 -24.5312 128.8612 
Day 6 79.99833
*
 15.25999 .043 2.5138 157.4829 
Day 7 93.28000
*
 14.64992 .025 13.8333 172.7267 
Day 8 102.11000
*
 14.56273 .017 22.2585 181.9615 
Day 9 110.83333
*
 14.54898 .012 30.9147 190.7519 
Day 10 114.16667
*
 14.51770 .011 34.0919 194.2414 
Day 5 Day 0 61.83500
*
 6.52545 .005 25.8176 97.8524 
Day 1 39.66667
*
 7.81247 .024 4.5571 74.7762 
Day 2 -39.83333 12.57870 .276 -97.1667 17.5001 
Day 3 -161.38833
*
 8.44575 .000 -198.2361 -124.5406 
Day 4 -52.16500 15.91199 .265 -128.8612 24.5312 
Day 6 27.83333 8.05226 .182 -7.8347 63.5013 
Day 7 41.11500
*
 6.82581 .023 6.1936 76.0364 
Day 8 49.94500
*
 6.63663 .011 14.4293 85.4607 
Day 9 58.66833
*
 6.60639 .005 23.0285 94.3081 
Day 10 62.00167
*
 6.53721 .004 26.0434 97.9599 
Day 6 Day 0 34.00167
*
 4.71778 .016 7.9617 60.0416 
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Day 1 11.83333 6.38049 .898 -15.8030 39.4697 
Day 2 -67.66667
*
 11.74307 .020 -124.5206 -10.8127 
Day 3 -189.22167
*
 7.14190 .000 -220.2140 -158.2293 
Day 4 -79.99833
*
 15.25999 .043 -157.4829 -2.5138 
Day 5 -27.83333 8.05226 .182 -63.5013 7.8347 
Day 7 13.28167 5.12520 .529 -11.6777 38.2410 
Day 8 22.11167 4.87040 .091 -3.3119 47.5352 
Day 9 30.83500
*
 4.82912 .021 5.2743 56.3957 
Day 10 34.16833
*
 4.73404 .015 8.2092 60.1275 
Day 7 Day 0 20.72000
*
 2.00254 .003 9.6669 31.7731 
Day 1 -1.44833 4.73956 1.000 -24.1425 21.2459 
Day 2 -80.94833
*
 10.93857 .012 -139.4704 -22.4262 
Day 3 -202.50333
*
 5.72359 .000 -230.9791 -174.0276 
Day 4 -93.28000
*
 14.64992 .025 -172.7267 -13.8333 
Day 5 -41.11500
*
 6.82581 .023 -76.0364 -6.1936 
Day 6 -13.28167 5.12520 .529 -38.2410 11.6777 
Day 8 8.83000 2.33956 .132 -1.8423 19.5023 
Day 9 17.55333
*
 2.25236 .002 6.9675 28.1392 
Day 10 20.88667
*
 2.04054 .002 10.0027 31.7707 
Day 8 Day 0 11.89000
*
 1.20969 .004 5.2131 18.5669 
Day 1 -10.27833 4.46280 .672 -33.3457 12.7890 
Day 2 -89.77833
*
 10.82153 .008 -148.8033 -30.7533 
Day 3 -211.33333
*
 5.49660 .000 -240.3545 -182.3122 
Day 4 -102.11000
*
 14.56273 .017 -181.9615 -22.2585 
Day 5 -49.94500
*
 6.63663 .011 -85.4607 -14.4293 
Day 6 -22.11167 4.87040 .091 -47.5352 3.3119 
Day 7 -8.83000 2.33956 .132 -19.5023 1.8423 
Day 9 8.72333
*
 1.58944 .011 1.8105 15.6362 
Day 10 12.05667
*
 1.27161 .002 5.5970 18.5163 
Day 9 Day 0 3.16667 1.03100 .371 -2.5240 8.8573 
Day 1 -19.00167 4.41771 .115 -42.2049 4.2016 
Day 2 -98.50167
*
 10.80302 .005 -157.6139 -39.3894 
Day 3 -220.05667
*
 5.46006 .000 -249.2123 -190.9010 
Day 4 -110.83333
*
 14.54898 .012 -190.7519 -30.9147 
Day 5 -58.66833
*
 6.60639 .005 -94.3081 -23.0285 
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Output: 
a. The mean differences of average trophozoites for day 3 with other days were positive and p-value is less than 0.05, hence day three 
marked a significantly different trophozoite count.  
Day 6 -30.83500
*
 4.82912 .021 -56.3957 -5.2743 
Day 7 -17.55333
*
 2.25236 .002 -28.1392 -6.9675 
Day 8 -8.72333
*
 1.58944 .011 -15.6362 -1.8105 
Day 10 3.33333 1.10299 .356 -2.1387 8.8054 
Day 10 Day 0 -.16667 .39196 1.000 -2.3301 1.9968 
Day 1 -22.33500 4.31357 .063 -45.9571 1.2871 
Day 2 -101.83500
*
 10.76085 .005 -161.1542 -42.5158 
Day 3 -223.39000
*
 5.37614 .000 -252.9133 -193.8667 
Day 4 -114.16667
*
 14.51770 .011 -194.2414 -34.0919 
Day 5 -62.00167
*
 6.53721 .004 -97.9599 -26.0434 
Day 6 -34.16833
*
 4.73404 .015 -60.1275 -8.2092 
Day 7 -20.88667
*
 2.04054 .002 -31.7707 -10.0027 
Day 8 -12.05667
*
 1.27161 .002 -18.5163 -5.5970 
Day 9 -3.33333 1.10299 .356 -8.8054 2.1387 
*. The mean difference is significant at the 0.05 level. 
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Appendix F 
 
Raw data of trophozoite count in CN isolates of T. vaginalis for concentration of 10
5 
T. 
vaginalis/ml 
 
Isolates : Cervical neoplasia (CN) 1 
Days 
No of trophozoites x 10
5 
T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts 
1 50 68 70 62.67 11.02 -11.02 
2 122 135 106 121.00 14.53 -14.53 
3 333 397 355 361.67 32.52 -32.52 
4 245 229 237 237.00 8.00 -8.00 
5 77 75 44 65.33 18.50 -18.50 
6 3 4 2 3.00 1.00 -1.00 
7 0 0 0 0.00 0.00 0.00 
       
Isolates : Cervical neoplasia (CN) 2 
Days 
No of trophozoites x 10
5 
T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts 
1 39 19 37 31.67 11.02 -11.02 
2 156 166 128 150.00 19.70 -19.70 
3 390 400 321 370.33 43.02 -43.02 
4 200 222 242 221.33 21.01 -21.01 
5 32 49 21 34.00 14.11 -14.11 
6 4 5 10 6.33 3.21 -3.21 
7 0 0 0 0.00 0.00 0.00 
       
Isolates : Cervical neoplasia (CN) 3 
Days 
No of trophozoites x 10
5 
T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts 
1 39 46 39 41.33 4.04 -4.04 
2 153 154 112 139.67 23.97 -23.97 
3 453 500 578 510.33 63.14 -63.14 
4 287 249 266 267.33 19.04 -19.04 
5 45 40 38 41.00 3.61 -3.61 
6 21 11 9 13.67 6.43 -6.43 
7 0 0 0 0.00 0.00 0.00 
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Isolates : Cervical neoplasia (CN) 4 
Days 
No of trophozoites x 10
5 
T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts 
1 89 77 70 78.67 9.61 -9.61 
2 143 133 149 141.67 8.08 -8.08 
3 375 412 477 421.33 51.64 -51.64 
4 251 222 210 227.67 21.08 -21.08 
5 100 98 75 91.00 13.89 -13.89 
6 13 25 33 23.67 10.07 -10.07 
7 0 0 0 0.00 0.00 0.00 
       
Isolates : Cervical neoplasia (CN) 5 
Days 
No of trophozoites x 10
5 
T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts 
1 30 36 39 35.00 4.58 -4.58 
2 175 177 151 167.67 14.47 -14.47 
3 399 380 418 399.00 19.00 -19.00 
4 205 237 212 218.00 16.82 -16.82 
5 78 37 45 53.33 21.73 -21.73 
6 1 0 0 0.33 0.58 -0.58 
7 0 0 0 0.00 0.00 0.00 
       
Isolates : Cervical neoplasia (CN) 6 
Days 
No of trophozoites x 10
5 
T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts 
1 35 49 69 51.00 17.09 -17.09 
2 103 124 155 127.33 26.16 -26.16 
3 521 498 519 512.67 12.74 -12.74 
4 259 230 203 230.67 28.01 -28.01 
5 111 121 97 109.67 12.06 -12.06 
6 40 37 23 33.33 9.07 -9.07 
7 0 0 0 0.00 0.00 0.00 
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Appendix G 
 
1. Raw data on average mean of amoeboid form in six CN isolates (CN1-CN6) at 
10
5 
T. vaginalis/ml (overcrowding of parasites). 
Isolates : Cervical neoplasia (CN) 1 
Days 
No of amoeboid x 10
5 
T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 1 1 2 1.33 0.58 -0.58 
2 3 3 3 3.00 0.00 0.00 
3 10 4 8 7.33 3.06 -3.06 
4 1 2 2 1.67 0.58 -0.58 
5 0 0 0 0.00 0.00 0.00 
       
Isolates : Cervical neoplasia (CN) 2 
Days 
No of amoeboid x 10
5 
T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 1 4 1 2.00 1.73 -1.73 
2 5 5 6 5.33 0.58 -0.58 
3 11 20 12 14.33 4.93 -4.93 
4 1 2 1 1.33 0.58 -0.58 
5 0 0 0 0.00 0.00 0.00 
 
Isolates : Cervical neoplasia (CN) 3 
Days 
No of amoeboid x 10
5 
T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 1 2 1 1.33 0.58 -0.58 
2 7 8 6 7.00 1.00 -1.00 
3 10 5 8 7.67 2.52 -2.52 
4 0 0 1 0.33 0.58 -0.58 
5 0 0 0 0.00 0.00 0.00 
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Isolates : Cervical neoplasia (CN) 4 
Days 
No of amoeboid x 10
5 
T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 3 5 2 3.33 1.53 -1.53 
2 11 10 8 9.67 1.53 -1.53 
3 15 15 9 13.00 3.46 -3.46 
4 3 2 0 1.67 1.53 -1.53 
5 0 0 0 0.00 0.00 0.00 
 
       
Isolates : Cervical neoplasia (CN) 5 
Days 
No of amoeboid x 10
4 
T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 1 4 4 3.00 1.73 -1.73 
2 3 9 10 7.33 3.79 -3.79 
3 5 11 12 9.33 3.79 -3.79 
4 1 1 3 1.67 1.15 -1.15 
5 0 0 0 0.00 0.00 0.00 
       
Isolates : Cervical neoplasia (CN) 6 
Days 
No of amoeboid x 10
5 
T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 2 2 2 2.00 0.00 0.00 
2 3 5 5 4.33 1.15 -1.15 
3 7 7 9 7.67 1.15 -1.15 
4 1 2 0 1.00 1.00 -1.00 
5 0 0 0 0.00 0.00 0.00 
 
 
 
 
 
 
 
 
 
 
147 
 
Appendix H 
Raw data on average mean of amoeboid forms in six CN isolates (CN1-CN6) for 
different horse serum concentrations. 
1. 10 % horse serum concentrations 
Horse serum concentrations : 10% 
Isolates : Cervical neoplasia (CN) 1 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 3 2 2 2.33 0.58 -0.58 
3 3 3 2 2.67 0.58 -0.58 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
 
Isolates : Cervical neoplasia (CN) 2 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0  
2 3 1 2 2.00 1.00 -1.00  
3 3 1 3 2.33 1.15 - 1.15  
4 0 0 0 0.00 0.00  0 
5 0 0 0 0.00 0.00 0  
 
Isolates : Cervical neoplasia (CN) 3 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 1 1 2 1.33 0.58 -0.58 
3 3 2 2 2.33 0.58 -0.58 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
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Isolates : Cervical neoplasia (CN) 5 
Days 
No of amoeboid x 10
4 
T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 1 0 0.33 0.58 -0.58 
2 1 2 0 1.00 1.00 -1.00 
3 3 3 3 3.00 0.00 0.00 
4 0 1 0 0.33 0.58 -0.58 
5 0 0 0 0.00 0.00 0.00 
       
Isolates : Cervical neoplasia (CN) 6 
Days 
No of amoeboid x 10
4 
T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 0 2 0 0.67 1.15 -1.15 
3 3 4 6 4.33 1.53 -1.53 
4 1 2 0 1.00 1.00 -1.00 
5 0 0 0 0.00 0.00 0.00 
 
 
 
 
 
 
 
 
 
 
Isolates : Cervical neoplasia (CN) 4 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 0 0 1 0.33 0.58 -0.58 
3 1 2 2 1.67 0.58 -0.58 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
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2. 5%  horse serum concentrations 
Horse serum concentrations : 5% 
Isolates : Cervical neoplasia (CN) 1 
Days 
No of amoeboid x 10
4 
T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 0 1 0 0.33 0.58 -0.58 
3 4 2 3 3.00 1.00 -1.00 
4 1 1 0 0.67 0.58 -0.58 
5 0 0 0 0.00 0.00 0.00 
    
Isolates : Cervical neoplasia (CN) 2 
Days 
No of amoeboid x 10
4 
T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 1 0 0 0.33 0.58 -0.58 
3 2 2 2 2.00 0.00 0.00 
4 1 0 1 0.67 0.58 -0.58 
5 0 0 0 0.00 0.00 0.00 
     
Isolates : Cervical neoplasia (CN) 3 
Days 
No of amoeboid x 10
4 
T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 1 0 0 0.33 0.58 -0.58 
2 1 1 1 1.00 0.00 0.00 
3 3 2 2 2.33 0.58 -0.58 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
 
Isolates : Cervical neoplasia (CN) 4 
Days 
No of amoeboid x 10
4 
T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 1 2 0 1.00 1.00 -1.00 
3 2 2 2 2.00 0.00 0.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
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Isolates : Cervical neoplasia (CN) 5 
Days 
No of amoeboid x 10
4 
T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 1 0 0.33 0.58 -0.58 
2 0 2 0 0.67 1.15 -1.15 
3 3 3 3 3.00 0.00 0.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
    
Isolates : Cervical neoplasia (CN) 6 
Days 
No of amoeboid x 10
4 
T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 1 0 0.33 0.58 -0.58 
2 1 2 0 1.00 1.00 -1.00 
3 2 5 6 4.33 2.08 -2.08 
4 1 0 0 0.33 0.58 -0.58 
5 0 0 0 0.00 0.00 0.00 
 
3. 15 %  horse serum concentrations 
Horse serum concentrations : 15% 
Isolates : Cervical neoplasia (CN) 1 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 3 1 0 1.33 1.53 -1.53 
2 2 9 2 4.33 4.04 -4.04 
3 6 7 3 5.33 2.08 -2.08 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
      
Isolates : Cervical neoplasia (CN) 2 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 2 1 0 1.00 1.00 -1.00 
2 7 4 2 4.33 2.52 -2.52 
3 1 3 2 2.00 1.00 -1.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
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Isolates : Cervical neoplasia (CN) 3 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 1 0 0.33 0.58 -0.58 
2 3 5 7 5.00 2.00 -2.00 
3 1 3 2 2.00 1.00 -1.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
 
Isolates : Cervical neoplasia (CN) 4 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 1 0 0 0.33 0.58 -0.58 
2 2 4 6 4.00 2.00 -2.00 
3 4 6 3 4.33 1.53 -1.53 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
      
Isolates : Cervical neoplasia (CN) 5 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 10 5 6 7.00 2.65 -2.65 
3 6 8 9 7.67 1.53 -1.53 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
      
Isolates : Cervical neoplasia (CN) 6 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 6 8 9 7.67 1.53 -1.53 
3 5 3 1 3.00 2.00 -2.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
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4. Raw data on average mean of amoeboid form in six CN isolates (CN1-CN6) for 
20 %  horse serum concentrations 
Horse serum concentrations : 20% 
Isolates : Cervical neoplasia (CN) 1 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 2 5 3 3.33 1.53 -1.53 
3 2 3 2 2.33 0.58 -0.58 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
      
Isolates : Cervical neoplasia (CN) 2 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 3 8 5 5.33 2.52 -2.52 
3 3 3 2 2.67 0.58 -0.58 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
     
Isolates : Cervical neoplasia (CN) 3 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 2 4 5 3.67 1.53 -1.53 
3 3 3 2 2.67 0.58 -0.58 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
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Isolates : Cervical neoplasia (CN) 4 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 5 2 4 3.67 1.53 -1.53 
3 2 1 3 2.00 1.00 -1.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
Isolates : Cervical neoplasia (CN) 5 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 5 5 3 4.33 1.15 -1.15 
3 3 4 5 4.00 1.00 -1.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
      
Isolates : Cervical neoplasia (CN) 6 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 2 2 2 2.00 0.00 0.00 
3 3 2 1 2.00 1.00 -1.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
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Appendix I 
Raw data on average mean of amoeboid forms in six CN isolates (CN1-CN6) for 
different concentrations of metronidazole drug. 
 
1. 0.001 mg/ml of metronidazole drug 
 
Metro drug : 0.001 mg/ml 
Isolates : Cervical neoplasia (CN) 1 
Days 
No of amoeboid x 10
4 
T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 2 1 2 1.67 0.58 -0.58 
3 0 0 0 0.00 0.00 0.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
    
Isolates : Cervical neoplasia (CN) 2 
Days 
No of amoeboid x 10
4 
T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 2 2 1 1.67 0.58 -0.58 
3 0 0 0 0.00 0.00 0.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
     
Isolates : Cervical neoplasia (CN) 3 
Days 
No of amoeboid x 10
4 
T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 2 2 3 2.33 0.58 -0.58 
3 0 0 0 0.00 0.00 0.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
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Isolates : Cervical neoplasia (CN) 4 
Days 
No of amoeboid x 10
4 
T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 2 2 1 1.67 0.58 -0.58 
3 0 0 0 0.00 0.00 0.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
 
 
   
Isolates : Cervical neoplasia (CN) 5 
Days 
No of amoeboid x 10
4 
T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 1 0 2 1.00 1.00 -1.00 
3 0 0 0 0.00 0.00 0.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
 
Isolates : Cervical neoplasia (CN) 6 
Days 
No of amoeboid x 10
4 
T. vaginalis/ml 
Standard 
Deviation (±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 1 1 1 1.00 0.00 0.00 
3 0 0 0 0.00 0.00 0.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
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2. 0.0001 mg/ml of metronidazole drug 
Metro drug : 0.0001 mg/ml 
Isolates : Cervical neoplasia (CN) 1 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 1 2 1 1.33 0.58 -0.58 
3 2 2 2 2.00 0.00 0.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
    
Isolates : Cervical neoplasia (CN) 2 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00   
2 2 3 2 2.33 0.58   
3 3 1 2 2.00 1.00   
4 0 0 0 0.00 0.00   
5 0 0 0 0.00 0.00   
    
Isolates : Cervical neoplasia (CN) 3 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 1 1 2 1.33 0.58 -0.58 
3 4 1 2 2.33 1.53 -1.53 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
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Isolates : Cervical neoplasia (CN) 4 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 1 0 1 0.67 0.58 -0.58 
3 2 2 4 2.67 1.15 -1.15 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
    
Isolates : Cervical neoplasia (CN) 5 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 1 1 1 1.00 0.00 0.00 
3 3 3 2 2.67 0.58 -0.58 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
    
Isolates : Cervical neoplasia (CN) 6 
Days 
No of amoeboid x 10
4 
 T. vaginalis/ml Standard 
Deviation 
(±) Replicate 1 Replicate 2 Replicate 3 
Average 
counts  
1 0 0 0 0.00 0.00 0.00 
2 0 1 0 0.33 0.58 -0.58 
3 5 3 1 3.00 2.00 -2.00 
4 0 0 0 0.00 0.00 0.00 
5 0 0 0 0.00 0.00 0.00 
Control  
No of amoeboid x 10
4 
 T. vaginalis/ml 
Average 
counts  
DAY1 DAY 2 DAY 3 DAY 4 
DAY 
5 
CN1 0 2 3 1 0 6.00 ± 1.30 
CN2 0 3 3 1 0 7.00 ± 1.52 
CN3 0 2 2 1 0 5.00 ± 1.00 
CN4 0 3 2 0 0 5.00 ± 1.41 
CN5 0 3 2 0 0 5.00 ± 1.41 
CN6 0 2 3 1 0 6.00 ± 1.30 
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Appendix J 
Statistical analysis of average amoeboid forms in CN isolates of T. vaginalis between 10
4 
T. vaginalis/ml and 10
5 
T. vaginalis/ml 
 
 
 
Output:  p-value is less than 0.05 (bold), thus there is a significant difference in average amoeboid count between days for the two cell 
concentrations. Average amoeboid forms in 10
5 
T. vaginalis/ml is higher than in 10
4 
T. vaginalis/ml in day 1 to day 4. 
Independent Samples Test 
 Levene's Test for 
Equality of Variances 
t-test for Equality of Means 
F Sig. T df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Day 1 
Equal variances 
assumed 
9.512 .012 -5.893 10 .000 -2.05500 .34874 -2.83204 -1.27796 
Equal variances not 
assumed 
  
-5.893 5.414 .002 -2.05500 .34874 -2.93124 -1.17876 
Day 2 
Equal variances 
assumed 
12.347 .006 -5.280 10 .000 -5.16500 .97829 -7.34477 -2.98523 
Equal variances not 
assumed 
  
-5.280 5.109 .003 -5.16500 .97829 -7.66378 -2.66622 
Day 3 
Equal variances 
assumed 
13.950 .004 -5.256 10 .000 -6.66500 1.26815 -9.49061 -3.83939 
Equal variances not 
assumed 
  
-5.256 5.462 .003 -6.66500 1.26815 -9.84361 -3.48639 
Day 4 
Equal variances 
assumed 
1.930 .195 -3.155 10 .010 -.78000 .24726 -1.33094 -.22906 
Equal variances not 
assumed 
  
-3.155 7.549 .015 -.78000 .24726 -1.35618 -.20382 
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Appendix K 
 
Statistical analysis between different concentrations of horse serum for amoeboid forms in CN isolates (CN1-CN6) using Dunnett 
T3. 
 
Multiple Comparisons 
Dependent Variable: Average amoeboid count  
 Dunnett T3 
(I) Different horse serum 
concentrations 
(J) Different horse serum 
concentrations 
Mean 
Difference (I-J) 
Std. Error Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
1% 
5% -3.94500
*
 .45058 .002 -5.8878 -2.0022 
10% -4.33333
*
 .43016 .001 -6.1880 -2.4786 
15% -9.94500
*
 1.14406 .002 -14.8778 -5.0122 
20% -6.33333
*
 .66053 .001 -9.1813 -3.4854 
5% 
1% 3.94500
*
 .45058 .002 2.0022 5.8878 
10% -.38833 .62295 .999 -2.5493 1.7727 
15% -6.00000
*
 1.22959 .017 -10.7881 -1.2119 
20% -2.38833 .79958 .118 -5.2417 .4651 
10% 
1% 4.33333
*
 .43016 .001 2.4786 6.1880 
5% .38833 .62295 .999 -1.7727 2.5493 
15% -5.61167
*
 1.22226 .024 -10.4034 -.8200 
20% -2.00000 .78825 .227 -4.8315 .8315 
15% 
1% 9.94500
*
 1.14406 .002 5.0122 14.8778 
5% 6.00000
*
 1.22959 .017 1.2119 10.7881 
10% 5.61167
*
 1.22226 .024 .8200 10.4034 
20% 3.61167 1.32105 .180 -1.2235 8.4468 
20% 
1% 6.33333
*
 .66053 .001 3.4854 9.1813 
5% 2.38833 .79958 .118 -.4651 5.2417 
10% 2.00000 .78825 .227 -.8315 4.8315 
15% -3.61167 1.32105 .180 -8.4468 1.2235 
*. The mean difference is significant at the 0.05 level. 
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Appendix L 
Statistical analysis between different concentrations of metronidazole drug for amoeboid forms in CN isolates (CN1-CN6) using 
Tukey HSD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Output: 
p-value is less than 0.05. Hence there is a significant difference of average amoeboid forms between different concentrations of 
metronidazole drug with significantly higher count in control. Between the two concentrations, average amoeboid forms in 0.0001 
mg/ml were significantly higher than in 0.001 mg/ml. 
Multiple Comparisons 
Dependent Variable: Average count  
 Tukey HSD 
 
(I) Effect of 
metronidazole drug 
(J) Effect of 
metronidazole drug 
Mean 
Difference (I-
J) 
Std. Error Sig. 95% Confidence Interval 
Lower 
Bound 
Upper Bound 
Control 
0.001 7.11000
*
 .40416 .000 6.0602 8.1598 
0.0001 5.05667
*
 .40416 .000 4.0069 6.1065 
0.001 
Control -7.11000
*
 .40416 .000 -8.1598 -6.0602 
0.0001 -2.05333
*
 .40416 .000 -3.1031 -1.0035 
0.0001 
Control -5.05667
*
 .40416 .000 -6.1065 -4.0069 
0.001 2.05333
*
 .40416 .000 1.0035 3.1031 
*. The mean difference is significant at the 0.05 level. 
